<!DOCTYPE html>
<html lang="en" class="no-js">
    <head>
        <title>Bioinformatics-based identification of miR-542-5p as a predictive biomarker in breast cancer therapy | Hereditas | Full Text</title>

        

    <meta name="citation_abstract" content="Tamoxifen is the first-line hormone therapy for estrogen receptor alpha positive (ERα+) breast cancer. However, about 40% of patients with ERα + breast cancer who receive tamoxifen therapy eventually develop resistance resulting in a poor prognosis. The aim of this study was to mine available data sets in the Gene Expression Omnibus (GEO) database, including in vitro (cell lines) and in vivo (tissue samples), and to identify all miRNAs associated with tamoxifen resistance (TamR) in breast cancer. Secondly, this study aimed to predict the key gene regulatory networks of newly found TamR-related miRNAs and evaluate the potential role of the miRNAs and targets as potential prognosis biomarkers for breast cancer patients. Microarray data sets from two different studies were used from the GEO database: 1. GSE66607: miRNA of MCF-7 TamR cells; 2. GSE37405: TamR tissues. Differentially expressed microRNAs (miRNAs) were identified in both data sets and 5 differentially expressed miRNAs were found to overlap between the two data sets. Profiles of GSE37405 and data from the Kaplan-Meier Plotter Database (KMPD) along with Gene Expression Profiling Interactive Analysis (GEPIA) were used to reveal the relationship between these 5 miRNAs and overall survival. The results showed that has-miR-542-5p was the only miRNA associated with overall survival of ERα + breast cancer patients who received adjuvant tamoxifen. Targets of has-miR-542-5p were predicted by miRanda and TargetScan, and the mRNA expression of the three 3 target gene, Tyrosine 3-Monooxygenase/Tryptophan 5-Monooxygenase Activation Protein Beta (YWHAB), Lymphocyte Antigen 9 (LY9), and Secreted Frizzled Related Protein 1 (SFRP1) were associated with overall survival in 2 different databases. Copy-number alterations (CNAs) of SFRP1 confer survival disadvantage to breast cancer patients and alter the mRNA expression of SFRP1 in cBioPortal database. This study indicates that miRNA has-miR-542-5p is associated with TamR and can predict prognosis of breast cancer patients. Furthermore, has-miR-542-5p may be acting through a mechanism involving the target genes YWHAB, LY9, and SFRP1. Overall, has-miR-542-5p is a predictive biomarker and potential target for therapy of breast cancer patients."/>

    <meta name="description" content="Tamoxifen is the first-line hormone therapy for estrogen receptor alpha positive (ERα+) breast cancer. However, about 40% of patients with ERα + breast cancer who receive tamoxifen therapy eventually develop resistance resulting in a poor prognosis. The aim of this study was to mine available data sets in the Gene Expression Omnibus (GEO) database, including in vitro (cell lines) and in vivo (tissue samples), and to identify all miRNAs associated with tamoxifen resistance (TamR) in breast cancer. Secondly, this study aimed to predict the key gene regulatory networks of newly found TamR-related miRNAs and evaluate the potential role of the miRNAs and targets as potential prognosis biomarkers for breast cancer patients. Microarray data sets from two different studies were used from the GEO database: 1. GSE66607: miRNA of MCF-7 TamR cells; 2. GSE37405: TamR tissues. Differentially expressed microRNAs (miRNAs) were identified in both data sets and 5 differentially expressed miRNAs were found to overlap between the two data sets. Profiles of GSE37405 and data from the Kaplan-Meier Plotter Database (KMPD) along with Gene Expression Profiling Interactive Analysis (GEPIA) were used to reveal the relationship between these 5 miRNAs and overall survival. The results showed that has-miR-542-5p was the only miRNA associated with overall survival of ERα + breast cancer patients who received adjuvant tamoxifen. Targets of has-miR-542-5p were predicted by miRanda and TargetScan, and the mRNA expression of the three 3 target gene, Tyrosine 3-Monooxygenase/Tryptophan 5-Monooxygenase Activation Protein Beta (YWHAB), Lymphocyte Antigen 9 (LY9), and Secreted Frizzled Related Protein 1 (SFRP1) were associated with overall survival in 2 different databases. Copy-number alterations (CNAs) of SFRP1 confer survival disadvantage to breast cancer patients and alter the mRNA expression of SFRP1 in cBioPortal database. This study indicates that miRNA has-miR-542-5p is associated with TamR and can predict prognosis of breast cancer patients. Furthermore, has-miR-542-5p may be acting through a mechanism involving the target genes YWHAB, LY9, and SFRP1. Overall, has-miR-542-5p is a predictive biomarker and potential target for therapy of breast cancer patients."/>

    <meta name="journal_id" content="41065"/>

    <meta name="dc.title" content="Bioinformatics-based identification of miR-542-5p as a predictive biomarker in breast cancer therapy"/>

    <meta name="dc.source" content="Hereditas 2018 155:1"/>

    <meta name="dc.format" content="text/html"/>

    <meta name="dc.publisher" content="BioMed Central"/>

    <meta name="dc.date" content="2018-01-15"/>

    <meta name="dc.type" content="OriginalPaper"/>

    <meta name="dc.language" content="En"/>

    <meta name="dc.copyright" content="2018 The Author(s)"/>

    <meta name="dc.rightsAgent" content="reprints@biomedcentral.com"/>

    <meta name="dc.description" content="Tamoxifen is the first-line hormone therapy for estrogen receptor alpha positive (ER&#945;+) breast cancer. However, about 40% of patients with ER&#945;&#8201;+&#8201;breast cancer who receive tamoxifen therapy eventually develop resistance resulting in a poor prognosis. The aim of this study was to mine available data sets in the Gene Expression Omnibus (GEO) database, including in vitro (cell lines) and in vivo (tissue samples), and to identify all miRNAs associated with tamoxifen resistance (TamR) in breast cancer. Secondly, this study aimed to predict the key gene regulatory networks of newly found TamR-related miRNAs and evaluate the potential role of the miRNAs and targets as potential prognosis biomarkers for breast cancer patients. Microarray data sets from two different studies were used from the GEO database: 1. GSE66607: miRNA of MCF-7 TamR cells; 2. GSE37405: TamR tissues. Differentially expressed microRNAs (miRNAs) were identified in both data sets and 5 differentially expressed miRNAs were found to overlap between the two data sets. Profiles of GSE37405 and data from the Kaplan-Meier Plotter Database (KMPD) along with Gene Expression Profiling Interactive Analysis (GEPIA) were used to reveal the relationship between these 5 miRNAs and overall survival. The results showed that has-miR-542-5p was the only miRNA associated with overall survival of ER&#945;&#8201;+&#8201;breast cancer patients who received adjuvant tamoxifen. Targets of has-miR-542-5p were predicted by miRanda and TargetScan, and the mRNA expression of the three 3 target gene, Tyrosine 3-Monooxygenase/Tryptophan 5-Monooxygenase Activation Protein Beta (YWHAB), Lymphocyte Antigen 9 (LY9), and Secreted Frizzled Related Protein 1 (SFRP1) were associated with overall survival in 2 different databases. Copy-number alterations (CNAs) of SFRP1 confer survival disadvantage to breast cancer patients and alter the mRNA expression of SFRP1 in cBioPortal database. This study indicates that miRNA has-miR-542-5p is associated with TamR and can predict prognosis of breast cancer patients. Furthermore, has-miR-542-5p may be acting through a mechanism involving the target genes YWHAB, LY9, and SFRP1. Overall, has-miR-542-5p is a predictive biomarker and potential target for therapy of breast cancer patients."/>

    <meta name="prism.issn" content="1601-5223"/>

    <meta name="prism.publicationName" content="Hereditas"/>

    <meta name="prism.publicationDate" content="2018-01-15"/>

    <meta name="prism.volume" content="155"/>

    <meta name="prism.number" content="1"/>

    <meta name="prism.section" content="OriginalPaper"/>

    <meta name="prism.startingPage" content="17"/>

    <meta name="prism.copyright" content="2018 The Author(s)"/>

    <meta name="prism.rightsAgent" content="reprints@biomedcentral.com"/>

    <meta name="prism.url" content="https://hereditasjournal.biomedcentral.com/articles/10.1186/s41065-018-0055-7"/>

    <meta name="prism.doi" content="doi:10.1186/s41065-018-0055-7"/>

    <meta name="citation_pdf_url" content="https://hereditasjournal.biomedcentral.com/track/pdf/10.1186/s41065-018-0055-7"/>

    <meta name="citation_fulltext_html_url" content="https://hereditasjournal.biomedcentral.com/articles/10.1186/s41065-018-0055-7"/>

    <meta name="citation_journal_title" content="Hereditas"/>

    <meta name="citation_publisher" content="BioMed Central"/>

    <meta name="citation_issn" content="1601-5223"/>

    <meta name="citation_title" content="Bioinformatics-based identification of miR-542-5p as a predictive biomarker in breast cancer therapy"/>

    <meta name="citation_volume" content="155"/>

    <meta name="citation_issue" content="1"/>

    <meta name="citation_publication_date" content="2018/12"/>

    <meta name="citation_online_date" content="2018/01/15"/>

    <meta name="citation_firstpage" content="17"/>

    <meta name="citation_article_type" content="Research"/>

    <meta name="citation_fulltext_world_readable" content=""/>

    <meta name="dc.identifier" content="doi:10.1186/s41065-018-0055-7"/>

    <meta name="DOI" content="10.1186/s41065-018-0055-7"/>

    <meta name="citation_doi" content="10.1186/s41065-018-0055-7"/>

    <meta name="dc.creator" content="Qiong-Ni Zhu"/>

    <meta name="dc.creator" content="Helen Renaud"/>

    <meta name="dc.creator" content="Ying Guo"/>

    <meta name="dc.subject" content="Animal Genetics and Genomics"/>

    <meta name="dc.subject" content="Evolutionary Biology"/>

    <meta name="citation_reference" content="citation_journal_title=Journal of the National Comprehensive Cancer Network : JNCCN; citation_title=Invasive breast cancer version 1.2016, NCCN clinical practice guidelines in oncology; citation_author=WJ Gradishar, BO Anderson, R Balassanian, SL Blair, HJ Burstein, A Cyr, AD Elias, WB Farrar, A Forero, SH Giordano; citation_volume=14; citation_publication_date=2016; citation_pages=324-354; citation_doi=10.6004/jnccn.2016.0037; citation_id=CR1"/>

    <meta name="citation_reference" content="citation_journal_title=Oncologist; citation_title=Breast cancer disparities: a multicenter comparison of tumor diagnosis, characteristics, and surgical treatment in China and the US; citation_author=PG Sivasubramaniam, B-L Zhang, Q Zhang, JS Smith, B Zhang, Z-H Tang, G-J Chen, X-M Xie, X X-Z, H-J Yang; citation_volume=20; citation_publication_date=2015; citation_pages=1044-1050; citation_doi=10.1634/theoncologist.2014-0290; citation_id=CR2"/>

    <meta name="citation_reference" content="citation_journal_title=Int J Cancer; citation_title=The pathologic characteristics of breast cancer in China and its shift during 1999-2008: a national-wide multicenter cross-sectional image over 10 years; citation_author=S Zheng, JQ Bai, J Li, JH Fan, Y Pang, QK Song, R Huang, HJ Yang, F Xu, N Lu, YL Qiao; citation_volume=131; citation_publication_date=2012; citation_pages=2622-2631; citation_doi=10.1002/ijc.27513; citation_id=CR3"/>

    <meta name="citation_reference" content="citation_journal_title=Endocr Relat Cancer; citation_title=Mechanisms of tamoxifen resistance; citation_author=A Ring, M Dowsett; citation_volume=11; citation_publication_date=2004; citation_pages=643-658; citation_doi=10.1677/erc.1.00776; citation_id=CR4"/>

    <meta name="citation_reference" content="citation_journal_title=Asian Pacific journal of cancer prevention : APJCP; citation_title=Age of diagnosis of breast cancer in china: almost 10 years earlier than in the United States and the European union; citation_author=QK Song, J Li, R Huang, JH Fan, RS Zheng, BN Zhang, B Zhang, ZH Tang, XM Xie, HJ Yang; citation_volume=15; citation_publication_date=2014; citation_pages=10021-10025; citation_doi=10.7314/APJCP.2014.15.22.10021; citation_id=CR5"/>

    <meta name="citation_reference" content="citation_journal_title=Oncol Rep; citation_title=Mechanisms associated with resistance to tamoxifen in estrogen receptor-positive breast cancer (review); citation_author=R Viedma-Rodriguez, L Baiza-Gutman, F Salamanca-Gomez, M Diaz-Zaragoza, G Martinez-Hernandez, R Ruiz Esparza-Garrido, MA Velazquez-Flores, D Arenas-Aranda; citation_volume=32; citation_publication_date=2014; citation_pages=3-15; citation_doi=10.3892/or.2014.3190; citation_id=CR6"/>

    <meta name="citation_reference" content="citation_journal_title=Cancer biology &amp; therapy; citation_title=Network-based approach to identify prognostic biomarkers for estrogen receptor-positive breast cancer treatment with tamoxifen; citation_author=R Liu, CX Guo, HH Zhou; citation_volume=16; citation_publication_date=2015; citation_pages=317-324; citation_doi=10.1080/15384047.2014.1002360; citation_id=CR7"/>

    <meta name="citation_reference" content="citation_journal_title=Curr Med Chem; citation_title=Tamoxifen resistance and epigenetic modifications in breast cancer cell lines; citation_author=E Badia, J Oliva, P Balaguer, V Cavailles; citation_volume=14; citation_publication_date=2007; citation_pages=3035-3045; citation_doi=10.2174/092986707782794023; citation_id=CR8"/>

    <meta name="citation_reference" content="citation_journal_title=Nat Rev Cancer; citation_title=Epigenetics and genetics. MicroRNAs en route to the clinic: progress in validating and targeting microRNAs for cancer therapy; citation_author=AL Kasinski, FJ Slack; citation_volume=11; citation_publication_date=2011; citation_pages=849-864; citation_doi=10.1038/nrc3166; citation_id=CR9"/>

    <meta name="citation_reference" content="citation_journal_title=BioEssays : news and reviews in molecular, cellular and developmental biology; citation_title=MicroRNA binding sites in the coding region of mRNAs: extending the repertoire of post-transcriptional gene regulation; citation_author=A Brummer, J Hausser; citation_volume=36; citation_publication_date=2014; citation_pages=617-626; citation_doi=10.1002/bies.201300104; citation_id=CR10"/>

    <meta name="citation_reference" content="citation_journal_title=Endocr Relat Cancer; citation_title=Roles for miRNAs in endocrine resistance in breast cancer; citation_author=P Muluhngwi, CM Klinge; citation_volume=22; citation_publication_date=2015; citation_pages=R279-R300; citation_doi=10.1530/ERC-15-0355; citation_id=CR11"/>

    <meta name="citation_reference" content="citation_journal_title=PLoS One; citation_title=Global microRNA expression profiling of high-risk ER+ breast cancers from patients receiving adjuvant tamoxifen mono-therapy: a DBCG study; citation_author=MB Lyng, AV Laenkholm, R Sokilde, KH Gravgaard, T Litman, HJ Ditzel; citation_volume=7; citation_publication_date=2012; citation_doi=10.1371/journal.pone.0036170; citation_id=CR12"/>

    <meta name="citation_reference" content="citation_journal_title=Oncotarget; citation_title=Integrative analysis of miRNA and gene expression reveals regulatory networks in tamoxifen-resistant breast cancer; citation_author=T Joshi, D Elias, J Stenvang, CL Alves, F Teng, MB Lyng, AE Lykkesfeldt, N Brunner, J Wang, R Gupta; citation_volume=7; citation_publication_date=2016; citation_pages=57239-57253; citation_id=CR13"/>

    <meta name="citation_reference" content="citation_journal_title=Proc Natl Acad Sci U S A; citation_title=Antiestrogen-resistant subclones of MCF-7 human breast cancer cells are derived from a common monoclonal drug-resistant progenitor; citation_author=KR Coser, BS Wittner, NF Rosenthal, SC Collins, A Melas, SL Smith, CJ Mahoney, K Shioda, KJ Isselbacher, S Ramaswamy, T Shioda; citation_volume=106; citation_publication_date=2009; citation_pages=14536-14541; citation_doi=10.1073/pnas.0907560106; citation_id=CR14"/>

    <meta name="citation_reference" content="citation_journal_title=J Pathol; citation_title=MicroRNA-519a is a novel oncomir conferring tamoxifen resistance by targeting a network of tumour-suppressor genes in ER+ breast cancer; citation_author=A Ward, K Shukla, A Balwierz, Z Soons, R Konig, O Sahin, S Wiemann; citation_volume=233; citation_publication_date=2014; citation_pages=368-379; citation_doi=10.1002/path.4363; citation_id=CR15"/>

    <meta name="citation_reference" content="citation_journal_title=Biochem Biophys Res Commun; citation_title=MiR-27b is epigenetically downregulated in tamoxifen resistant breast cancer cells due to promoter methylation and regulates tamoxifen sensitivity by targeting HMGB3; citation_author=X Li, Y Wu, A Liu, X Tang; citation_volume=477; citation_publication_date=2016; citation_pages=768-773; citation_doi=10.1016/j.bbrc.2016.06.133; citation_id=CR16"/>

    <meta name="citation_reference" content="citation_journal_title=Sci Rep; citation_title=MicroRNA-320a sensitizes tamoxifen-resistant breast cancer cells to tamoxifen by targeting ARPP-19 and ERRgamma; citation_author=M Lu, K Ding, G Zhang, M Yin, G Yao, H Tian, J Lian, L Liu, M Liang, T Zhu, F Sun; citation_volume=5; citation_publication_date=2015; citation_pages=8735; citation_doi=10.1038/srep08735; citation_id=CR17"/>

    <meta name="citation_reference" content="citation_journal_title=Sci Rep; citation_title=miR-378a-3p modulates tamoxifen sensitivity in breast cancer MCF-7 cells through targeting GOLT1A; citation_author=K Ikeda, K Horie-Inoue, T Ueno, T Suzuki, W Sato, T Shigekawa, A Osaki, T Saeki, E Berezikov, H Mano, S Inoue; citation_volume=5; citation_publication_date=2015; citation_doi=10.1038/srep13170; citation_id=CR18"/>

    <meta name="citation_reference" content="citation_journal_title=Nat Med; citation_title=Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy; citation_author=EA Collisson, A Sadanandam, P Olson, WJ Gibb, M Truitt, S Gu, J Cooc, J Weinkle, GE Kim, L Jakkula; citation_volume=17; citation_publication_date=2011; citation_pages=500-503; citation_doi=10.1038/nm.2344; citation_id=CR19"/>

    <meta name="citation_reference" content="citation_journal_title=Nucleic Acids Res; citation_title=NCBI GEO: archive for functional genomics data sets--update; citation_author=T Barrett, SE Wilhite, P Ledoux, C Evangelista, IF Kim, M Tomashevsky, KA Marshall, KH Phillippy, PM Sherman, M Holko; citation_volume=41; citation_publication_date=2013; citation_pages=D991-D995; citation_doi=10.1093/nar/gks1193; citation_id=CR20"/>

    <meta name="citation_reference" content="citation_journal_title=Breast Cancer Res Treat; citation_title=miRpower: a web-tool to validate survival-associated miRNAs utilizing expression data from 2178 breast cancer patients; citation_author=A Lanczky, A Nagy, G Bottai, G Munkacsy, A Szabo, L Santarpia, B Gyorffy; citation_volume=160; citation_publication_date=2016; citation_pages=439-446; citation_doi=10.1007/s10549-016-4013-7; citation_id=CR21"/>

    <meta name="citation_reference" content="citation_journal_title=Breast Cancer Res Treat; citation_title=An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients; citation_author=B Gyorffy, A Lanczky, AC Eklund, C Denkert, J Budczies, Q Li, Z Szallasi; citation_volume=123; citation_publication_date=2010; citation_pages=725-731; citation_doi=10.1007/s10549-009-0674-9; citation_id=CR22"/>

    <meta name="citation_reference" content="Tang Z, Li C, Kang B, Gao G, Li C, Zhang Z. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017;"/>

    <meta name="citation_reference" content="Gao J, Aksoy BA, Dogrusoz U, Dresdner G, Gross B, Sumer SO, Sun Y, Jacobsen A, Sinha R, Larsson E, et al: Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Science signaling 2013, 6:pl1."/>

    <meta name="citation_reference" content="citation_journal_title=Int J Mol Sci; citation_title=The role of MicroRNAs as predictors of response to tamoxifen treatment in breast cancer patients; citation_author=NG Egeland, S Lunde, K Jonsdottir, TH Lende, D Cronin-Fenton, B Gilje, EA Janssen, H Soiland; citation_volume=16; citation_publication_date=2015; citation_pages=24243-24275; citation_doi=10.3390/ijms161024243; citation_id=CR25"/>

    <meta name="citation_reference" content="citation_journal_title=Oncol Rep; citation_title=H19 lncRNA mediates 17beta-estradiol-induced cell proliferation in MCF-7 breast cancer cells; citation_author=H Sun, G Wang, Y Peng, Y Zeng, QN Zhu, TL Li, JQ Cai, HH Zhou, YS Zhu; citation_volume=33; citation_publication_date=2015; citation_pages=3045-3052; citation_doi=10.3892/or.2015.3899; citation_id=CR26"/>

    <meta name="citation_reference" content="citation_journal_title=Cell Death Dis; citation_title=Downregulation of microRNA-27b-3p enhances tamoxifen resistance in breast cancer by increasing NR5A2 and CREB1 expression; citation_author=J Zhu, Z Zou, P Nie, X Kou, B Wu, S Wang, Z Song, J He; citation_volume=7; citation_publication_date=2016; citation_doi=10.1038/cddis.2016.361; citation_id=CR27"/>

    <meta name="citation_reference" content="citation_journal_title=FEBS Lett; citation_title=MicroRNA-335-5p and -3p synergize to inhibit estrogen receptor alpha expression and promote tamoxifen resistance; citation_author=EC Martin, AK Conger, TJ Yan, VT Hoang, DF Miller, A Buechlein, DB Rusch, KP Nephew, BM Collins-Burow, ME Burow; citation_volume=591; citation_publication_date=2017; citation_pages=382-392; citation_doi=10.1002/1873-3468.12538; citation_id=CR28"/>

    <meta name="citation_reference" content="citation_journal_title=Cancer Lett; citation_title=Tamoxifen differentially regulates miR-29b-1 and miR-29a expression depending on endocrine-sensitivity in breast cancer cells; citation_author=P Muluhngwi, A Krishna, SL Vittitow, JT Napier, KM Richardson, M Ellis, JL Mott, CM Klinge; citation_volume=388; citation_publication_date=2016; citation_pages=230-238; citation_doi=10.1016/j.canlet.2016.12.007; citation_id=CR29"/>

    <meta name="citation_reference" content="Karimi G, Alamolhida N, Behravan J, Mosaffa F. MiR 221/222 as new players in tamoxifen resistance. Curr Pharm Des. 2016;"/>

    <meta name="citation_reference" content="citation_journal_title=Cell Oncol; citation_title=Differential expression of miR-139, miR-486 and miR-21 in breast cancer patients sub-classified according to lymph node status; citation_author=L Rask, E Balslev, R Sokilde, E Hogdall, H Flyger, J Eriksen, T Litman; citation_volume=37; citation_publication_date=2014; citation_pages=215-227; citation_doi=10.1007/s13402-014-0176-6; citation_id=CR31"/>

    <meta name="citation_reference" content="citation_journal_title=Int J Cancer; citation_title=Accurate prediction of neuroblastoma outcome based on miRNA expression profiles; citation_author=JH Schulte, B Schowe, P Mestdagh, L Kaderali, P Kalaghatgi, S Schlierf, J Vermeulen, B Brockmeyer, K Pajtler, T Thor; citation_volume=127; citation_publication_date=2010; citation_pages=2374-2385; citation_doi=10.1002/ijc.25436; citation_id=CR32"/>

    <meta name="citation_reference" content="citation_journal_title=Cancer Lett; citation_title=MicroRNA-542-5p as a novel tumor suppressor in neuroblastoma; citation_author=I Bray, A Tivnan, K Bryan, NH Foley, KM Watters, L Tracey, AM Davidoff, RL Stallings; citation_volume=303; citation_publication_date=2011; citation_pages=56-64; citation_doi=10.1016/j.canlet.2011.01.016; citation_id=CR33"/>

    <meta name="citation_reference" content="citation_journal_title=IUBMB Life; citation_title=miRNA expression in breast cancer varies with lymph node metastasis and other clinicopathologic features; citation_author=B Wang, J Li, M Sun, L Sun, X Zhang; citation_volume=66; citation_publication_date=2014; citation_pages=371-377; citation_doi=10.1002/iub.1273; citation_id=CR34"/>

    <meta name="citation_reference" content="citation_journal_title=J Pathol; citation_title=Micro-RNA signature of the epithelial-mesenchymal transition in endometrial carcinosarcoma; citation_author=MA Castilla, G Moreno-Bueno, L Romero-Perez, K Van De Vijver, M Biscuola, MA Lopez-Garcia, J Prat, X Matias-Guiu, A Cano, E Oliva, J Palacios; citation_volume=223; citation_publication_date=2011; citation_pages=72-80; citation_doi=10.1002/path.2802; citation_id=CR35"/>

    <meta name="citation_reference" content="citation_journal_title=Biomedicine &amp; pharmacotherapy = Biomedecine &amp; pharmacotherapie; citation_title=LncRNA MEG3 inhibits cell epithelial-mesenchymal transition by sponging miR-421 targeting E-cadherin in breast cancer; citation_author=W Zhang, S Shi, J Jiang, X Li, H Lu, F Ren; citation_volume=91; citation_publication_date=2017; citation_pages=312-319; citation_doi=10.1016/j.biopha.2017.04.085; citation_id=CR36"/>

    <meta name="citation_reference" content="citation_journal_title=Biomedicine &amp; pharmacotherapy = Biomedecine &amp; pharmacotherapie; citation_title=MicroRNA-421 inhibits breast cancer metastasis by targeting metastasis associated 1; citation_author=Y Pan, G Jiao, C Wang, J Yang, W Yang; citation_volume=83; citation_publication_date=2016; citation_pages=1398-1406; citation_doi=10.1016/j.biopha.2016.08.058; citation_id=CR37"/>

    <meta name="citation_reference" content="citation_journal_title=Nature; citation_title=Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance; citation_author=KR Fischer, A Durrans, S Lee, J Sheng, F Li, ST Wong, H Choi, T El Rayes, S Ryu, J Troeger; citation_volume=527; citation_publication_date=2015; citation_pages=472-476; citation_doi=10.1038/nature15748; citation_id=CR38"/>

    <meta name="citation_reference" content="citation_journal_title=Br J Cancer; citation_title=Construction of therapeutically relevant human prostate epithelial fate map by utilising miRNA and mRNA microarray expression data; citation_author=JK Rane, A Ylipaa, R Adamson, VM Mann, MS Simms, AT Collins, T Visakorpi, M Nykter, NJ Maitland; citation_volume=113; citation_publication_date=2015; citation_pages=611-615; citation_doi=10.1038/bjc.2015.262; citation_id=CR39"/>

    <meta name="citation_reference" content="citation_journal_title=Cell Death Differ; citation_title=A set of miRNAs participates in the cellular senescence program in human diploid fibroblasts; citation_author=R Faraonio, P Salerno, F Passaro, C Sedia, A Iaccio, R Bellelli, TC Nappi, M Comegna, S Romano, G Salvatore; citation_volume=19; citation_publication_date=2012; citation_pages=713-721; citation_doi=10.1038/cdd.2011.143; citation_id=CR40"/>

    <meta name="citation_reference" content="citation_journal_title=Molecular cancer research : MCR; citation_title=Targeting abnormal DNA repair in therapy-resistant breast cancers; citation_author=LA Tobin, C Robert, P Nagaria, S Chumsri, W Twaddell, OB Ioffe, GE Greco, AH Brodie, AE Tomkinson, FV Rassool; citation_volume=10; citation_publication_date=2012; citation_pages=96-107; citation_doi=10.1158/1541-7786.MCR-11-0255; citation_id=CR41"/>

    <meta name="citation_reference" content="citation_journal_title=CA Cancer J Clin; citation_title=MicroRNAome genome: a treasure for cancer diagnosis and therapy; citation_author=I Berindan-Neagoe, C Monroig Pdel, B Pasculli, GA Calin; citation_volume=64; citation_publication_date=2014; citation_pages=311-336; citation_doi=10.3322/caac.21244; citation_id=CR42"/>

    <meta name="citation_reference" content="citation_journal_title=Proteome Sci; citation_title=Differential protein expression in perfusates from metastasized rat livers; citation_author=Y Zhang, M Li, L Wei, L Zhu, S Hu, S Wu, S Ma, Y Gao; citation_volume=11; citation_publication_date=2013; citation_pages=37; citation_doi=10.1186/1477-5956-11-37; citation_id=CR43"/>

    <meta name="citation_reference" content="citation_journal_title=Asian Pacific journal of cancer prevention : APJCP; citation_title=Protein profiles associated with Anoikis resistance of metastatic MDA-MB-231 breast cancer cells; citation_author=C Akekawatchai, S Roytrakul, S Kittisenachai, P Isarankura-Na-Ayudhya, S Jitrapakdee; citation_volume=17; citation_publication_date=2016; citation_pages=581-590; citation_doi=10.7314/APJCP.2016.17.2.581; citation_id=CR44"/>

    <meta name="citation_reference" content="citation_journal_title=Oncotarget; citation_title=Validation of a network-based strategy for the optimization of combinatorial target selection in breast cancer therapy: siRNA knockdown of network targets in MDA-MB-231 cells as an in vitro model for inhibition of tumor development; citation_author=TM Tilli, N Carels, JA Tuszynski, M Pasdar; citation_volume=7; citation_publication_date=2016; citation_pages=63189-63203; citation_doi=10.18632/oncotarget.11055; citation_id=CR45"/>

    <meta name="citation_reference" content="citation_journal_title=J Immunol; citation_title=Ly9 (CD229)-deficient mice exhibit T cell defects yet do not share several phenotypic characteristics associated with SLAM- and SAP-deficient mice; citation_author=DB Graham, MP Bell, MM McCausland, CJ Huntoon, J van Deursen, WA Faubion, S Crotty, DJ McKean; citation_volume=176; citation_publication_date=2006; citation_pages=291-300; citation_doi=10.4049/jimmunol.176.1.291; citation_id=CR46"/>

    <meta name="citation_reference" content="citation_journal_title=J Immunol; citation_title=Systemic lupus erythematosus immune complexes increase the expression of SLAM family members CD319 (CRACC) and CD229 (LY-9) on plasmacytoid dendritic cells and CD319 on CD56(dim) NK cells; citation_author=N Hagberg, J Theorell, H Schlums, ML Eloranta, YT Bryceson, L Ronnblom; citation_volume=191; citation_publication_date=2013; citation_pages=2989-2998; citation_doi=10.4049/jimmunol.1301022; citation_id=CR47"/>

    <meta name="citation_reference" content="citation_journal_title=Oncotarget; citation_title=In vivo and in vitro effects of microRNA-27a on proliferation, migration and invasion of breast cancer cells through targeting of SFRP1 gene via Wnt/beta-catenin signaling pathway; citation_author=LY Kong, M Xue, QC Zhang, S CF; citation_volume=8; citation_publication_date=2017; citation_pages=15507-15519; citation_id=CR48"/>

    <meta name="citation_reference" content="citation_journal_title=Mol Cancer Ther; citation_title=Reexpression of tumor suppressor, sFRP1, leads to antitumor synergy of combined HDAC and methyltransferase inhibitors in chemoresistant cancers; citation_author=SJ Cooper, CA von Roemeling, KH Kang, LA Marlow, SK Grebe, ME Menefee, HW Tun, G Colon-Otero, EA Perez, JA Copland; citation_volume=11; citation_publication_date=2012; citation_pages=2105-2115; citation_doi=10.1158/1535-7163.MCT-11-0873; citation_id=CR49"/>

    <meta name="citation_reference" content="citation_journal_title=Epigenetics; citation_title=SFRP1 CpG island methylation locus is associated with renal cell cancer susceptibility and disease recurrence; citation_author=F Atschekzei, J Hennenlotter, S Janisch, A Grosshennig, W Trankenschuh, S Waalkes, I Peters, T Dork, AS Merseburger, A Stenzl; citation_volume=7; citation_publication_date=2012; citation_pages=447-457; citation_doi=10.4161/epi.19614; citation_id=CR50"/>

    <meta name="citation_author" content="Qiong-Ni Zhu"/>

    <meta name="citation_author_institution" content="Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, People&#8217;s Republic of China"/>

    <meta name="citation_author_institution" content="Institute of Clinical Pharmacology, Central South University, Changsha, People&#8217;s Republic of China"/>

    <meta name="citation_author_institution" content="Hunan Key Laboratory of Pharmacogenetics, Changsha, People&#8217;s Republic of China"/>

    <meta name="citation_author" content="Helen Renaud"/>

    <meta name="citation_author_institution" content="University of Kansas Medical Center, Kansas City, USA"/>

    <meta name="citation_author" content="Ying Guo"/>

    <meta name="citation_author_institution" content="Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, People&#8217;s Republic of China"/>

    <meta name="citation_author_institution" content="Institute of Clinical Pharmacology, Central South University, Changsha, People&#8217;s Republic of China"/>

    <meta name="citation_author_institution" content="Hunan Key Laboratory of Pharmacogenetics, Changsha, People&#8217;s Republic of China"/>



        <meta charset="UTF-8"/>
        <meta http-equiv="X-UA-Compatible" content="IE=edge"/>
        <meta name="viewport" content="width=device-width, initial-scale=1"/>

        <!-- For IE 9 and below -->
<!--[if IE]><link rel="shortcut icon" href=/static/images/favicons//favicon.ico><![endif]-->
<!-- Touch Icons - iOS and Android 2.1+ -->
<link rel="apple-touch-icon" href=/static/images/favicons/bmc/favicon-3f5c56eaaa.png>
<!-- Firefox, Chrome, Safari, IE 11+ and Opera -->
<link rel="icon" href=/static/images/favicons/bmc/favicon-3f5c56eaaa.png>


        <script>(function(H){H.className=H.className.replace(/\bno-js\b/,'js')})(document.documentElement)</script>
        <script>(function(d){if (sessionStorage.fontsLoaded){d.style.setProperty('--font-family-sans', 'Europa');d.style.setProperty('--font-family-serif', 'Noto Serif')}})(document.documentElement);</script>

        <link rel="stylesheet" media="screen" href=/static/styles/basic/basic-a31ca85bc2.css>
<link rel="stylesheet" media="print" href=/static/styles/bmc/print-3a6240f456.css>

<link rel="stylesheet" class="js-ctm" href=/static/styles/bmc/main-84414d3d47.css
      media="only screen and (-webkit-min-device-pixel-ratio:0) and (min-color-index:0), (-ms-high-contrast: none), only all and (min--moz-device-pixel-ratio:0) and (min-resolution: 3e1dpcm)">

        

        <script src="/static/js/app-bundle-8d61e6ef37.js" defer></script>
        
        <script>
            window.airbrakeErrors = [];
            window.onerror = function(error) {window.airbrakeErrors.push(error);}
        </script>
        
    <script type="text/javascript">
        config = {
            env: 'live',
            site: 'hereditasjournal.biomedcentral.com',
            siteWithPath: 'hereditasjournal.biomedcentral.com' + window.location.pathname,
            twitterHashtag: '',
            cmsPrefix: 'https://studio-cms.springernature.com/studio/',
            
            doi: '10.1186/s41065-018-0055-7',
            figshareScriptUrl: 'https://widgets.figshare.com/static/figshare.js',
            publisherBrand: 'BioMed Central'
        };
    </script>

        
    <script type="text/javascript">
        dataLayer = [{"content":{"article":{"doi":"10.1186/s41065-018-0055-7","articleType":"Research","peerReviewType":"Closed","supplement":null,"keywords":"Breast cancer;Tamoxifen resistance;Bioinformatics;miRNA-542-5p"},"contentInfo":{"imprint":"BioMed Central","title":"Bioinformatics-based identification of miR-542-5p as a predictive biomarker in breast cancer therapy","publishedAt":1515974400000,"publishedAtDate":"2018-01-15","author":["Qiong-Ni Zhu","Helen Renaud","Ying Guo"],"collection":[]},"attributes":{"deliveryPlatform":"oscar","template":"rebrand","cms":null,"copyright":{"creativeCommonsType":"CC BY + CC0","openAccess":true},"environment":"live"},"journal":{"siteKey":"hereditasjournal.biomedcentral.com","volume":"155","issue":"1","title":"Hereditas","type":"AJs Life","journalID":41065,"gaCode":"UA-62066850-11","section":[]},"category":{"pmc":{"primarySubject":"Life Sciences"},"contentType":"Research","publishingSegment":"Genetics & Heredity (Life)"}},"session":{"authentication":{"authenticationID":[]}},"version":"1.0.0","page":{"category":{"pageType":"article"}}}]

    </script>

        <script src="https://cdn.cookielaw.org/consent/7d6f4b4f-77fb-43b9-b429-eb1e1eeac6aa.js" id="onetrust-bmc-control" charset="UTF-8"></script>
        
    
        
    

        
    
        
            
                <!-- Google Tag Manager -->
                <script>
                    (function (w, d, s, l, i) {
                    w[l] = w[l] || [];
                    w[l].push({'gtm.start': new Date().getTime(), event: 'gtm.js'});
                    var f = d.getElementsByTagName(s)[0],
                            j = d.createElement(s),
                            dl = l != 'dataLayer' ? '&l=' + l : '';
                    j.async = true;
                    j.src = 'https://www.googletagmanager.com/gtm.js?id=' + i + dl;
                    f.parentNode.insertBefore(j, f);
                })(window, document, 'script', 'dataLayer', 'GTM-TDGJHK');
                </script>
                <!-- End Google Tag Manager -->
            
        
    


        
    
    <link rel="canonical" href="https://hereditasjournal.biomedcentral.com/articles/10.1186/s41065-018-0055-7"/>
    

        
        
        <meta property="og:url" content="https://hereditasjournal.biomedcentral.com/articles/10.1186/s41065-018-0055-7"/>
        <meta property="og:type" content="article"/>
        <meta property="og:site_name" content="Hereditas"/>
        <meta property="og:title" content="Bioinformatics-based identification of miR-542-5p as a predictive biomarker in breast cancer therapy"/>
        <meta property="og:description" content="Tamoxifen is the first-line hormone therapy for estrogen receptor alpha positive (ERα+) breast cancer. However, about 40% of patients with ERα + breast cancer who receive tamoxifen therapy eventually develop resistance resulting in a poor prognosis. The aim of this study was to mine available data sets in the Gene Expression Omnibus (GEO) database, including in vitro (cell lines) and in vivo (tissue samples), and to identify all miRNAs associated with tamoxifen resistance (TamR) in breast cancer. Secondly, this study aimed to predict the key gene regulatory networks of newly found TamR-related miRNAs and evaluate the potential role of the miRNAs and targets as potential prognosis biomarkers for breast cancer patients. Microarray data sets from two different studies were used from the GEO database: 1. GSE66607: miRNA of MCF-7 TamR cells; 2. GSE37405: TamR tissues. Differentially expressed microRNAs (miRNAs) were identified in both data sets and 5 differentially expressed miRNAs were found to overlap between the two data sets. Profiles of GSE37405 and data from the Kaplan-Meier Plotter Database (KMPD) along with Gene Expression Profiling Interactive Analysis (GEPIA) were used to reveal the relationship between these 5 miRNAs and overall survival. The results showed that has-miR-542-5p was the only miRNA associated with overall survival of ERα + breast cancer patients who received adjuvant tamoxifen. Targets of has-miR-542-5p were predicted by miRanda and TargetScan, and the mRNA expression of the three 3 target gene, Tyrosine 3-Monooxygenase/Tryptophan 5-Monooxygenase Activation Protein Beta (YWHAB), Lymphocyte Antigen 9 (LY9), and Secreted Frizzled Related Protein 1 (SFRP1) were associated with overall survival in 2 different databases. Copy-number alterations (CNAs) of SFRP1 confer survival disadvantage to breast cancer patients and alter the mRNA expression of SFRP1 in cBioPortal database. This study indicates that miRNA has-miR-542-5p is associated with TamR and can predict prognosis of breast cancer patients. Furthermore, has-miR-542-5p may be acting through a mechanism involving the target genes YWHAB, LY9, and SFRP1. Overall, has-miR-542-5p is a predictive biomarker and potential target for therapy of breast cancer patients."/>
        <meta property="og:image" content="https://images.springer.com/sgw/journals/medium/41065.jpg"/>
    
    </head>

    <body class="journal journal-fulltext"
          
          >
        
    
        
            
                <!-- Google Tag Manager (noscript) -->
                <noscript>
                    <iframe src="https://www.googletagmanager.com/ns.html?id=GTM-TDGJHK"
                            height="0" width="0" style="display:none;visibility:hidden"></iframe>
                </noscript>
                <!-- End Google Tag Manager (noscript) -->
            
        
    


        

        

    <div class="u-vh-full">
        <div class="u-visually-hidden" aria-hidden="true">
    
    <?xml version="1.0" encoding="UTF-8"?><!DOCTYPE svg PUBLIC "-//W3C//DTD SVG 1.1//EN" "http://www.w3.org/Graphics/SVG/1.1/DTD/svg11.dtd"><svg xmlns="http://www.w3.org/2000/svg"><defs><filter id="a" filterUnits="userSpaceOnUse" x="0" y="0" width="60.643" height="31.01"><feColorMatrix values="1 0 0 0 0 0 1 0 0 0 0 0 1 0 0 0 0 0 1 0"/></filter></defs><symbol id="icon-arrow-down" viewBox="0 0 16 8"><path d="M8 6l6-6h2L8 8 0 0h2l6 6"/></symbol><symbol id="icon-arrow-left-bullet" viewBox="0 0 8 16"><path d="M3 8l5 5v3L0 8l8-8v3L3 8z"/></symbol><symbol id="icon-arrow-right-bullet" viewBox="0 0 8 16"><path d="M5 8L0 3V0l8 8-8 8v-3l5-5z"/></symbol><symbol id="icon-arrow-right" viewBox="0 0 32 64"><path d="M0 0v64l32-32z"/></symbol><symbol id="icon-close" viewBox="0 0 23.998 23.999"><path d="M20.998 0l-8.999 9L3 0 0 3l8.999 9L0 20.999l3 3L11.999 15l8.999 8.999 3-3L14.999 12l8.999-9z"/></symbol><symbol id="icon-community" viewBox="0 0 60.643 31.01"><mask maskUnits="userSpaceOnUse" x="0" y="0" width="60.643" height="31.01" id="b"><path fill="#FFF" d="M0 31.01h60.643V0H0z" filter="url(#a)"/></mask><path mask="url(#b)" d="M60.643 25.497L50.005 14.86a7.925 7.925 0 1 0-7.669 0l-6.847 6.847-1.334-1.334a7.925 7.925 0 0 0-3.834-14.861 7.925 7.925 0 0 0-3.834 14.861l-1.334 1.334-6.847-6.847a7.925 7.925 0 1 0-7.669 0L0 25.497h21.362L15.85 31.01h28.943l-5.514-5.513h21.364z"/></symbol><symbol id="icon-download" viewBox="-301 390 9 14"><path d="M-301 395.6l4.5 5.1 4.5-5.1h-3V390h-3v5.6h-3zm0 6.5h9v1.9h-9z"/></symbol><symbol id="icon-ext-link" viewBox="0 0 16 16"><path fill="#676767" d="M12.9 16H3.1C1.4 16 0 14.6 0 12.9V3.2C0 1.4 1.4 0 3.1 0h3.7v1H3.1C2 1 1 2 1 3.2v9.7C1 14 2 15 3.1 15h9.7c1.2 0 2.1-1 2.1-2.1V8.7h1v4.2c.1 1.7-1.3 3.1-3 3.1z"/><path fill="#676767" d="M12.8 2.5l.7.7-9 8.9-.7-.7 9-8.9z"/><path fill="#676767" d="M9.7 0L16 6.2V0z"/></symbol><symbol id="icon-info-bordered" viewBox="470.812 270.868 18 18"><path d="M479.812 270.868c-4.972 0-9 4.029-9 9s4.028 9 9 9c4.971 0 9-4.029 9-9s-4.029-9-9-9zm0 16.875a7.875 7.875 0 0 1-7.875-7.875 7.875 7.875 0 1 1 15.75 0 7.875 7.875 0 0 1-7.875 7.875z"/><path d="M479.284 279.586c.089-.238-.024-.361-.13-.361-.489 0-1.123 1.16-1.359 1.16-.093 0-.173-.092-.173-.174 0-.238.581-.801.751-.971.526-.506 1.217-.895 1.979-.895.567 0 1.174.346.703 1.639l-.952 2.604c-.079.199-.224.531-.224.746 0 .092.054.186.159.186.395 0 1.121-1.135 1.304-1.135.067 0 .158.086.158.199 0 .385-1.542 2.043-2.874 2.043-.477 0-.804-.225-.804-.732 0-.641.447-1.734.538-1.963l.924-2.346zm.727-3.41c0-.586.498-1.066 1.082-1.066.527 0 .91.357.91.906 0 .615-.501 1.068-1.098 1.068-.541-.002-.894-.361-.894-.908z"/></symbol><symbol id="icon-opr" viewBox="0 0 18 18"><path d="M.9 2.5c-.2-.2-.4-.3-.6-.2-.3.2-.3.4-.3.6 0 .8 0 1.7.1 2.5 0 .5.3.7.7.6.9 0 1.7-.2 2.5-.3h.2c.5-.2.6-.5.3-.8-.2-.2-.4-.4-.6-.5-.1-.1-.2-.2-.4-.3.5-.6 1-1.1 1.7-1.5 4.6-3 10.9-.5 12 4.9.9 4.4-2.2 8.6-6.7 9.2-3.7.5-7.2-1.6-8.4-5.1 0-.1-.1-.2-.1-.3-.1-.3-.5-.5-.8-.4-.3.1-.5.4-.4.8.4 1.3 1.1 2.4 2 3.4 1.4 1.5 3.1 2.4 5.1 2.8 3 .5 5.6-.2 7.8-2.2 2.1-1.9 3-4.2 3-6.9-.1-4-3.1-7.6-7.1-8.4-3.3-.9-6.2 0-8.6 2.3-.2.1-.3.3-.5.5-.3-.2-.6-.5-.9-.7z"/><path d="M13 4.7c-2.6 1.6-4.5 3.6-5.3 4.6L5.6 7.7l-.9.7L8.3 12c.6-1.6 2.6-4.6 4.9-6.8l-.2-.5z"/></symbol><symbol id="icon-quotation" viewBox="0 0.333 55.932 35.619"><path d="M43.738.333L31.545 12.207v23.745h24.387V12.207H43.738zm-31.545 0L0 12.207v23.745h24.386V12.207H12.193z"/></symbol><symbol id="icon-remove" viewBox="-296 388 18 18"><path d="M-291.7 396.1h9v2h-9z"/><path d="M-287 405.5c-4.7 0-8.5-3.8-8.5-8.5s3.8-8.5 8.5-8.5 8.5 3.8 8.5 8.5-3.8 8.5-8.5 8.5zm0-16c-4.1 0-7.5 3.4-7.5 7.5s3.4 7.5 7.5 7.5 7.5-3.4 7.5-7.5-3.4-7.5-7.5-7.5z"/></symbol><symbol id="icon-ribbon" viewBox="0 0 36 72"><path d="M0 0v72h.053L18 54.054 35.945 72H36V0H0zm25.8 11.4l3.001 3L15 28.2l-7.801-7.8 3-3L15 22.201 25.8 11.4z"/></symbol><symbol id="icon-rss" viewBox="0 0 24 24"><g fill="#F26822"><ellipse cx="3.305" cy="20.702" rx="3.306" ry="3.298"/><path d="M15.978 24h-4.684c0-6.224-5.057-11.27-11.294-11.27V8.058c8.824 0 15.978 7.137 15.978 15.942z"/><path d="M19.2 23.95C19.2 13.366 10.604 4.79 0 4.79V0c13.255 0 24 10.723 24 23.95h-4.8z"/></g></symbol><symbol id="icon-search" viewBox="0 0 16 16"><path d="M6.276 12.257C2.815 12.257 0 9.508 0 6.128 0 2.749 2.815 0 6.276 0c3.462 0 6.277 2.749 6.277 6.128.002 3.38-2.815 6.129-6.277 6.129zm0-10.772c-2.622 0-4.755 2.083-4.755 4.643 0 2.562 2.133 4.644 4.755 4.644 2.623 0 4.756-2.082 4.756-4.644 0-2.56-2.134-4.643-4.756-4.643z"/><path d="M16 13.751L13.641 16l-4.875-4.82 2.36-2.248L16 13.751z"/></symbol><symbol id="icon-speech-bubble" viewBox="0 0 40 54"><path d="M0 0v40h6.667v13.334L20 40h20V0z"/></symbol><symbol id="icon-error" viewBox="2.002 0 14 14"><path d="M16.002 11.949L13.951 14 9.002 9.051 4.053 14l-2.051-2.051L6.951 7 2.002 2.05 4.053 0l4.949 4.95L13.951 0l2.051 2.049L11.053 7l4.949 4.949z"/></symbol><symbol id="icon-info" viewBox="5.502 0 7 14"><path d="M8.165 5.923c.146-.384-.04-.577-.209-.577-.783 0-1.798 1.856-2.177 1.856-.15 0-.277-.147-.277-.279 0-.383.933-1.282 1.203-1.557.846-.811 1.949-1.434 3.174-1.434.908 0 1.879.555 1.125 2.63l-1.526 4.167c-.126.32-.358.854-.358 1.198 0 .148.088.298.255.298.632 0 1.796-1.818 2.091-1.818.105 0 .252.134.252.321C11.717 11.345 9.245 14 7.11 14c-.763 0-1.289-.361-1.289-1.176 0-1.027.717-2.778.865-3.145l1.479-3.756zm1.144-4.211C9.309.771 10.111 0 11.045 0c.845 0 1.457.577 1.457 1.456 0 .983-.804 1.709-1.757 1.709-.866-.001-1.436-.578-1.436-1.453z"/></symbol><symbol id="icon-success" viewBox="0 0 16 14"><path d="M15.592 0c-4.867 2.984-8.4 6.751-9.987 8.641L1.717 5.595 0 6.979l6.717 6.832c1.157-2.961 4.817-8.748 9.287-12.86L15.592 0z"/></symbol><symbol id="icon-warning" viewBox="7.002 0 2.789 14"><path d="M7.002 11.211h2.789V14H7.002v-2.789zM7.002 0v3.436l.741 5.326h1.326l.723-5.326V0h-2.79z"/></symbol><symbol id="icon-facebook-bordered" viewBox="463.812 263.868 32 32"><path d="M479.812 263.868c-8.837 0-16 7.163-16 16s7.163 16 16 16 16-7.163 16-16-7.163-16-16-16zm0 30c-7.732 0-14-6.269-14-14s6.268-14 14-14 14 6.269 14 14-6.267 14-14 14z"/><path d="M483.025 280.48l.32-2.477h-2.453v-1.582c0-.715.199-1.207 1.227-1.207h1.311v-2.213a17.753 17.753 0 0 0-1.907-.098c-1.894 0-3.186 1.154-3.186 3.271V278h-2.142v2.477h2.142v6.354h2.557v-6.354l2.131.003z"/></symbol><symbol id="icon-facebook" viewBox="0 0 24 24"><circle fill="#4D67A4" cx="12" cy="12" r="12"/><path fill="#FFF" d="M8.396 10.143h2.137V8.165s-.092-1.292.892-2.274c.979-.979 2.298-.887 4.177-.724v2.21h-1.387s-.586-.013-.861.303c-.271.315-.24.764-.24.875v1.588h2.41l-.311 2.458h-2.116v6.336h-2.56v-6.345H8.396v-2.449z"/></symbol><symbol id="icon-gplus-bordered" viewBox="463.812 263.868 32 32"><path d="M479.812 263.868c-8.838 0-16 7.163-16 16s7.162 16 16 16c8.837 0 16-7.163 16-16s-7.163-16-16-16zm0 30c-7.732 0-14-6.269-14-14s6.268-14 14-14c7.731 0 14 6.269 14 14s-6.267 14-14 14z"/><path d="M480.5 273.117c.123.076.26.185.416.334.146.152.289.343.432.562.135.211.258.459.359.746.086.286.129.619.129 1.004-.012.7-.164 1.262-.465 1.683a5.374 5.374 0 0 1-.461.562c-.186.176-.375.35-.58.527a2.65 2.65 0 0 0-.322.41.908.908 0 0 0-.176.553c0 .205.059.375.18.508.102.129.199.238.299.336l.662.545a6.48 6.48 0 0 1 1.086 1.119c.293.415.445.955.459 1.625 0 .949-.42 1.789-1.256 2.521-.869.76-2.123 1.15-3.762 1.177-1.373-.015-2.4-.308-3.074-.879-.682-.534-1.023-1.172-1.023-1.917 0-.359.111-.766.336-1.211.215-.443.602-.837 1.172-1.174a6.126 6.126 0 0 1 1.998-.725 15.415 15.415 0 0 1 1.723-.173 3.996 3.996 0 0 1-.377-.596 1.347 1.347 0 0 1-.193-.74c0-.174.023-.317.074-.433a8.83 8.83 0 0 1 .121-.338 5.973 5.973 0 0 1-.633.035c-1.043-.012-1.838-.339-2.381-.979-.574-.603-.861-1.3-.861-2.097 0-.961.404-1.832 1.217-2.616.559-.46 1.135-.757 1.736-.898a8.494 8.494 0 0 1 1.67-.182h3.916l-1.209.704h-1.207v.005l-.005.002zm.754 11.276c0-.498-.162-.932-.484-1.302-.346-.348-.881-.778-1.609-1.29a4.045 4.045 0 0 0-.439-.02c-.102-.016-.354 0-.768.039a8.141 8.141 0 0 0-1.244.275c-.1.036-.24.096-.42.17a2.713 2.713 0 0 0-.553.355 1.985 1.985 0 0 0-.459.592c-.145.25-.215.551-.215.901 0 .687.311 1.253.932 1.698.596.444 1.404.68 2.432.688.928-.014 1.629-.217 2.117-.612.476-.385.71-.886.71-1.494zm-2.729-5.743a1.843 1.843 0 0 0 1.289-.556c.164-.249.271-.506.318-.767a7.32 7.32 0 0 0 .041-.659c0-.772-.195-1.552-.594-2.336a2.611 2.611 0 0 0-.73-.921 1.894 1.894 0 0 0-1.064-.352 1.723 1.723 0 0 0-1.324.64c-.299.437-.438.92-.428 1.457 0 .709.209 1.444.623 2.211.201.356.459.659.775.912.323.248.686.371 1.094.371zm9.698.077h-2.055v-2.056h-.996v2.056h-2.053v.998h2.053v2.052h.996v-2.052h2.055z"/></symbol><symbol id="icon-gplus" viewBox="0 0 24 24"><circle fill="#D84A36" cx="12" cy="12" r="12"/><g fill="#FFF"><path d="M12.012 12.111c-.304-.33-.07-.842.155-1.078.226-.241.639-.56.829-.74.193-.184.66-.605.674-1.868 0 0 .112-1.139-1.127-2.06h.977l1.038-.593h-3.507s-2.083-.067-3.085 1.207c-1 1.276-.966 2.871.114 3.77 1.08.898 2.371.648 2.371.648s-.197.422-.163.775c.036.353.421.849.504.965 0 0-2.386-.011-3.551 1.033-1.165 1.053-1.29 3.097 1.021 3.803 2.312.707 5.303-.055 5.906-2.277 0 0 .262-.908-.189-1.683-.459-.775-1.663-1.571-1.967-1.902zm-2.555-1.83c-.744-1-1.308-2.953 0-3.783 0 0 .955-.579 1.801.266.846.846 1.082 2.277.928 3.003-.15.727-.563.897-.739 1.008-.185.111-1.249.504-1.99-.494zm3.668 5.481c-.035.393-.083 1.254-1.491 1.664-1.409.408-3.826-.264-3.757-1.914 0 0 .006-.698.449-1.089.445-.396 1.094-.794 3.029-.819 0 0 .643.473 1.072.809.427.332.733.952.698 1.349z"/><path d="M16.323 11.055V9.803h-.752v1.252h-1.255v.748h1.255v1.256h.752v-1.256h1.248v-.748z"/></g></symbol><symbol id="icon-linkedin" viewBox="0 0 24 24"><circle fill="#0178B5" cx="12" cy="12" r="12"/><g fill="#FFF"><circle cx="8.022" cy="8.043" r="1.256"/><path d="M6.929 10.246h2.17v6.967h-2.17zm3.533 6.967h2.157v-3.594s-.078-1.627 1.219-1.627c1.301 0 1.211 1.231 1.211 1.635v3.586h2.183v-3.775s.129-2.745-1.472-3.191c-1.605-.445-2.661.071-3.219.985v-.985h-2.079v6.966z"/></g></symbol><symbol id="icon-reddit" viewBox="0 0 24 24"><circle fill="#BCBCBC" cx="12" cy="12" r="12"/><path fill="#FFF" d="M4.661 9.741c.941 0 1.703.761 1.703 1.704 0 .938-.762 1.705-1.703 1.705s-1.704-.767-1.704-1.705c0-.943.763-1.704 1.704-1.704zm13.844 0a1.704 1.704 0 1 1 .001 3.409 1.704 1.704 0 0 1-.001-3.409z"/><path fill="#FFF" d="M11.736 8.732c4.285 0 7.762 2.283 7.762 5.104 0 2.812-3.477 5.1-7.762 5.1-4.288 0-7.762-2.285-7.762-5.1.001-2.82 3.474-5.104 7.762-5.104z"/><path fill="#010101" d="M11.736 19.262c-4.461 0-8.088-2.437-8.088-5.426 0-2.994 3.626-5.431 8.088-5.431 4.457 0 8.087 2.437 8.087 5.431 0 2.989-3.63 5.426-8.087 5.426zm0-10.205c-4.104 0-7.438 2.145-7.438 4.779 0 2.633 3.334 4.773 7.438 4.773 4.098 0 7.437-2.142 7.437-4.773 0-2.636-3.339-4.779-7.437-4.779z"/><circle fill="#FFF" cx="18.014" cy="5.765" r="1.385"/><path fill="#010101" d="M18.014 7.456a1.694 1.694 0 0 1-1.695-1.691c0-.934.764-1.694 1.695-1.694s1.693.762 1.693 1.694c0 .934-.762 1.691-1.693 1.691zm0-2.734c-.574 0-1.043.469-1.043 1.043s.469 1.041 1.043 1.041a1.042 1.042 0 0 0 0-2.084zM3.818 13.275a2.068 2.068 0 0 1-1.068-1.811 2.074 2.074 0 0 1 3.538-1.466l-.458.462a1.412 1.412 0 0 0-1.007-.42 1.424 1.424 0 0 0-.688 2.669l-.317.566zm15.866 0l-.316-.566a1.43 1.43 0 0 0 .73-1.245c0-.784-.635-1.424-1.42-1.424-.381 0-.736.149-1.008.42l-.459-.462a2.074 2.074 0 1 1 2.473 3.277z"/><path fill="#F04B23" d="M9.165 11.604c.704 0 1.272.564 1.272 1.27a1.273 1.273 0 1 1-1.272-1.27zm5.321 0a1.274 1.274 0 1 1-1.275 1.27c0-.704.57-1.27 1.275-1.27z"/><path fill="#010101" d="M11.79 8.915a.327.327 0 0 1-.307-.44l1.472-4.181 3.616.862c.177.044.283.22.238.395a.32.32 0 0 1-.391.239l-3.045-.729-1.275 3.632a.334.334 0 0 1-.308.222zm-.069 8.376c-2.076 0-2.908-.939-2.943-.982a.332.332 0 0 1 .035-.461.334.334 0 0 1 .459.033c.019.021.713.758 2.449.758 1.766 0 2.539-.763 2.549-.767a.324.324 0 1 1 .469.446c-.04.043-.954.973-3.018.973z"/></symbol><symbol id="icon-twitter-bordered" viewBox="463.812 263.868 32 32"><path d="M486.416 276.191a5.622 5.622 0 0 1-1.554.429 2.718 2.718 0 0 0 1.19-1.502 5.456 5.456 0 0 1-1.72.657 2.71 2.71 0 0 0-1.979-.854 2.711 2.711 0 0 0-2.642 3.326 7.681 7.681 0 0 1-5.586-2.831 2.714 2.714 0 0 0 .839 3.618 2.748 2.748 0 0 1-1.227-.339v.031a2.71 2.71 0 0 0 2.174 2.656 2.735 2.735 0 0 1-1.229.049 2.726 2.726 0 0 0 2.531 1.883 5.442 5.442 0 0 1-4.01 1.123 7.672 7.672 0 0 0 4.155 1.215c4.983 0 7.71-4.129 7.71-7.711 0-.115-.004-.232-.006-.351a5.41 5.41 0 0 0 1.354-1.399z"/><path d="M479.812 263.868c-8.837 0-16 7.163-16 16s7.163 16 16 16 16-7.163 16-16-7.163-16-16-16zm0 30c-7.732 0-14-6.269-14-14s6.268-14 14-14 14 6.269 14 14-6.267 14-14 14z"/></symbol><symbol id="icon-twitter" viewBox="0 0 24 24"><circle fill="#26A7DF" cx="12" cy="12" r="12"/><path fill="#FFF" d="M5.903 6.768s2.176 2.883 5.953 3.082c0 0-.51-1.702 1.058-3.004 1.568-1.305 3.508-.2 3.879.292 0 0 1.104-.172 1.875-.691 0 0-.252.995-1.18 1.594 0 0 1.086-.146 1.596-.439 0 0-.533.853-1.447 1.503 0 0 .381 3.595-2.709 6.57-3.09 2.971-8.176 2.352-10.012.797 0 0 2.495.277 4.249-1.219 0 0-2.074-.037-2.671-1.973 0 0 1.036.08 1.215-.119 0 0-2.232-.539-2.254-2.873 0 0 .68.339 1.297.359 0-.001-2.153-1.557-.849-3.879z"/></symbol><symbol id="icon-weibo-bordered" viewBox="463.812 263.868 32 32"><path d="M479.812 263.868c-8.838 0-16 7.163-16 16s7.162 16 16 16c8.837 0 16-7.163 16-16s-7.163-16-16-16zm0 30c-7.732 0-14-6.269-14-14s6.268-14 14-14c7.731 0 14 6.269 14 14s-6.267 14-14 14z"/><path d="M478.552 285.348c-2.616.261-4.876-.926-5.044-2.649-.167-1.722 1.814-3.33 4.433-3.588 2.609-.263 4.871.926 5.041 2.647.165 1.721-1.818 3.331-4.43 3.59m5.23-5.718c-.226-.065-.374-.109-.259-.403.25-.639.276-1.188.005-1.581-.515-.734-1.915-.693-3.521-.021 0 0-.508.224-.378-.181.247-.798.209-1.468-.178-1.852-.87-.878-3.194.032-5.183 2.027-1.489 1.494-2.357 3.082-2.357 4.453 0 2.619 3.354 4.213 6.631 4.213 4.297 0 7.154-2.504 7.154-4.493.001-1.198-1.007-1.881-1.914-2.162"/><path fill="#020202" d="M486.637 274.833a4.176 4.176 0 0 0-3.982-1.291.608.608 0 0 0-.465.72.604.604 0 0 0 .72.466 2.968 2.968 0 0 1 2.827.92 3 3 0 0 1 .625 2.918.602.602 0 0 0 .39.762.603.603 0 0 0 .763-.391v-.001a4.218 4.218 0 0 0-.878-4.103"/><path fill="#020202" d="M485.041 276.276a2.037 2.037 0 0 0-1.938-.63.518.518 0 0 0-.396.621.517.517 0 0 0 .617.398c.336-.071.702.03.947.307s.312.649.207.979a.52.52 0 0 0 .336.654.523.523 0 0 0 .657-.336 2.038 2.038 0 0 0-.43-1.993m-6.347 5.951c-.09.156-.293.233-.451.166-.151-.062-.204-.235-.115-.389.093-.155.284-.229.44-.168.157.056.214.235.126.391m-.832 1.074c-.253.405-.795.58-1.202.396-.403-.186-.521-.655-.27-1.051.248-.39.771-.566 1.176-.393.413.17.543.636.296 1.048m.95-2.864c-1.244-.326-2.65.294-3.19 1.396-.553 1.119-.021 2.369 1.236 2.775 1.303.42 2.84-.225 3.374-1.436.526-1.183-.132-2.402-1.42-2.735"/></symbol><symbol id="icon-weibo" viewBox="4 4 24 24"><circle fill="#C8E8F9" cx="16" cy="16" r="12"/><path fill="#FFF" d="M9.098 18.194c0 1.981 2.574 3.593 5.757 3.593 3.178 0 5.756-1.611 5.756-3.593 0-1.989-2.578-3.601-5.756-3.601-3.183.001-5.757 1.612-5.757 3.601"/><path fill="#DF0A21" d="M14.991 21.496c-2.817.278-5.244-.996-5.428-2.85-.183-1.855 1.95-3.586 4.767-3.862 2.813-.278 5.243.996 5.428 2.849.18 1.855-1.957 3.584-4.767 3.863m5.628-6.155c-.24-.067-.404-.116-.279-.432.27-.688.299-1.278.004-1.699-.551-.791-2.062-.748-3.789-.022 0-.001-.548.241-.406-.191.266-.859.224-1.577-.191-1.993-.937-.942-3.437.037-5.577 2.18-1.602 1.61-2.533 3.317-2.533 4.789 0 2.817 3.606 4.533 7.13 4.533 4.626 0 7.701-2.696 7.701-4.834.001-1.292-1.085-2.027-2.06-2.331"/><path fill="#F4992C" d="M23.689 10.182a4.492 4.492 0 0 0-4.283-1.39.651.651 0 1 0 .269 1.275 3.2 3.2 0 0 1 3.045.99 3.224 3.224 0 0 1 .672 3.138.647.647 0 0 0 .418.823.647.647 0 0 0 .816-.421v-.003a4.51 4.51 0 0 0-.937-4.412"/><path fill="#F4992C" d="M21.973 11.736a2.183 2.183 0 0 0-2.086-.679.56.56 0 0 0-.428.667.554.554 0 0 0 .662.43v.001c.361-.075.754.034 1.018.33.266.299.34.698.227 1.054a.563.563 0 0 0 .359.706.563.563 0 0 0 .709-.362 2.2 2.2 0 0 0-.461-2.147"/><path fill="#13110C" d="M15.143 18.139c-.1.17-.315.251-.483.179-.168-.07-.222-.255-.128-.42.097-.167.311-.248.479-.182.165.062.228.252.132.423m-.896 1.155c-.271.434-.854.625-1.295.425-.433-.195-.561-.707-.285-1.128.269-.426.832-.609 1.265-.427.443.183.58.688.315 1.13m1.024-3.084c-1.34-.351-2.852.32-3.434 1.506-.597 1.206-.021 2.546 1.33 2.984 1.402.453 3.055-.243 3.629-1.543.569-1.275-.142-2.587-1.525-2.947"/></symbol></svg>
</div>

        <a class="u-visually-hidden u-visually-hidden-focus" href="#main-content">
    <span class="c-banner c-banner--info">Skip to content</span>
</a>

        
            
    <div class="adsbox c-ad c-ad--LB1">
        <div class="c-ad__inner" >
            <p class="c-ad__label">Advertisement</p>
            <div id="div-gpt-ad-LB1"
                 data-gpt-unitpath="/270604982/bmc/hereditasjournal/articles"
                 data-gpt-sizes="728x90,970x90"
                 data-gpt-targeting="pos=LB1;doi=10.1186/s41065-018-0055-7;kwrd=Breast cancer,Tamoxifen resistance,Bioinformatics,miRNA-542-5p;pmc=L32030,L21001;">
                <noscript>
                    <a href="//pubads.g.doubleclick.net/gampad/jump?iu=/270604982/bmc/hereditasjournal/articles&amp;sz=728x90,970x90&amp;pos=LB1&amp;doi=10.1186/s41065-018-0055-7&amp;kwrd=Breast cancer,Tamoxifen resistance,Bioinformatics,miRNA-542-5p&amp;pmc=L32030,L21001&amp;">
                        <img data-test="gpt-advert-fallback-img"
                             src="//pubads.g.doubleclick.net/gampad/ad?iu=/270604982/bmc/hereditasjournal/articles&amp;sz=728x90,970x90&amp;pos=LB1&amp;doi=10.1186/s41065-018-0055-7&amp;kwrd=Breast cancer,Tamoxifen resistance,Bioinformatics,miRNA-542-5p&amp;pmc=L32030,L21001&amp;"
                             alt="Advertisement"
                             width="728"
                             height="90">
                    </a>
                </noscript>
            </div>
        </div>
    </div>

        
         
    <div id="membership-message-loader-desktop" class="placeholder" data-placeholder="/placeholder/v1/membership/message"></div>


<header class="c-popup-search ctx-publisher-header" id="top" data-test="publisher-header">
    <nav class="c-navbar">
        <div class="u-container">
            
            <div class="basic-white-logo c-navbar__logo u-margin-right-xxl" itemscope itemtype="http://schema.org/Organization" data-test="navbar-logo-header">
                <link itemprop="parentOrganization" href="#parentOrganization" />
                <div class="c-logo">
    <a href="https://www.biomedcentral.com" itemprop="url">
        <img src=/static/images/bmc/logos/logo-bmc-white-aj-e3a70ae848.svg alt="BMC" itemprop="logo">
        <div class="c-logo__strapline">
            <img src=/static/images/bmc/logos/logo-bmc-white-strapline-sn-e7b1d6e67f.svg alt="Part of Springer Nature">
        </div>
    </a>
</div>
            </div>
            <button
                type="button"
                class="c-navbar__link c-dropdown js-publisher-menu-button u-hidden-at-lg"
                id="publisher-header-menu-button"
                data-toggle="collapse"
                data-test="publisher-header-menu-toggle"
                data-toggle-linked="publisher-header"
                data-target="publisher-header-search publisher-header-menu"
                aria-controls="publisher-header-menu publisher-header-search"
                aria-expanded="false">
                <span class="c-dropdown__toggle">Menu</span>
            </button>
            <div class="c-navbar__content c-collapse" id="publisher-header-menu">
                
    <ul class="c-navbar__nav" data-test="publisher-navigation">
        
        <li class="c-navbar__item">
            <a class="c-navbar__link" href="//www.biomedcentral.com/journals">
                Explore journals
            </a>
        </li>
        
        <li class="c-navbar__item">
            <a class="c-navbar__link" href="//www.biomedcentral.com/getpublished">
                Get published
            </a>
        </li>
        
        <li class="c-navbar__item">
            <a class="c-navbar__link" href="//www.biomedcentral.com/about">
                About BMC
            </a>
        </li>
        
    </ul>


                <ul class="c-navbar__nav">
                    <li class="c-navbar__item">
                        <a data-replace="true"
                           data-placeholder="/placeholder/v1/username"
                           class="c-navbar__link"
                           href="https://www.biomedcentral.com/login"
                           data-test="login-link"
                           data-track="click"
                           data-track-category="Account"
                           data-track-action="Click Login Link">
                            <span class="u-js-shown">Login</span>
                            <span class="u-js-hidden">My Account</span>
                        </a>
                    </li>
                    <li class="c-navbar__item">
                        <button
                            type="button"
                            class="c-navbar__link js-publisher-search-button u-hidden-at-lt-lg"
                            data-toggle="collapse"
                            data-test="header-search-button"
                            data-target="publisher-header-search publisher-header-menu publisher-header-menu-button"
                            aria-controls="publisher-header-search publisher-header-menu"
                            aria-expanded="false">
                            <span class="c-flex c-flex--align-center">
                                Search
                                <svg class="c-icon u-margin-left-xs" width="14" height="14" aria-hidden="true">
                                    <use xlink:href="#icon-search"></use>
                                </svg>
                            </span>
                        </button>
                    </li>
                </ul>
            </div>
        </div>
    </nav>
    <div class="c-popup-search__content c-collapse js-publisher-search-bar" id="publisher-header-search">
        <div class="u-container">
            <div class="c-popup-search__container">
                <div class="ctx-search">
    <form role="search" class="c-form-field c-form-field--inline" method="GET" action="//www.biomedcentral.com/search" data-track="submit"
        data-track-category="Search and Results" data-track-action="Submit search" data-dynamic-track-label data-track-label="" data-test="global-search">
        <label for="publisherSearch" class="u-visually-hidden">Search all BMC articles</label>
        <input id="publisherSearch" class="c-form-field__input js-publisher-search-input" autocomplete="off" role="textbox" data-test="search-input" name="query" type="text" value="" placeholder="Search all BMC articles"/>
        <button class="c-button c-button--secondary" type="submit" data-test="search-submit-button">
    <span class="u-visually-hidden">Search</span>
    <svg class="c-icon" width="16" height="16" aria-hidden="true">
        <use xlink:href="#icon-search"></use>
    </svg>
</button>


        <input type="hidden" name="searchType" value="publisherSearch"/>
    </form>
</div>

            </div>
        </div>
    </div>
</header>


        
            <header class="c-journal-header c-journal-header--hereditas ctx-journal-header">
                <div class="u-container">
                    <div class="c-journal-header__inner ">
                        
                        <div class="c-journal-title" id="journalTitle">
                            <a href="/">
    
        
    
    <span class="c-journal-title__text ">Hereditas</span>
    
</a>
                        </div>
                        
                    </div>
                </div>
                <div class="c-navbar">
                    <div class="u-container">
                        
                            <button type="button"
                                    class="c-navbar__link c-dropdown u-hidden-at-lg"
                                    data-toggle="collapse"
                                    data-test="journal-header-menu"
                                    data-toggle-linked="journal-header"
                                    data-target="journal-menu"
                                    aria-controls="journal-menu"
                                    aria-expanded="false">
                                    <span class="c-dropdown__toggle">Menu</span>
                            </button>
                            <div class="c-navbar__content c-collapse" id="journal-menu">
                                <nav class="c-navbar__nav">
                                    <ul class="c-navbar__nav c-navbar__nav--journal" role="menu" data-test="site-navigation">
                                        
                                            <li class="c-navbar__item" role="menuitem">
                                                <a class="c-navbar__link" href='/'>Home</a>
                                            </li>
                                        
                                            <li class="c-navbar__item" role="menuitem">
                                                <a class="c-navbar__link" href='/about'>About</a>
                                            </li>
                                        
                                            <li class="c-navbar__item" role="menuitem">
                                                <a class="c-navbar__link c-navbar__link--is-shown" href='/articles'>Articles</a>
                                            </li>
                                        
                                            <li class="c-navbar__item" role="menuitem">
                                                <a class="c-navbar__link" href='/submission-guidelines'>Submission Guidelines</a>
                                            </li>
                                        
                                    </ul>
                                </nav>
                            </div>
                        
                    </div>
                </div>
                <div class="c-journal-header__identity c-journal-header__identity--ocean-light-blue">
                    
                </div>
            </header>
            
        

        <div class="u-container u-margin-top-xl u-margin-bottom-xl" id="main-content">
            <div class="c-content-layout c-content-layout--fulltext" data-component="sticky-container">
                <div class="c-content-layout__nav u-hidden-at-lt-xl">
                    <nav xmlns="" xmlns:fn="http://www.w3.org/2005/xpath-functions" xmlns:meta="http://www.springer.com/app/meta" id="ArticleNavigation" aria-labelledby="toc-menu-title" data-component="sticky"><h3 id="toc-menu-title" class="u-visually-hidden" data-test="toc-title">Table of Contents</h3><ol class="c-nav c-nav--stacked" role="menu" id="tocMenu" aria-expanded="true" data-article-toc=""><li role="menuitem" class="c-nav__item"><a class="c-nav__link" href="#Abs1" data-track-category="Table of Contents" data-track="click" data-track-action="Link Clicked" data-track-label="Abstract" data-test="abstract-link">Abstract</a></li><li role="menuitem" class="c-nav__item"><a class="c-nav__link" href="#Sec1" data-track-category="Table of Contents" data-track="click" data-track-action="Link Clicked" data-track-label="Background">Background</a></li><li role="menuitem" class="c-nav__item"><a class="c-nav__link" href="#Sec2" data-track-category="Table of Contents" data-track="click" data-track-action="Link Clicked" data-track-label="Methods">Methods</a></li><li role="menuitem" class="c-nav__item"><a class="c-nav__link" href="#Sec8" data-track-category="Table of Contents" data-track="click" data-track-action="Link Clicked" data-track-label="Result">Result</a></li><li role="menuitem" class="c-nav__item"><a class="c-nav__link" href="#Sec14" data-track-category="Table of Contents" data-track="click" data-track-action="Link Clicked" data-track-label="Discussion">Discussion</a></li><li role="menuitem" class="c-nav__item"><a class="c-nav__link" href="#Sec15" data-track-category="Table of Contents" data-track="click" data-track-action="Link Clicked" data-track-label="Conclusion">Conclusion</a></li><li role="menuitem" class="c-nav__item"><a class="c-nav__link" href="#Decs" data-test="declarations-link" data-track-category="Table of Contents" data-track="click" data-track-action="Link Clicked" data-track-label="Declarations">
                  Declarations
                </a></li><li role="menuitem" class="c-nav__item"><a class="c-nav__link" href="#Bib1" data-track-category="Table of Contents" data-track="click" data-track-action="Link Clicked" data-track-label="References">References</a></li></ol></nav>
                </div>

                <main class="c-content-layout__main">
                    <article itemscope itemtype="http://schema.org/ScholarlyArticle">
                        
                        
    <div class="FulltextWrapper">
        <ul class="c-article-identifiers u-reset-list">
            <li class="c-article-identifiers__item" data-test="article-category">Research</li>
            <li class="c-article-identifiers__item" data-test="open-access">
                <span class="u-text-open-access">Open Access</span>
            </li>
            
            
        </ul>
    </div>

                        <div class="FulltextWrapper"><div xmlns="" xmlns:fn="http://www.w3.org/2005/xpath-functions" xmlns:meta="http://www.springer.com/app/meta" class="MainTitleSection"><h1 xmlns="http://www.w3.org/1999/xhtml" class="ArticleTitle" itemprop="headline" lang="en">Bioinformatics-based identification of miR-542-5p as a predictive biomarker in breast cancer therapy</h1></div><div xmlns="" xmlns:fn="http://www.w3.org/2005/xpath-functions" xmlns:meta="http://www.springer.com/app/meta" class="AuthorNames" data-author-affiliations="true"><ul class="u-listReset"><li class="Author hasAffil" data-jumpto="Aff" data-test="author-name"><span xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" class="AuthorName" itemprop="author" itemscope="" itemtype="http://schema.org/Person">Qiong-Ni&nbsp;Zhu</span><sup><a href="#Aff1" class="AffiliationID">1</a>, <a href="#Aff2" class="AffiliationID">2</a>, <a href="#Aff3" class="AffiliationID">3</a></sup>, </li><li class="Author hasAffil" data-jumpto="Aff" data-test="author-name"><span xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" class="AuthorName" itemprop="author" itemscope="" itemtype="http://schema.org/Person">Helen&nbsp;Renaud</span><sup><a href="#Aff4" class="AffiliationID">4</a></sup> and </li><li class="Author hasAffil" data-jumpto="Aff" data-test="author-name"><span xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" class="AuthorName" itemprop="author" itemscope="" itemtype="http://schema.org/Person">Ying&nbsp;Guo</span><sup><a href="#Aff1" class="AffiliationID">1</a>, <a href="#Aff2" class="AffiliationID">2</a>, <a href="#Aff3" class="AffiliationID">3</a></sup><a href="mailto:guoying881212@csu.edu.cn" class="EmailAuthor" title="Email author"><span class="ContactIcon" aria-hidden="true"></span><span class="u-srOnly">Email author</span></a></li></ul></div><div xmlns="" xmlns:fn="http://www.w3.org/2005/xpath-functions" xmlns:meta="http://www.springer.com/app/meta" class="ArticleContextInformation"><div class="ContextInformation"><div class="ContextInformationJournalTitles"><span class="ArticleCitation"><span itemscope="" itemtype="http://schema.org/Periodical" itemid="#periodical"><span xmlns="http://www.w3.org/1999/xhtml" class="JournalTitle">Hereditas</span></span><span class="ArticleCitation_Year">2018</span><span class="ArticleCitation_Volume"><strong itemprop="isPartOf" itemtype="http://schema.org/PublicationVolume"><link itemprop="isPartOf" href="#periodical">155</strong>:17</span></span></div><p class="ArticleDOI"><a itemprop="sameAs" class="u-text-inherit" href="https://doi.org/10.1186/s41065-018-0055-7">https://doi.org/10.1186/s41065-018-0055-7</a></p><p class="Copyright">© &nbsp;The Author(s)&nbsp;2018</p></div></div><ul class="ArticleHistory u-reset-list"><li class="History HistoryReceived"><strong>Received: </strong><span>13&nbsp;December&nbsp;2017</span></li><li class="History HistoryAccepted"><strong>Accepted: </strong><span>4&nbsp;January&nbsp;2018</span></li><li class="History HistoryOnlineDate"><strong>Published: </strong><span itemprop="datePublished">15&nbsp;January&nbsp;2018</span></li></ul></div>
                        
                        
                        
    

                        <div class="FulltextWrapper"><section xmlns="" xmlns:fn="http://www.w3.org/2005/xpath-functions" xmlns:meta="http://www.springer.com/app/meta" class="Abstract Section1 RenderAsSection1 c-section" id="Abs1" lang="en"><h2 class="c-section__heading"><a href="#Abstract" data-test="abstract-heading" data-disable-click-event-default="">Abstract</a></h2><div class="c-section__content" id="Abstract"><div xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" class="AbstractSection" id="ASec1">
                <h3 xmlns="" class="Heading">Background</h3>
                <p id="Par1" class="Para">Tamoxifen is the first-line hormone therapy for estrogen receptor alpha positive (ERα+) breast cancer. However, about 40% of patients with ERα + breast cancer who receive tamoxifen therapy eventually develop resistance resulting in a poor prognosis. The aim of this study was to mine available data sets in the Gene Expression Omnibus (GEO) database, including in vitro (cell lines) and in vivo (tissue samples), and to identify all miRNAs associated with tamoxifen resistance (TamR) in breast cancer. Secondly, this study aimed to predict the key gene regulatory networks of newly found TamR-related miRNAs and evaluate the potential role of the miRNAs and targets as potential prognosis biomarkers for breast cancer patients.</p>
              </div><div xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" class="AbstractSection" id="ASec2">
                <h3 xmlns="" class="Heading">Result</h3>
                <p id="Par2" class="Para">Microarray data sets from two different studies were used from the GEO database: 1. GSE66607: miRNA of MCF-7 TamR cells; 2. GSE37405: TamR tissues. Differentially expressed microRNAs (miRNAs) were identified in both data sets and 5 differentially expressed miRNAs were found to overlap between the two data sets. Profiles of GSE37405 and data from the Kaplan-Meier Plotter Database (KMPD) along with Gene Expression Profiling Interactive Analysis (GEPIA) were used to reveal the relationship between these 5 miRNAs and overall survival. The results showed that has-miR-542-5p was the only miRNA associated with overall survival of ERα + breast cancer patients who received adjuvant tamoxifen. Targets of has-miR-542-5p were predicted by miRanda and TargetScan, and the mRNA expression of the three 3 target gene, Tyrosine 3-Monooxygenase/Tryptophan 5-Monooxygenase Activation Protein Beta (YWHAB), Lymphocyte Antigen 9 (LY9), and Secreted Frizzled Related Protein 1 (SFRP1) were associated with overall survival in 2 different databases. Copy-number alterations (CNAs) of SFRP1 confer survival disadvantage to breast cancer patients and alter the mRNA expression of SFRP1 in cBioPortal database.</p>
              </div><div xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" class="AbstractSection" id="ASec3">
                <h3 xmlns="" class="Heading">Conclusion</h3>
                <p id="Par3" class="Para">This study indicates that miRNA has-miR-542-5p is associated with TamR and can predict prognosis of breast cancer patients. Furthermore, has-miR-542-5p may be acting through a mechanism involving the target genes YWHAB, LY9, and SFRP1. Overall, has-miR-542-5p is a predictive biomarker and potential target for therapy of breast cancer patients.</p>
              </div></div></section><section xmlns:func="http://oscar.fig.bmc.com" class="KeywordGroup Section1 RenderAsSection1 c-section" lang="en"><h2 xmlns="" xmlns:fn="http://www.w3.org/2005/xpath-functions" xmlns:meta="http://www.springer.com/app/meta" class="Heading js-ToggleCollapseSection c-section__heading" data-sticky-update="true"><a href="#Keywords" data-toggle="collapse" data-toggle-disable-clickoff="" data-target="Keywords">Keywords</a></h2><div class="js-CollapseSection CollapseSection c-section__content" data-test="collapse-section" id="Keywords"><ul class="c-keywords"><li class="c-keywords__item" itemprop="about">Breast cancer</li><li class="c-keywords__item" itemprop="about">Tamoxifen resistance</li><li class="c-keywords__item" itemprop="about">Bioinformatics</li><li class="c-keywords__item" itemprop="about">miRNA-542-5p</li></ul></div></section>
            <section xmlns="" xmlns:fn="http://www.w3.org/2005/xpath-functions" xmlns:meta="http://www.springer.com/app/meta" id="Sec1" class="Section1 RenderAsSection1 c-section"><h2 class="Heading js-ToggleCollapseSection c-section__heading" data-sticky-update="true"><a href="#Background" data-toggle="collapse" data-toggle-disable-clickoff="" data-target="Background">Background</a></h2><div class="js-CollapseSection CollapseSection c-section__content" id="Background" data-test="collapse-section"><p xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" id="Par19" class="Para">Breast cancer is the most common malignancy among women and second leading cause of cancer death in the USA [<span class="CitationRef"><a href="#CR1" data-toggle="citation">1</a></span>–<span class="CitationRef"><a href="#CR3" data-toggle="citation">3</a></span>]. Tamoxifen is a selective estrogen receptor modulator and one of the most effective adjuvant treatments for estrogen receptor alpha positive (ERα+) breast cancer patients in clinical practice. Unfortunately, about 40% of breast cancer patients with ERα + who receive tamoxifen therapy develop tamoxifen resistance (TamR) [<span class="CitationRef"><a href="#CR4" data-toggle="citation">4</a></span>, <span class="CitationRef"><a href="#CR5" data-toggle="citation">5</a></span>].</p><p xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" id="Par20" class="Para">The mechanisms of TamR include aberrant ERα expression, altered signal transduction pathways, imbalance of co-regulatory proteins, genetic polymorphisms in tamoxifen metabolism [<span class="CitationRef"><a href="#CR6" data-toggle="citation">6</a></span>, <span class="CitationRef"><a href="#CR7" data-toggle="citation">7</a></span>], and epigenetic modifications including expression changes of microRNAs (miRNAs) [<span class="CitationRef"><a href="#CR8" data-toggle="citation">8</a></span>]. miRNAs are a class of small non-coding RNAs that post-transcriptionally control the translation and stability of mRNAs [<span class="CitationRef"><a href="#CR9" data-toggle="citation">9</a></span>] by forming specific base-pairing interactions between the 5′ end of the miRNA (seed region) and the miRNA response elements within the coding region or untranslated regions (UTRs) of mRNAs, leading to mRNA destabilization and/or translational inhibition [<span class="CitationRef"><a href="#CR10" data-toggle="citation">10</a></span>]. Fundamentally, miRNAs provide an extra level of regulation to gene expression.</p><p xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" id="Par21" class="Para">The role of miRNAs in the progression of endocrine-resistant breast cancer is of intense interest as they are promising biomarkers and therapeutic targets to counter metastatic disease [<span class="CitationRef"><a href="#CR11" data-toggle="citation">11</a></span>]. Consequently, studies are rapidly emerging on the role of miRNAs in endocrine resistant breast cancer [<span class="CitationRef"><a href="#CR12" data-toggle="citation">12</a></span>, <span class="CitationRef"><a href="#CR13" data-toggle="citation">13</a></span>]. Several miRNAs have been associated with TamR in MCF-7 cells exposed to tamoxifen (1&nbsp;μM) for &gt;12&nbsp;months [<span class="CitationRef"><a href="#CR14" data-toggle="citation">14</a></span>]. For example, expressions of miR-190b and miR-516a-5p were altered in TamR cells and were predictive of treatment outcome in a cohort of ERα + breast cancer patients receiving adjuvant tamoxifen mono-therapy [<span class="CitationRef"><a href="#CR13" data-toggle="citation">13</a></span>]; miR-519a confers TamR by targeting a network of tumor-suppressor genes in ERα + breast cancer [<span class="CitationRef"><a href="#CR15" data-toggle="citation">15</a></span>]; miR-27b is epigenetically downregulated in TamR breast cancer cells due to promoter methylation and also regulates tamoxifen sensitivity by targeting High Mobility Group Box&nbsp;3 [<span class="CitationRef"><a href="#CR16" data-toggle="citation">16</a></span>]; miR-320a sensitizes TamR breast cancer cells to tamoxifen by targeting CAMP Regulated Phosphoprotein 19 and ERRγ in breast cancer cells and tissues [<span class="CitationRef"><a href="#CR17" data-toggle="citation">17</a></span>]; and miR-378a-3p regulates tamoxifen sensitivity in MCF-7 cells through targeting Golgi Transport 1A [<span class="CitationRef"><a href="#CR18" data-toggle="citation">18</a></span>].</p><p xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" id="Par22" class="Para">In this study, we used a meta-analysis approach to discover which miRNAs are associated with TamR across multiple studies in order to reveal strong miRNA candidates and down-stream target genes that can be used as predictive biomarkers and novel targets for therapy. To accomplish this, we mined the Gene Expression Omnibus (GEO) database and analyzed all the available in vitro (cell lines) and in vivo (tissue samples) data sets for miRNAs associated with TamR in breast cancer, identified all the miRNAs related to TamR, predicted the key gene regulatory network of a novel miRNA associated with TamR, and evaluated the potential role of this miRNA and target genes as prognosis biomarkers for breast cancer patients. This is the first study to indicate and validate the potential association of miR-542-5p and its downstream genes Tyrosine 3-Monooxygenase/Tryptophan 5-Monooxygenase Activation Protein Beta (YWHAB), Lymphocyte Antigen 9 (LY9), and Secreted Frizzled Related Protein 1 (SFRP1) with the prognosis of breast cancer.</p></div></section>
            <section xmlns="" xmlns:fn="http://www.w3.org/2005/xpath-functions" xmlns:meta="http://www.springer.com/app/meta" id="Sec2" class="Section1 RenderAsSection1 c-section"><h2 class="Heading js-ToggleCollapseSection c-section__heading" data-sticky-update="true"><a href="#Methods" data-toggle="collapse" data-toggle-disable-clickoff="" data-target="Methods">Methods</a></h2><div class="js-CollapseSection CollapseSection c-section__content" id="Methods" data-test="collapse-section"><section id="Sec3" class="Section2 RenderAsSection2">
                <h3 class="Heading">Microarray data</h3>
                <p xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" id="Par23" class="Para">From the GEO database we searched all available data on tamoxifen treated samples of breast cancer tissue (with resistance status) and all TamR breast cancer cell samples (Additional&nbsp;file&nbsp;<span class="InternalRef"><a href="#MOESM1">1</a></span>), and found two sets of miRNA microarrays: GSE66607 and GSE37405. GSE66607 employed an Affymetrix GeneChip® miRNA 3.0 microarray to identify differentially expressed miRNAs between tamoxifen sensitive MCF7 parent cells and tamoxifen-induced resistant cells. The dataset of GSE37405 employed an Exiqon mercury LNA microRNA array on 152 ERα + primary tumors from high-risk breast cancer patients, all patients had received adjuvant tamoxifen as mono-therapy (median clinical follow-up: 4.6&nbsp;years). Patients were divided into two groups, patients without recurrence (denoted N <em xmlns="" class="EmphasisTypeItalic">n</em> = 76), and recurrence (denoted R n = 76) [<span class="CitationRef"><a href="#CR12" data-toggle="citation">12</a></span>].</p>
              </section><section id="Sec4" class="Section2 RenderAsSection2">
                <h3 class="Heading">Quality control</h3>
                <p xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" id="Par24" class="Para">To ensure accuracy and reliability of this experimental design, the median value of NUSE (Normalized Unscaled Standard Errors) and the median value of RLE (Relative Log Expression) were used as evaluation criteria for each microarray. This method has been previously published [<span class="CitationRef"><a href="#CR19" data-toggle="citation">19</a></span>].</p>
              </section><section id="Sec5" class="Section2 RenderAsSection2">
                <h3 class="Heading">Identification of differentially expressed genes</h3>
                <p xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" id="Par25" class="Para">In GSE66607, differentially expressed genes were analyzed by Gene Cloud of Biotechnology Information (GCBI) working platform (GMINIX Informatics Ltd. Co, Shanghai, P. R. China), the rank is sorted by the absolute value of the fold change. Differentially expressed genes in GSE37405 were analyzed using GEO2R, an R-based web application that helps users analyze GEO data [<span class="CitationRef"><a href="#CR20" data-toggle="citation">20</a></span>]. Data points with a <em xmlns="" class="EmphasisTypeItalic">p</em>-value &lt;0.05 were retained (<span class="ExternalRef"><a href="https://www.ncbi.nlm.nih.gov/geo/geo2r/?acc=GSE37405"><span class="RefSource">https://www.ncbi.nlm.nih.gov/geo/geo2r/?acc=GSE37405</span></a></span>). All data are displayed as log2 transformed.</p>
              </section><section id="Sec6" class="Section2 RenderAsSection2">
                <h3 class="Heading">Strategy</h3>
                <div xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" id="Par26" class="Para">As shown in Fig.&nbsp;<span class="InternalRef"><a href="#Fig1">1</a></span> we used a multi-step strategy to identify miRNAs that become differentially expressed in TamR breast cancer cells and tissues. First, significantly changed miRNAs in GSE66607 (cells) and GSE37405 (tissues) were identified. Second, GSE37405 and Kaplan-Meier Plotter Database (KMPD) - an online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1809 patients who accept endocrine therapy [<span class="CitationRef"><a href="#CR21" data-toggle="citation">21</a></span>] with miRpower of breast cancer as the validated set [<span class="CitationRef"><a href="#CR21" data-toggle="citation">21</a></span>] were used to screen overlapped miRNAs in step 1 that related to overall survival. Third, Targets of miRNAs were predicted by miRanda and TargetScan, to reveal the relationship between miRNA target genes and overall survival, the following tools and databases were used: KMPD, GEO (Affymetrix HGU133A and HGU133 + 2 microarrays) [<span class="CitationRef"><a href="#CR22" data-toggle="citation">22</a></span>], and Gene Analysis Differential genes analysis (GEPIA). GEPIA is a newly developed interactive web server using a standard processing pipeline for analyzing the RNA sequencing expression data of 9736 tumors and 8587 normal samples in the Cancer Genome Atlas (TCGA) and the Genotype-Tissue Expression projects [<span class="CitationRef"><a href="#CR23" data-toggle="citation">23</a></span>]. In addition, Molecular Taxonomy of Breast Cancer International Consortium (METABRIC) and TCGA Provisional data in cBioPortal [<span class="CitationRef"><a href="#CR24" data-toggle="citation">24</a></span>] were used to investigate the relationship between mutation/ Copy-number alterations (CNAs) and patients overall survival as well as the mRNA expression of target genes in breast cancer.<figure xmlns="" class="Figure" id="Fig1"><div xmlns="http://www.w3.org/1999/xhtml" class="MediaObject" id="MO1">
                      <a target="_blank" rel="noopener" href="https://media.springernature.com/full/springer-static/image/art%3A10.1186%2Fs41065-018-0055-7/MediaObjects/41065_2018_55_Fig1_HTML.gif"><img class="c-lazy-image u-js-shown" src="https://media.springernature.com/lw5/springer-static/image/art%3A10.1186%2Fs41065-018-0055-7/MediaObjects/41065_2018_55_Fig1_HTML.gif" alt="Fig. 1" data-lazy-load="true" data-src="https://media.springernature.com/lw785/springer-static/image/art%3A10.1186%2Fs41065-018-0055-7/MediaObjects/41065_2018_55_Fig1_HTML.gif"></img><noscript><img src="https://media.springernature.com/lw785/springer-static/image/art%3A10.1186%2Fs41065-018-0055-7/MediaObjects/41065_2018_55_Fig1_HTML.gif" alt="Fig. 1"></img></noscript></a>
                    </div><figcaption class="Caption" lang="en"><div xmlns="http://www.w3.org/1999/xhtml" class="CaptionContent"><span class="CaptionNumber">Fig. 1</span>
                        <p xmlns="" class="SimplePara">The multi-step strategy used in this study. First, significantly changed miRNAs in GSE66607 (cells for miRNA in MCF-7/TamR vs MCF-7) and GSE37405 (tissues for breast cancer tissues) were identified. Second, GSE37405 and Kaplan-Meier Plotter Database (KMPD) for miRpower of breast cancer as the validated set were used to screen overlapped miRNAs in step 1 that related to overall survival. Third, for the target mRNA genes, KMPD, and Gene Expression Profiling Interactive Analysis (GEPIA), were used to reveal the relationship between target genes and overall survival</p>
                      </div></figcaption></figure></div>
              </section><section id="Sec7" class="Section2 RenderAsSection2">
                <h3 class="Heading">Statistical analysis</h3>
                <p xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" id="Par27" class="Para">For each triplicate of microarray data, analysis of variance for comparisons between more than two groups was used in analyzing the CNAs and mRNA expression. A <em xmlns="" class="EmphasisTypeItalic">p</em>-value of &lt;0.05 was considered statistically significant. Differences in dichotomous variables between groups were compared using Pearson’s chi-square statistic or Fisher’s exact test. Differences in continuous variables between groups were compared using the median score test. Kaplan-Meier overall survival curves were computed and compared using the log-rank statistic. Adjusted <em xmlns="" class="EmphasisTypeItalic">p</em>-values were computed using Sidak’s procedure for pairwise comparisons after a significant log-rank test in overall survival value.</p>
              </section></div></section>
            <section xmlns="" xmlns:fn="http://www.w3.org/2005/xpath-functions" xmlns:meta="http://www.springer.com/app/meta" id="Sec8" class="Section1 RenderAsSection1 c-section"><h2 class="Heading js-ToggleCollapseSection c-section__heading" data-sticky-update="true"><a href="#Result" data-toggle="collapse" data-toggle-disable-clickoff="" data-target="Result">Result</a></h2><div class="js-CollapseSection CollapseSection c-section__content" id="Result" data-test="collapse-section"><section id="Sec9" class="Section2 RenderAsSection2">
                <h3 class="Heading">Identification of differentially expressed genes</h3>
                <div xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" id="Par28" class="Para">There were 91 differentially expressed genes (48 up-regulated and 43 down-regulated miRNA genes) between normal and TamR MCF-7 cells in GSE66607 (Additional&nbsp;file&nbsp;<span class="InternalRef"><a href="#MOESM2">2</a></span>). In GSE37405, 325 miRNAs were substituted as differentially expressed genes (Additional&nbsp;file&nbsp;<span class="InternalRef"><a href="#MOESM3">3</a></span>). The two differentially expressed gene sets were overlapped and 5 miRNAs (Fig.&nbsp;<span class="InternalRef"><a href="#Fig2">2a</a></span>, hsa-miR-324-3p, hsa-miR-486-5p, hsa-miR-940, hsa-miR-542-5p, hsa-miR-421) were identified(Additional&nbsp;file&nbsp;<span class="InternalRef"><a href="#MOESM4">4</a></span>).<figure xmlns="" class="Figure" id="Fig2"><div xmlns="http://www.w3.org/1999/xhtml" class="MediaObject" id="MO2">
                      <a target="_blank" rel="noopener" href="https://media.springernature.com/full/springer-static/image/art%3A10.1186%2Fs41065-018-0055-7/MediaObjects/41065_2018_55_Fig2_HTML.gif"><img class="c-lazy-image u-js-shown" src="https://media.springernature.com/lw5/springer-static/image/art%3A10.1186%2Fs41065-018-0055-7/MediaObjects/41065_2018_55_Fig2_HTML.gif" alt="Fig. 2" data-lazy-load="true" data-src="https://media.springernature.com/lw785/springer-static/image/art%3A10.1186%2Fs41065-018-0055-7/MediaObjects/41065_2018_55_Fig2_HTML.gif"></img><noscript><img src="https://media.springernature.com/lw785/springer-static/image/art%3A10.1186%2Fs41065-018-0055-7/MediaObjects/41065_2018_55_Fig2_HTML.gif" alt="Fig. 2"></img></noscript></a>
                    </div><figcaption class="Caption" lang="en"><div xmlns="http://www.w3.org/1999/xhtml" class="CaptionContent"><span class="CaptionNumber">Fig. 2</span>
                        <p xmlns="" class="SimplePara">Survival of tamoxifen resistance specific markers. <strong class="EmphasisTypeBold">a</strong>. The two Gene Expression Omnibus (GEO) sets (GSE66607 and GSE37405) were overlapped and 5 miRNAs (Fig. <span xmlns="http://www.w3.org/1999/xhtml" class="InternalRef"><a href="#Fig2">2a</a></span>, hsa-miR-324-3p, hsa-miR-486-5p, hsa-miR-940, hsamiR-542-5p, hsa-miR-421) were obtained. <strong class="EmphasisTypeBold">b</strong>. Association of has-miR-542-5p expression with tamoxifen resistance outcome in GSE37405. Survival curves were generated using the Kaplan-Meier method and the log rank test was used to assess the statistical significance of differences. (Log Rank =0.019), Red: high expression; black: low expression. <strong class="EmphasisTypeBold">c</strong>. In the Molecular Taxonomy of Breast Cancer International Consortium (METABRIC) data set, the high expression of has-miR-542-5p was also associated with overall survival in patients with ER- positive endocrine therapy in 695 patients (logrankP = 0.00041, HR = 0.6(0.45–0.8). Red: high expression; black: low expression</p>
                      </div></figcaption></figure></div>
              </section><section id="Sec10" class="Section2 RenderAsSection2">
                <h3 class="Heading">Survival analysis of TamR specific markers</h3>
                <p xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" id="Par29" class="Para">Kaplan-Meier analysis of GSE37405 showed that high expression of has-miR-542-5p in TamR breast cancer tissues conferred a survival advantage to patients with tamoxifen systemic treatment [logRank (Mantel-Cox) <em xmlns="" class="EmphasisTypeItalic">p</em> = 0.019, HR = 0.31(0.11–0.875), Fig. <span class="InternalRef"><a href="#Fig2">2b</a></span>]. In the METABRIC data set of KMPD, the high expression of has-miR-542-5p was also associated with overall survival in 695 patients with ERα + breast cancer receiving endocrine therapy [logrankP = 0.00041, HR = 0.6 (0.45–0.8), Fig. <span class="InternalRef"><a href="#Fig2">2c</a></span>]. Expression of the other 4 TamR-related miRNAs was not associated with overall survival in the GSE37405 dataset, but 2 of them [hsa-miR-486-5p: logrankP = 0.04900, HR = 0.74 (0.55–1); hsa-miR-421: logrankP = 0.05800, HR = 1.33 (0.99–1.8)] seemed to be conferred a survival relationship to patients with tamoxifen systemic treatment in the KMPD dataset (Additional file <span class="InternalRef"><a href="#MOESM4">4</a></span>).</p>
              </section><section id="Sec11" class="Section2 RenderAsSection2">
                <h3 class="Heading">miRNA target gene prediction and overall survival</h3>
                <section id="Sec12" class="Section3 RenderAsSection3">
                  <h4 class="Heading">1 miRNA target prediction</h4>
                  <div xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" id="Par30" class="Para">Since miRNAs negatively regulate gene expression, upregulated miRNAs may result in downregulated target mRNAs. Targets of miRNAs were predicted by miRanda and TargetScan(Additional&nbsp;file&nbsp;<span class="InternalRef"><a href="#MOESM5">5</a></span>). A total of three has-miR-542-5p target mRNAs were closely related to overall survival (Fig.&nbsp;<span class="InternalRef"><a href="#Fig3">3</a></span>) of breast cancer patients in both KMPD and GEPIA, and these are: YWHAB, LY9, and SFRP1.<figure xmlns="" class="Figure" id="Fig3"><div xmlns="http://www.w3.org/1999/xhtml" class="MediaObject" id="MO3">
                        <a target="_blank" rel="noopener" href="https://media.springernature.com/full/springer-static/image/art%3A10.1186%2Fs41065-018-0055-7/MediaObjects/41065_2018_55_Fig3_HTML.gif"><img class="c-lazy-image u-js-shown" src="https://media.springernature.com/lw5/springer-static/image/art%3A10.1186%2Fs41065-018-0055-7/MediaObjects/41065_2018_55_Fig3_HTML.gif" alt="Fig. 3" data-lazy-load="true" data-src="https://media.springernature.com/lw785/springer-static/image/art%3A10.1186%2Fs41065-018-0055-7/MediaObjects/41065_2018_55_Fig3_HTML.gif"></img><noscript><img src="https://media.springernature.com/lw785/springer-static/image/art%3A10.1186%2Fs41065-018-0055-7/MediaObjects/41065_2018_55_Fig3_HTML.gif" alt="Fig. 3"></img></noscript></a>
                      </div><figcaption class="Caption" lang="en"><div xmlns="http://www.w3.org/1999/xhtml" class="CaptionContent"><span class="CaptionNumber">Fig. 3</span>
                          <p xmlns="" class="SimplePara">The mRNA expression of has-miR-542-5p target genes and overall survival value. The mRNA expression of has-miR-542-5p target genes including Tyrosine 3-Monooxygenase/Tryptophan 5-Monooxygenase Activation Protein Beta (YWHAB), Lymphocyte Antigen 9 (LY9), and Secreted Frizzled Related Protein 1 (SFRP1) associated with overall survival in breast cancer. The left panel (YWHAB <strong class="EmphasisTypeBold">a</strong>, LY9 <strong class="EmphasisTypeBold">c</strong>, SFRP1 <strong class="EmphasisTypeBold">e</strong>) were verified in Gene Expression Profiling Interactive Analysis (GEPIA) database Red: high expression; blue: low expression; and the right panel (YWHAB <strong class="EmphasisTypeBold">b</strong>, LY9 <strong class="EmphasisTypeBold">d</strong>, SFRP1 <strong class="EmphasisTypeBold">f</strong>) results comes from KMPD. Red: high expression; black: low expression</p>
                        </div></figcaption></figure></div>
                </section>
                <section id="Sec13" class="Section3 RenderAsSection3">
                  <h4 class="Heading">2 survival analysis of target genes</h4>
                  <p xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" id="Par31" class="Para">High expression of YWHAB confers a survival disadvantage to breast cancer patients in both GEPIA with TCGA samples [logRank <em xmlns="" class="EmphasisTypeItalic">p</em> = 0.0057, HR (high) =1.6, Fig. <span class="InternalRef"><a href="#Fig3">3a</a></span>] and KMPD with GEO samples [217718_s_at, logRank <em xmlns="" class="EmphasisTypeItalic">p</em> = 8e-04, HR = 1.44(1.16–1.79), Fig. <span class="InternalRef"><a href="#Fig3">3b</a></span>]. While high expression of the other two target genes LY9 [GEPIA: logrankp = 0.038, HR (high) = 0.71, Fig. <span class="InternalRef"><a href="#Fig3">3c</a></span>; KMPD: 210370_s_at, logRank<em xmlns="" class="EmphasisTypeItalic">p</em> = 0.00014, HR = 0.66(0.53–0.82), Fig. <span class="InternalRef"><a href="#Fig3">3d</a></span>] and SFRP1 [GEPIA: logrankP = 0.028, HR(high) = 0.7, Fig. <span class="InternalRef"><a href="#Fig3">3e</a></span>; KMPD: 202037_s_at, logRank <em xmlns="" class="EmphasisTypeItalic">p</em> = 0.00031, HR = 0.72(0.58–0.9), Fig. <span class="InternalRef"><a href="#Fig3">3f</a></span>] conferred a survival advantage to breast cancer patients.</p>
                  <div xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" id="Par32" class="Para">The cBioPortal was used to identify CNAs associated with survival in YWHAB, LY9 and SFRP1 and the relationship between CNAs and mRNA expression. There are 10% cases had genetic alterations in SFRP1 (Fig.&nbsp;<span class="InternalRef"><a href="#Fig4">4a</a></span>), and these alterations confer survival disadvantage to breast cancer patients in TCGA and METABRIC cohort [Fig. <span class="InternalRef"><a href="#Fig4">4d</a></span> logrank <em xmlns="" class="EmphasisTypeItalic">P</em> = 0.011, HR = 1.245 (1.051–1.474)]. The mRNA expression of SFRP1 was lower in cases with deep deletion (<em xmlns="" class="EmphasisTypeItalic">p</em> = 0.502), shallow deletion (p = 0.000), gain (<em xmlns="" class="EmphasisTypeItalic">p</em> = 0.007) and amplification (<em xmlns="" class="EmphasisTypeItalic">p</em> = 0.046) than that without change in METABRIC samples (Fig.&nbsp;<span class="InternalRef"><a href="#Fig5">5e</a></span>), which was similar to the results in TCGA (Fig. <span class="InternalRef"><a href="#Fig5">5f</a></span>). Alterations of the other 2 genes were not associated with overall survival in the cBioPortal (and Fig. <span class="InternalRef"><a href="#Fig4">4b and c</a></span>). And the difference between the mRNA expression and CNAs of these 2 genes were not obvious (Fig. <span class="InternalRef"><a href="#Fig5">5a and b</a></span> for YWHAB, c and d for LY9). In addition, the mutations of the predicted genes were also investigated in the cBioPortal, and they are all rare ones and little data is available for further analysis.<figure xmlns="" class="Figure" id="Fig4"><div xmlns="http://www.w3.org/1999/xhtml" class="MediaObject" id="MO4">
                        <a target="_blank" rel="noopener" href="https://media.springernature.com/full/springer-static/image/art%3A10.1186%2Fs41065-018-0055-7/MediaObjects/41065_2018_55_Fig4_HTML.gif"><img class="c-lazy-image u-js-shown" src="https://media.springernature.com/lw5/springer-static/image/art%3A10.1186%2Fs41065-018-0055-7/MediaObjects/41065_2018_55_Fig4_HTML.gif" alt="Fig. 4" data-lazy-load="true" data-src="https://media.springernature.com/lw785/springer-static/image/art%3A10.1186%2Fs41065-018-0055-7/MediaObjects/41065_2018_55_Fig4_HTML.gif"></img><noscript><img src="https://media.springernature.com/lw785/springer-static/image/art%3A10.1186%2Fs41065-018-0055-7/MediaObjects/41065_2018_55_Fig4_HTML.gif" alt="Fig. 4"></img></noscript></a>
                      </div><figcaption class="Caption" lang="en"><div xmlns="http://www.w3.org/1999/xhtml" class="CaptionContent"><span class="CaptionNumber">Fig. 4</span>
                          <p xmlns="" class="SimplePara">Copy-number alterations of has-miR-542-5p target genes and overall survival value. Has-miR-542-5p target genes expression associated with copy-number alterations in breast cancer. <strong class="EmphasisTypeBold">a</strong>: The overall alteration situation of the 3 genes. <strong class="EmphasisTypeBold">b</strong>-<strong class="EmphasisTypeBold">d</strong>: The relationship between Copy-number alterations (CNAs) and overall survival value verified in cBioPortal (TCGA and Metabric) database (<strong class="EmphasisTypeBold">b</strong> for YWHAB, <strong class="EmphasisTypeBold">c</strong> for LY9, <strong class="EmphasisTypeBold">d</strong> for SFRP1) black: case without alterations; green: case with alterations</p>
                        </div></figcaption></figure><figure xmlns="" class="Figure" id="Fig5"><div xmlns="http://www.w3.org/1999/xhtml" class="MediaObject" id="MO5">
                        <a target="_blank" rel="noopener" href="https://media.springernature.com/full/springer-static/image/art%3A10.1186%2Fs41065-018-0055-7/MediaObjects/41065_2018_55_Fig5_HTML.gif"><img class="c-lazy-image u-js-shown" src="https://media.springernature.com/lw5/springer-static/image/art%3A10.1186%2Fs41065-018-0055-7/MediaObjects/41065_2018_55_Fig5_HTML.gif" alt="Fig. 5" data-lazy-load="true" data-src="https://media.springernature.com/lw785/springer-static/image/art%3A10.1186%2Fs41065-018-0055-7/MediaObjects/41065_2018_55_Fig5_HTML.gif"></img><noscript><img src="https://media.springernature.com/lw785/springer-static/image/art%3A10.1186%2Fs41065-018-0055-7/MediaObjects/41065_2018_55_Fig5_HTML.gif" alt="Fig. 5"></img></noscript></a>
                      </div><figcaption class="Caption" lang="en"><div xmlns="http://www.w3.org/1999/xhtml" class="CaptionContent"><span class="CaptionNumber">Fig. 5</span>
                          <p xmlns="" class="SimplePara">CNAs and mRNA expression of has-miR-542-5p target genes. Has-miR-542-5p target genes expression associated with CNAs in breast cancer. The left panel (<strong class="EmphasisTypeBold">a</strong> for YWHAB, <strong class="EmphasisTypeBold">c</strong> for LY9, <strong class="EmphasisTypeBold">e</strong> for SFRP1) were verified in Metabric database; and the right panel (<strong class="EmphasisTypeBold">b</strong> for YWHAB, <strong class="EmphasisTypeBold">d</strong> for LY9, <strong class="EmphasisTypeBold">f</strong> for SFRP1) results comes from KMPD. These samples were separated in to five categories, 1-Deep deletion (homozygous deletion), 2-Shallow deletion (heterozygous deletion), 3-diploid, 4-Gain (low level amplification), and 5-amplification (high level amplification). <em class="EmphasisTypeItalic">p</em> &lt; 0.05 compared to diploid group</p>
                        </div></figcaption></figure></div>
                </section>
              </section></div></section>
            <section xmlns="" xmlns:fn="http://www.w3.org/2005/xpath-functions" xmlns:meta="http://www.springer.com/app/meta" id="Sec14" class="Section1 RenderAsSection1 c-section"><h2 class="Heading js-ToggleCollapseSection c-section__heading" data-sticky-update="true"><a href="#Discussion" data-toggle="collapse" data-toggle-disable-clickoff="" data-target="Discussion">Discussion</a></h2><div class="js-CollapseSection CollapseSection c-section__content" id="Discussion" data-test="collapse-section"><p xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" id="Par33" class="Para">In the present study, we mined all miRNA profiling data of breast cancer available in the GEO database to examine miRNA changes associated with TamR, and identified a novel target for TamR diagnosis and prognosis of breast cancer patients. It is interesting to note that we found highly expressed has-miR-542-5p is associated with better overall survival in patients with ERα + breast cancer receiving endocrine therapy. In addition, three targets of has-miR-542-5p (YWHAB, LY9 and SFRP1) were also associated with prognosis in these patients.</p><p xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" id="Par34" class="Para">Understanding the molecular mechanism of TamR is of critical importance for diagnosis and treatment of breast cancer patients [<span class="CitationRef"><a href="#CR25" data-toggle="citation">25</a></span>, <span class="CitationRef"><a href="#CR26" data-toggle="citation">26</a></span>]. The results for 4 of the 5 TamR-related miRNAs found in this study corroborate with past findings. For instance, down regulation of miR-27b-3p enhances TamR in breast cancer by increasing NR5A2 and CREB1 expression [<span class="CitationRef"><a href="#CR27" data-toggle="citation">27</a></span>]; deep sequencing analysis of the breast cancer cell line MCF7 over-expressing miR-335-5p and miR-335-3p revealed that this miRNA duplex represses gene expressions of factors involved in the ERα signaling pathway; thus, enhancing TamR in MCF7 cells [<span class="CitationRef"><a href="#CR28" data-toggle="citation">28</a></span>]; miR-29b-1 has tumor suppressor activity in TamR cells [<span class="CitationRef"><a href="#CR29" data-toggle="citation">29</a></span>]; and miR-221/222 is involved in cell cycle deregulation in breast cancer drug resistance [<span class="CitationRef"><a href="#CR30" data-toggle="citation">30</a></span>]. Therefore, the novel strategy used in our study provides a reliable and robust meta-analysis approach to find strong miRNA candidates for prognosis biomarkers or novel therapeutic targets. Moreover, in the current study all the available miRNA data of breast cancer in GEO were included in the analysis and investigated with a comprehensive examination and validation. With this approach we identified a novel and very promising TamR-associated miRNA.</p><p xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" id="Par35" class="Para">Examining the relationship between TamR-related miRNAs and overall survival using data from GSE37405 and METABRIC, we identified a new candidate factor for prognosis, has-miR-542-5p. Two of the other 4 miRNAs, has-miR-486-5p and has-miR-421, might also be associated with overall survival in ERα + breast cancer patients receiving endocrine therapy. A significant change in their expressions was detected in the larger sample set (Additional file <span class="InternalRef"><a href="#MOESM4">4</a></span>); however, there are discrepancies in the expressions of these 2 miRNAs between the GEO and KMPD databases, which might be caused by different sample sizes of the datasets. The role that has-miR-486-5p plays in the prognosis of breast cancer patients has also been indicated in other investigations [<span class="CitationRef"><a href="#CR31" data-toggle="citation">31</a></span>].</p><p xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" id="Par36" class="Para">Studies have described the function of has-mir-542-5p in cancers. Kaplan-Meier survival analysis revealed significantly reduced event-free survival in patients with low miR-542-5p expression (<em xmlns="" class="EmphasisTypeItalic">p</em> &lt; 0.001, log-rank test) in neuroblastoma, which is consistent with the results of our study [<span class="CitationRef"><a href="#CR32" data-toggle="citation">32</a></span>, <span class="CitationRef"><a href="#CR33" data-toggle="citation">33</a></span>]. The difference of transcript/translation expression for has-miR-542-5p between local and metastatic disease is very obvious in neuroblastoma [<span class="CitationRef"><a href="#CR32" data-toggle="citation">32</a></span>], breast cancers [<span class="CitationRef"><a href="#CR34" data-toggle="citation">34</a></span>], and endometrial carcinosarcoma [<span class="CitationRef"><a href="#CR35" data-toggle="citation">35</a></span>]. Our research shows that high expression of has-miR-542-5p confers a survival advantage to patients receiving tamoxifen treatment (Fig. <span class="InternalRef"><a href="#Fig2">2b</a></span>), though has-miR-542-5p is overexpressed in breast cancer with lymph node metastasis [<span class="CitationRef"><a href="#CR34" data-toggle="citation">34</a></span>]. Together, these studies suggest that has-miR-542-5p might be closely associated with epithelial-mesenchymal transition (EMT), a process by which epithelial cells lose their cell polarity and cell-cell adhesion ability, thus gaining migratory and invasive properties. Has-miR-421, another differentially expressed miRNA found in our study to be related to overall survival in the KMPD dataset, has previously been found to inhibit breast cancer metastasis by target E-cadherin [<span class="CitationRef"><a href="#CR36" data-toggle="citation">36</a></span>] or metastasis associated 1 [<span class="CitationRef"><a href="#CR37" data-toggle="citation">37</a></span>]. Recurring tumors after treatment with chemotherapy have an increased proportion of cells expressing EMT-associated genes, thus highlighting the importance of EMT in therapeutic resistance in breast cancer [<span class="CitationRef"><a href="#CR38" data-toggle="citation">38</a></span>]. Other processes might also be involved in TamR. For instance, inhibition of miR-542-5p promoted efficient DNA repair and activated expression of Notch reporters [<span class="CitationRef"><a href="#CR39" data-toggle="citation">39</a></span>]. In another report, miR-542-5p induced double-strand DNA breaks and reactive oxygen species accumulation in transfected cells [<span class="CitationRef"><a href="#CR40" data-toggle="citation">40</a></span>], which might be related to the significantly increased sensitivity of therapy-resistant derivatives of breast cancer cells to a complex of DNA ligase III inhibitors that increased the number of DNA double-strand breaks [<span class="CitationRef"><a href="#CR41" data-toggle="citation">41</a></span>].</p><p xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" id="Par37" class="Para">MiRNAs affect the development of various diseases by inhibiting the expression of their target mRNAs [<span class="CitationRef"><a href="#CR42" data-toggle="citation">42</a></span>]. Understanding the relevance of miRNA and mRNA expression patterns in TamR breast cancer is important to elucidate the relationship between the pathophysiological process and gene transcription. We analyzed the relationship of the downstream target genes of miR-542-5p with survival of the patients in the KMPD and GEPIA databases, and found 3 target genes (YWHAB, LY9 and SFRP1) associated with overall survival. YWHAB plays a key role in cellular proliferation and oncogenic transformation and has been reported to be involved in the development of breast cancer [<span class="CitationRef"><a href="#CR43" data-toggle="citation">43</a></span>] and the activation of tumor/metastasis pathways and inhibition of apoptosis [<span class="CitationRef"><a href="#CR44" data-toggle="citation">44</a></span>]. Knockdown of YWHAB upregulated connectivity hubs, successfully inhibited in vitro proliferation, colony formation, anchorage independence, migration and invasion in MDA-MB-231 cells [<span class="CitationRef"><a href="#CR45" data-toggle="citation">45</a></span>]. This is consistent with our results that high YWHAB expression is associated with poor overall survival in breast cancer patients (Fig. <span class="InternalRef"><a href="#Fig3">3a, b</a></span>), which could also be explained by low expression of has-mir-542-5p for these patients shown in Fig. <span class="InternalRef"><a href="#Fig2">2b, c</a></span>.</p><p xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" id="Par38" class="Para">The hazard ratio of the other two target genes (LY9 and SFRP1) could not be explained by negative regulation of miR-542-5p. This may be due to the different mechanism or other regulating factors in breast cancer. LY9 belongs to the signaling lymphocyte activation molecules family of immunomodulatory receptors and interacts with the adaptor molecule signaling lymphocyte activation molecules-associated protein [<span class="CitationRef"><a href="#CR46" data-toggle="citation">46</a></span>], which is involved in hematopoietic stem cell differentiation pathways and lineage-specific markers [<span class="CitationRef"><a href="#CR47" data-toggle="citation">47</a></span>]. Diseases associated with LY9 include Systemic Lupus Erythematosus. To our knowledge, there is no previously published report associating LY9 with breast cancer; thus, further studies are needed to evaluate the role of LY9 in the development of TamR breast cancer. SFRPs act as soluble modulators of Wnt-pathway signaling, which is associated with cancer proliferation, migration and invasion of breast cancer cells. Studies have reported that miR-27a affects in vivo and in vitro proliferation, migration, and invasion of breast cancer cells through targeting the SFRP1 gene via Wnt/β-catenin signaling pathway [<span class="CitationRef"><a href="#CR48" data-toggle="citation">48</a></span>]. Expression of SFRP1 leads to antitumor synergy of combined HDAC and methyltransferase inhibitors in chemo-resistant cancers [<span class="CitationRef"><a href="#CR49" data-toggle="citation">49</a></span>]. Furthermore, SFRP1 DNA methylation was reported to accumulate with age in normal-appearing kidney tissues and be associated with increased renal cancer risk [<span class="CitationRef"><a href="#CR50" data-toggle="citation">50</a></span>], which indicates the importance of SFRP1 in cancer. In the present study, CNAs of SFRP1 gene is also closely related to prognosis (Fig. <span class="InternalRef"><a href="#Fig4">4d</a></span>), which might be related to the decreased mRNA expression in patients with these genetic alterations (Fig. <span class="InternalRef"><a href="#Fig5">5</a></span> e and f). The mechanism of how has-mir-542-5p regulates TamR in breast cancer and how it influences its downstream target genes warrants further study.</p></div></section>
            <section xmlns="" xmlns:fn="http://www.w3.org/2005/xpath-functions" xmlns:meta="http://www.springer.com/app/meta" id="Sec15" class="Section1 RenderAsSection1 c-section"><h2 class="Heading js-ToggleCollapseSection c-section__heading" data-sticky-update="true"><a href="#Conclusion" data-toggle="collapse" data-toggle-disable-clickoff="" data-target="Conclusion">Conclusion</a></h2><div class="js-CollapseSection CollapseSection c-section__content" id="Conclusion" data-test="collapse-section"><p xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" id="Par39" class="Para">In conclusion, our study provides a comprehensive bioinformatics analysis of TamR-related miRNAs and reveals the association of certain miRNAs with the overall survival of breast cancer patients. The current study indicates that has-miR-542-5p is related to TamR and affects the prognosis of breast cancer patients. Regulating the target genes YWHAB, LY9 and SFRP1 may be a possible mechanism of has-miR-542-5p in TamR of breast cancer.</p></div></section>
          <section xmlns="" xmlns:fn="http://www.w3.org/2005/xpath-functions" xmlns:meta="http://www.springer.com/app/meta" class="AbbreviationGroup Section1 RenderAsSection1 c-section"><h2 class="Heading js-ToggleCollapseSection c-section__heading" data-sticky-update="true"><a href="#Abbreviations" data-toggle="collapse" data-toggle-disable-clickoff="" data-target="Abbreviations">Abbreviations</a></h2><div class="js-CollapseSection CollapseSection c-section__content" data-test="collapse-section" id="Abbreviations"><div class="DefinitionList">
                <dl class="DefinitionListEntry"><dt class="Term"><dfn>CNAs:&nbsp;</dfn></dt><dd class="Description">
                    <p xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" id="Par4" class="Para">Copy-number alterations</p>
                  </dd></dl>
                <dl class="DefinitionListEntry"><dt class="Term"><dfn>EMT:&nbsp;</dfn></dt><dd class="Description">
                    <p xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" id="Par5" class="Para">Epithelial-mesenchymal transition</p>
                  </dd></dl>
                <dl class="DefinitionListEntry"><dt class="Term"><dfn>ERα + :&nbsp;</dfn></dt><dd class="Description">
                    <p xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" id="Par6" class="Para">Estrogen receptor alpha positive</p>
                  </dd></dl>
                <dl class="DefinitionListEntry"><dt class="Term"><dfn>GCBI:&nbsp;</dfn></dt><dd class="Description">
                    <p xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" id="Par7" class="Para">Gene Cloud of Biotechnology Information</p>
                  </dd></dl>
                <dl class="DefinitionListEntry"><dt class="Term"><dfn>GEO:&nbsp;</dfn></dt><dd class="Description">
                    <p xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" id="Par8" class="Para">Gene Expression Omnibus</p>
                  </dd></dl>
                <dl class="DefinitionListEntry"><dt class="Term"><dfn>GEPIA:&nbsp;</dfn></dt><dd class="Description">
                    <p xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" id="Par9" class="Para">Gene Expression Profiling Interactive Analysis</p>
                  </dd></dl>
                <dl class="DefinitionListEntry"><dt class="Term"><dfn>KMPD:&nbsp;</dfn></dt><dd class="Description">
                    <p xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" id="Par10" class="Para">Kaplan-Meier Plotter Database</p>
                  </dd></dl>
                <dl class="DefinitionListEntry"><dt class="Term"><dfn>LY9:&nbsp;</dfn></dt><dd class="Description">
                    <p xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" id="Par11" class="Para">Lymphocyte Antigen 9</p>
                  </dd></dl>
                <dl class="DefinitionListEntry"><dt class="Term"><dfn>METABRIC:&nbsp;</dfn></dt><dd class="Description">
                    <p xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" id="Par12" class="Para">Molecular Taxonomy of Breast Cancer International Consortium</p>
                  </dd></dl>
                <dl class="DefinitionListEntry"><dt class="Term"><dfn>MIRNA:&nbsp;</dfn></dt><dd class="Description">
                    <p xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" id="Par13" class="Para">MicroRNA</p>
                  </dd></dl>
                <dl class="DefinitionListEntry"><dt class="Term"><dfn>SFRP1:&nbsp;</dfn></dt><dd class="Description">
                    <p xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" id="Par14" class="Para">Secreted Frizzled Related Protein 1</p>
                  </dd></dl>
                <dl class="DefinitionListEntry"><dt class="Term"><dfn>TamR:&nbsp;</dfn></dt><dd class="Description">
                    <p xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" id="Par15" class="Para">Tamoxifen resistance</p>
                  </dd></dl>
                <dl class="DefinitionListEntry"><dt class="Term"><dfn>TCGA:&nbsp;</dfn></dt><dd class="Description">
                    <p xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" id="Par16" class="Para">The Cancer Genome Atlas</p>
                  </dd></dl>
                <dl class="DefinitionListEntry"><dt class="Term"><dfn>UTRs:&nbsp;</dfn></dt><dd class="Description">
                    <p xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" id="Par17" class="Para">Untranslated regions</p>
                  </dd></dl>
                <dl class="DefinitionListEntry"><dt class="Term"><dfn>YWHAB:&nbsp;</dfn></dt><dd class="Description">
                    <p xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" id="Par18" class="Para">Tyrosine 3-Monooxygenase/Tryptophan 5-Monooxygenase Activation Protein Beta</p>
                  </dd></dl>
              </div></div></section><section xmlns="" xmlns:fn="http://www.w3.org/2005/xpath-functions" xmlns:meta="http://www.springer.com/app/meta" class="Section1 RenderAsSection1 c-section" data-test="declarations-section" id="Decs"><h2 class="Heading js-ToggleCollapseSection c-section__heading" data-sticky-update="true"><a href="#Declarations" data-toggle="collapse" data-toggle-disable-clickoff="" data-target="Declarations">Declarations</a></h2><div class="js-CollapseSection CollapseSection c-section__content" data-test="collapse-section" id="Declarations"><div xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" class="Acknowledgments"><h3 xmlns="" class="Heading">Acknowledgements</h3><p xmlns="" class="SimplePara">We would like to thank Dr. Xi Li for expert assistance.</p><div id="FPar1" class="FormalPara FormalParaRenderingStyle1">
                <h3 xmlns="" class="Heading">Funding</h3>
                <p id="Par40" class="Para">This study was funded by National Natured Science Foundation of China (grant number No.81503563).</p>
              </div><div id="FPar2" class="FormalPara FormalParaRenderingStyle1">
                <h3 xmlns="" class="Heading">Availability of data and materials</h3>
                <p id="Par41" class="Para">All data produced by the study are disclosed in the manuscript and the additional files.</p>
              </div></div><div xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" class="FormalPara FormalParaRenderingStyle1"><h3 xmlns="" class="Heading">Authors’ contributions</h3><p xmlns="" class="SimplePara">Participated in research design: Q-NZ, YG. Performed data analysis: Q-NZ, YG. Wrote or contributed to the writing of the manuscript: Q-NZ, HR and YG. All authors read and approved the final manuscript.</p></div><div xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" class="Ethics">
              <div id="FPar3" class="FormalPara FormalParaRenderingStyle1">
                <h3 xmlns="" class="Heading">Ethics approval and consent to participate</h3>
                <p id="Par42" class="Para">Not applicable.</p>
              </div>
              <div id="FPar4" class="FormalPara FormalParaRenderingStyle1">
                <h3 xmlns="" class="Heading">Consent for publication</h3>
                <p id="Par43" class="Para">Not applicable.</p>
              </div>
              <div id="FPar5" class="FormalPara FormalParaRenderingStyle1">
                <h3 xmlns="" class="Heading">Competing interests</h3>
                <p id="Par44" class="Para">The authors declare that they have no competing interests.</p>
              </div>
              <div id="FPar6" class="FormalPara FormalParaRenderingStyle1">
                <h3 xmlns="" class="Heading">Publisher’s Note</h3>
                <p id="Par45" class="Para">Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
              </div>
            </div><div xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" class="License">
                <p xmlns="" class="SimplePara"><strong class="EmphasisTypeBold">Open Access</strong>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<span xmlns="http://www.w3.org/1999/xhtml" class="ExternalRef"><a href="http://creativecommons.org/licenses/by/4.0/"><span class="RefSource">http://creativecommons.org/licenses/by/4.0/</span></a></span>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<span xmlns="http://www.w3.org/1999/xhtml" class="ExternalRef"><a href="http://creativecommons.org/publicdomain/zero/1.0/"><span class="RefSource">http://creativecommons.org/publicdomain/zero/1.0/</span></a></span>) applies to the data made available in this article, unless otherwise stated.</p>
              </div><aside class="Appendix" id="App1">
              
                <h3 class="Heading">Additional files</h3><div id="widgetContainer" data-test="figshare-container"></div>
                <div xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" id="Par46" class="Para">
                  <div class="MediaObject" id="MOESM1">
                    <div xmlns="" class="esm-item "><div xmlns="http://www.w3.org/1999/xhtml" class="caption-container"><a href="https://static-content.springer.com/esm/art%3A10.1186%2Fs41065-018-0055-7/MediaObjects/41065_2018_55_MOESM1_ESM.xlsx"><span class="caption-number">Additional file 1:</span></a>
                          <span xmlns="" class="SimplePara">Data sets of tamoxifen resistant breast cancer samples in the GEO. (XLSX 10&nbsp;kb)</span>
                        </div></div>
                  </div>
                  <div class="MediaObject" id="MOESM2">
                    <div xmlns="" class="esm-item "><div xmlns="http://www.w3.org/1999/xhtml" class="caption-container"><a href="https://static-content.springer.com/esm/art%3A10.1186%2Fs41065-018-0055-7/MediaObjects/41065_2018_55_MOESM2_ESM.xlsx"><span class="caption-number">Additional file 2:</span></a>
                          <span xmlns="" class="SimplePara">Identification of DEGs&nbsp;in GSE66607. (XLSX 14&nbsp;kb)</span>
                        </div></div>
                  </div>
                  <div class="MediaObject" id="MOESM3">
                    <div xmlns="" class="esm-item "><div xmlns="http://www.w3.org/1999/xhtml" class="caption-container"><a href="https://static-content.springer.com/esm/art%3A10.1186%2Fs41065-018-0055-7/MediaObjects/41065_2018_55_MOESM3_ESM.xlsx"><span class="caption-number">Additional file 3:</span></a>
                          <span xmlns="" class="SimplePara">Identification of DEGs&nbsp;in GSE 67916. (XLSX 26&nbsp;kb)</span>
                        </div></div>
                  </div>
                  <div class="MediaObject" id="MOESM4">
                    <div xmlns="" class="esm-item "><div xmlns="http://www.w3.org/1999/xhtml" class="caption-container"><a href="https://static-content.springer.com/esm/art%3A10.1186%2Fs41065-018-0055-7/MediaObjects/41065_2018_55_MOESM4_ESM.xlsx"><span class="caption-number">Additional file 4:</span></a>
                          <span xmlns="" class="SimplePara">Rlationship between miRNA and overall survival rate for the overlap miRNAs. (XLSX 9&nbsp;kb)</span>
                        </div></div>
                  </div>
                  <div class="MediaObject" id="MOESM5">
                    <div xmlns="" class="esm-item "><div xmlns="http://www.w3.org/1999/xhtml" class="caption-container"><a href="https://static-content.springer.com/esm/art%3A10.1186%2Fs41065-018-0055-7/MediaObjects/41065_2018_55_MOESM5_ESM.xlsx"><span class="caption-number">Additional file 5:</span></a>
                          <span xmlns="" class="SimplePara">Predicted&nbsp;targets of has-miR-542-5p. (XLSX 32 kb)</span>
                        </div></div>
                  </div>
                </div>
              
            </aside></div></section></div>
                        <div class="FulltextWrapper"><section xmlns="" xmlns:fn="http://www.w3.org/2005/xpath-functions" xmlns:meta="http://www.springer.com/app/meta" class="Section1 RenderAsSection1 c-section Affiliations" id="Aff"><h2 class="Heading js-ToggleCollapseSection c-section__heading" data-sticky-update="true"><a href="#Author-Affiliations" data-toggle="collapse" data-toggle-disable-clickoff="" data-target="Author-Affiliations">Authors’ Affiliations</a></h2><div class="js-CollapseSection CollapseSection c-section__content c-section__content" data-test="collapse-section" id="Author-Affiliations"><div xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" class="Affiliation" id="Aff1"><span class="AffiliationNumber">(1)</span><div class="AffiliationText">Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, 410008, People’s Republic of China</div></div><div xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" class="Affiliation" id="Aff2"><span class="AffiliationNumber">(2)</span><div class="AffiliationText">Institute of Clinical Pharmacology, Central South University, Changsha, 410078, People’s Republic of China</div></div><div xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" class="Affiliation" id="Aff3"><span class="AffiliationNumber">(3)</span><div class="AffiliationText">Hunan Key Laboratory of Pharmacogenetics, Changsha, 410078, People’s Republic of China</div></div><div xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" class="Affiliation" id="Aff4"><span class="AffiliationNumber">(4)</span><div class="AffiliationText">University of Kansas Medical Center, Kansas City, KS&nbsp;66160, USA</div></div></div></section></div>
                        <div class="FulltextWrapper"><section xmlns="" xmlns:fn="http://www.w3.org/2005/xpath-functions" xmlns:meta="http://www.springer.com/app/meta" class="Section1 RenderAsSection1 c-section SectionTypeMaterialsAndMethods" id="Bib1"><h2 class="Heading js-ToggleCollapseSection c-section__heading" data-sticky-update="true"><a href="#References" data-toggle="collapse" data-toggle-disable-clickoff="" data-target="References">References</a></h2><div class="js-CollapseSection CollapseSection c-section__content" data-test="collapse-section" id="References"><ol class="BibliographyWrapper"><li class="Citation"><cite class="CitationContent" id="CR1" itemprop="citation" itemscope="" itemtype="http://schema.org/ScholarlyArticle"><span itemprop="headline">Gradishar WJ, Anderson BO, Balassanian R, Blair SL, Burstein HJ, Cyr A, Elias AD, Farrar WB, Forero A, Giordano SH, et al. Invasive breast cancer version 1.2016, NCCN clinical practice guidelines in oncology. Journal of the National Comprehensive Cancer Network : JNCCN. 2016;14:324–54.</span><span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a target="_blank" rel="noopener" href="https://doi.org/10.6004/jnccn.2016.0037"><span><span>View Article</span></span></a></span><span class="Occurrence OccurrencePID"><a target="_blank" rel="noopener nofollow" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=26957618"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener" href="http://scholar.google.com/scholar_lookup?title=Invasive%20breast%20cancer%20version%201.2016%2C%20NCCN%20clinical%20practice%20guidelines%20in%20oncology&amp;author=WJ.%20Gradishar&amp;author=BO.%20Anderson&amp;author=R.%20Balassanian&amp;author=SL.%20Blair&amp;author=HJ.%20Burstein&amp;author=A.%20Cyr&amp;author=AD.%20Elias&amp;author=WB.%20Farrar&amp;author=A.%20Forero&amp;author=SH.%20Giordano&amp;journal=Journal%20of%20the%20National%20Comprehensive%20Cancer%20Network%20%3A%20JNCCN&amp;volume=14&amp;pages=324-354&amp;publication_year=2016"><span><span>Google Scholar</span></span></a></span></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR2" itemprop="citation" itemscope="" itemtype="http://schema.org/ScholarlyArticle"><span itemprop="headline">Sivasubramaniam PG, Zhang B-L, Zhang Q, Smith JS, Zhang B, Tang Z-H, Chen G-J, Xie X-M, X-Z X, Yang H-J, et al. Breast cancer disparities: a multicenter comparison of tumor diagnosis, characteristics, and surgical treatment in China and the US. Oncologist. 2015;20:1044–50.</span><span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a target="_blank" rel="noopener" href="https://doi.org/10.1634/theoncologist.2014-0290"><span><span>View Article</span></span></a></span><span class="Occurrence OccurrencePID"><a target="_blank" rel="noopener nofollow" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=26240131"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrencePMCID"><a target="_blank" rel="noopener nofollow" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4571797"><span><span>PubMed Central</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener" href="http://scholar.google.com/scholar_lookup?title=Breast%20cancer%20disparities%3A%20a%20multicenter%20comparison%20of%20tumor%20diagnosis%2C%20characteristics%2C%20and%20surgical%20treatment%20in%20China%20and%20the%20US&amp;author=PG.%20Sivasubramaniam&amp;author=B-L.%20Zhang&amp;author=Q.%20Zhang&amp;author=JS.%20Smith&amp;author=B.%20Zhang&amp;author=Z-H.%20Tang&amp;author=G-J.%20Chen&amp;author=X-M.%20Xie&amp;author=X.%20X-Z&amp;author=H-J.%20Yang&amp;journal=Oncologist&amp;volume=20&amp;pages=1044-1050&amp;publication_year=2015"><span><span>Google Scholar</span></span></a></span></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR3" itemprop="citation" itemscope="" itemtype="http://schema.org/ScholarlyArticle"><span itemprop="headline">Zheng S, Bai JQ, Li J, Fan JH, Pang Y, Song QK, Huang R, Yang HJ, Xu F, Lu N, Qiao YL. The pathologic characteristics of breast cancer in China and its shift during 1999-2008: a national-wide multicenter cross-sectional image over 10 years. Int J Cancer. 2012;131:2622–31.</span><span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a target="_blank" rel="noopener" href="https://doi.org/10.1002/ijc.27513"><span><span>View Article</span></span></a></span><span class="Occurrence OccurrencePID"><a target="_blank" rel="noopener nofollow" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=22377956"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener" href="http://scholar.google.com/scholar_lookup?title=The%20pathologic%20characteristics%20of%20breast%20cancer%20in%20China%20and%20its%20shift%20during%201999-2008%3A%20a%20national-wide%20multicenter%20cross-sectional%20image%20over%2010%20years&amp;author=S.%20Zheng&amp;author=JQ.%20Bai&amp;author=J.%20Li&amp;author=JH.%20Fan&amp;author=Y.%20Pang&amp;author=QK.%20Song&amp;author=R.%20Huang&amp;author=HJ.%20Yang&amp;author=F.%20Xu&amp;author=N.%20Lu&amp;author=YL.%20Qiao&amp;journal=Int%20J%20Cancer&amp;volume=131&amp;pages=2622-2631&amp;publication_year=2012"><span><span>Google Scholar</span></span></a></span></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR4" itemprop="citation" itemscope="" itemtype="http://schema.org/ScholarlyArticle"><span itemprop="headline">Ring A, Dowsett M. Mechanisms of tamoxifen resistance. Endocr Relat Cancer. 2004;11:643–58.</span><span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a target="_blank" rel="noopener" href="https://doi.org/10.1677/erc.1.00776"><span><span>View Article</span></span></a></span><span class="Occurrence OccurrencePID"><a target="_blank" rel="noopener nofollow" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=15613444"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener" href="http://scholar.google.com/scholar_lookup?title=Mechanisms%20of%20tamoxifen%20resistance&amp;author=A.%20Ring&amp;author=M.%20Dowsett&amp;journal=Endocr%20Relat%20Cancer&amp;volume=11&amp;pages=643-658&amp;publication_year=2004"><span><span>Google Scholar</span></span></a></span></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR5" itemprop="citation" itemscope="" itemtype="http://schema.org/ScholarlyArticle"><span itemprop="headline">Song QK, Li J, Huang R, Fan JH, Zheng RS, Zhang BN, Zhang B, Tang ZH, Xie XM, Yang HJ, et al. Age of diagnosis of breast cancer in china: almost 10 years earlier than in the United States and the European union. Asian Pacific journal of cancer prevention : APJCP. 2014;15:10021–5.</span><span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a target="_blank" rel="noopener" href="https://doi.org/10.7314/APJCP.2014.15.22.10021"><span><span>View Article</span></span></a></span><span class="Occurrence OccurrencePID"><a target="_blank" rel="noopener nofollow" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=25520063"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener" href="http://scholar.google.com/scholar_lookup?title=Age%20of%20diagnosis%20of%20breast%20cancer%20in%20china%3A%20almost%2010%20years%20earlier%20than%20in%20the%20United%20States%20and%20the%20European%20union&amp;author=QK.%20Song&amp;author=J.%20Li&amp;author=R.%20Huang&amp;author=JH.%20Fan&amp;author=RS.%20Zheng&amp;author=BN.%20Zhang&amp;author=B.%20Zhang&amp;author=ZH.%20Tang&amp;author=XM.%20Xie&amp;author=HJ.%20Yang&amp;journal=Asian%20Pacific%20journal%20of%20cancer%20prevention%20%3A%20APJCP&amp;volume=15&amp;pages=10021-10025&amp;publication_year=2014"><span><span>Google Scholar</span></span></a></span></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR6" itemprop="citation" itemscope="" itemtype="http://schema.org/ScholarlyArticle"><span itemprop="headline">Viedma-Rodriguez R, Baiza-Gutman L, Salamanca-Gomez F, Diaz-Zaragoza M, Martinez-Hernandez G, Ruiz Esparza-Garrido R, Velazquez-Flores MA, Arenas-Aranda D. Mechanisms associated with resistance to tamoxifen in estrogen receptor-positive breast cancer (review). Oncol Rep. 2014;32:3–15.</span><span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a target="_blank" rel="noopener" href="https://doi.org/10.3892/or.2014.3190"><span><span>View Article</span></span></a></span><span class="Occurrence OccurrencePID"><a target="_blank" rel="noopener nofollow" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=24841429"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener" href="http://scholar.google.com/scholar_lookup?title=Mechanisms%20associated%20with%20resistance%20to%20tamoxifen%20in%20estrogen%20receptor-positive%20breast%20cancer%20%28review%29&amp;author=R.%20Viedma-Rodriguez&amp;author=L.%20Baiza-Gutman&amp;author=F.%20Salamanca-Gomez&amp;author=M.%20Diaz-Zaragoza&amp;author=G.%20Martinez-Hernandez&amp;author=R.%20Ruiz%20Esparza-Garrido&amp;author=MA.%20Velazquez-Flores&amp;author=D.%20Arenas-Aranda&amp;journal=Oncol%20Rep&amp;volume=32&amp;pages=3-15&amp;publication_year=2014"><span><span>Google Scholar</span></span></a></span></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR7" itemprop="citation" itemscope="" itemtype="http://schema.org/ScholarlyArticle"><span itemprop="headline">Liu R, Guo CX, Zhou HH. Network-based approach to identify prognostic biomarkers for estrogen receptor-positive breast cancer treatment with tamoxifen. Cancer biology &amp; therapy. 2015;16:317–24.</span><span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a target="_blank" rel="noopener" href="https://doi.org/10.1080/15384047.2014.1002360"><span><span>View Article</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener" href="http://scholar.google.com/scholar_lookup?title=Network-based%20approach%20to%20identify%20prognostic%20biomarkers%20for%20estrogen%20receptor-positive%20breast%20cancer%20treatment%20with%20tamoxifen&amp;author=R.%20Liu&amp;author=CX.%20Guo&amp;author=HH.%20Zhou&amp;journal=Cancer%20biology%20%26%20therapy&amp;volume=16&amp;pages=317-324&amp;publication_year=2015"><span><span>Google Scholar</span></span></a></span></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR8" itemprop="citation" itemscope="" itemtype="http://schema.org/ScholarlyArticle"><span itemprop="headline">Badia E, Oliva J, Balaguer P, Cavailles V. Tamoxifen resistance and epigenetic modifications in breast cancer cell lines. Curr Med Chem. 2007;14:3035–45.</span><span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a target="_blank" rel="noopener" href="https://doi.org/10.2174/092986707782794023"><span><span>View Article</span></span></a></span><span class="Occurrence OccurrencePID"><a target="_blank" rel="noopener nofollow" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=18220739"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrencePMCID"><a target="_blank" rel="noopener nofollow" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2789301"><span><span>PubMed Central</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener" href="http://scholar.google.com/scholar_lookup?title=Tamoxifen%20resistance%20and%20epigenetic%20modifications%20in%20breast%20cancer%20cell%20lines&amp;author=E.%20Badia&amp;author=J.%20Oliva&amp;author=P.%20Balaguer&amp;author=V.%20Cavailles&amp;journal=Curr%20Med%20Chem&amp;volume=14&amp;pages=3035-3045&amp;publication_year=2007"><span><span>Google Scholar</span></span></a></span></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR9" itemprop="citation" itemscope="" itemtype="http://schema.org/ScholarlyArticle"><span itemprop="headline">Kasinski AL, Slack FJ. Epigenetics and genetics. MicroRNAs en route to the clinic: progress in validating and targeting microRNAs for cancer therapy. Nat Rev Cancer. 2011;11:849–64.</span><span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a target="_blank" rel="noopener" href="https://doi.org/10.1038/nrc3166"><span><span>View Article</span></span></a></span><span class="Occurrence OccurrencePID"><a target="_blank" rel="noopener nofollow" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=22113163"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrencePMCID"><a target="_blank" rel="noopener nofollow" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4314215"><span><span>PubMed Central</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener" href="http://scholar.google.com/scholar_lookup?title=Epigenetics%20and%20genetics.%20MicroRNAs%20en%20route%20to%20the%20clinic%3A%20progress%20in%20validating%20and%20targeting%20microRNAs%20for%20cancer%20therapy&amp;author=AL.%20Kasinski&amp;author=FJ.%20Slack&amp;journal=Nat%20Rev%20Cancer&amp;volume=11&amp;pages=849-864&amp;publication_year=2011"><span><span>Google Scholar</span></span></a></span></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR10" itemprop="citation" itemscope="" itemtype="http://schema.org/ScholarlyArticle"><span itemprop="headline">Brummer A, Hausser J. MicroRNA binding sites in the coding region of mRNAs: extending the repertoire of post-transcriptional gene regulation. BioEssays : news and reviews in molecular, cellular and developmental biology. 2014;36:617–26.</span><span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a target="_blank" rel="noopener" href="https://doi.org/10.1002/bies.201300104"><span><span>View Article</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener" href="http://scholar.google.com/scholar_lookup?title=MicroRNA%20binding%20sites%20in%20the%20coding%20region%20of%20mRNAs%3A%20extending%20the%20repertoire%20of%20post-transcriptional%20gene%20regulation&amp;author=A.%20Brummer&amp;author=J.%20Hausser&amp;journal=BioEssays%20%3A%20news%20and%20reviews%20in%20molecular%2C%20cellular%20and%20developmental%20biology&amp;volume=36&amp;pages=617-626&amp;publication_year=2014"><span><span>Google Scholar</span></span></a></span></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR11" itemprop="citation" itemscope="" itemtype="http://schema.org/ScholarlyArticle"><span itemprop="headline">Muluhngwi P, Klinge CM. Roles for miRNAs in endocrine resistance in breast cancer. Endocr Relat Cancer. 2015;22:R279–300.</span><span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a target="_blank" rel="noopener" href="https://doi.org/10.1530/ERC-15-0355"><span><span>View Article</span></span></a></span><span class="Occurrence OccurrencePID"><a target="_blank" rel="noopener nofollow" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=26346768"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrencePMCID"><a target="_blank" rel="noopener nofollow" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4563344"><span><span>PubMed Central</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener" href="http://scholar.google.com/scholar_lookup?title=Roles%20for%20miRNAs%20in%20endocrine%20resistance%20in%20breast%20cancer&amp;author=P.%20Muluhngwi&amp;author=CM.%20Klinge&amp;journal=Endocr%20Relat%20Cancer&amp;volume=22&amp;pages=R279-R300&amp;publication_year=2015"><span><span>Google Scholar</span></span></a></span></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR12" itemprop="citation" itemscope="" itemtype="http://schema.org/ScholarlyArticle"><span itemprop="headline">Lyng MB, Laenkholm AV, Sokilde R, Gravgaard KH, Litman T, Ditzel HJ. Global microRNA expression profiling of high-risk ER+ breast cancers from patients receiving adjuvant tamoxifen mono-therapy: a DBCG study. PLoS One. 2012;7:e36170.</span><span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a target="_blank" rel="noopener" href="https://doi.org/10.1371/journal.pone.0036170"><span><span>View Article</span></span></a></span><span class="Occurrence OccurrencePID"><a target="_blank" rel="noopener nofollow" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=22623953"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrencePMCID"><a target="_blank" rel="noopener nofollow" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3356496"><span><span>PubMed Central</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener" href="http://scholar.google.com/scholar_lookup?title=Global%20microRNA%20expression%20profiling%20of%20high-risk%20ER%2B%20breast%20cancers%20from%20patients%20receiving%20adjuvant%20tamoxifen%20mono-therapy%3A%20a%20DBCG%20study&amp;author=MB.%20Lyng&amp;author=AV.%20Laenkholm&amp;author=R.%20Sokilde&amp;author=KH.%20Gravgaard&amp;author=T.%20Litman&amp;author=HJ.%20Ditzel&amp;journal=PLoS%20One&amp;volume=7&amp;publication_year=2012"><span><span>Google Scholar</span></span></a></span></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR13" itemprop="citation" itemscope="" itemtype="http://schema.org/ScholarlyArticle"><span itemprop="headline">Joshi T, Elias D, Stenvang J, Alves CL, Teng F, Lyng MB, Lykkesfeldt AE, Brunner N, Wang J, Gupta R, et al. Integrative analysis of miRNA and gene expression reveals regulatory networks in tamoxifen-resistant breast cancer. Oncotarget. 2016;7:57239–53.</span><span class="Occurrences"><span class="Occurrence OccurrencePID"><a target="_blank" rel="noopener nofollow" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=27528030"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrencePMCID"><a target="_blank" rel="noopener nofollow" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5302986"><span><span>PubMed Central</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener" href="http://scholar.google.com/scholar_lookup?title=Integrative%20analysis%20of%20miRNA%20and%20gene%20expression%20reveals%20regulatory%20networks%20in%20tamoxifen-resistant%20breast%20cancer&amp;author=T.%20Joshi&amp;author=D.%20Elias&amp;author=J.%20Stenvang&amp;author=CL.%20Alves&amp;author=F.%20Teng&amp;author=MB.%20Lyng&amp;author=AE.%20Lykkesfeldt&amp;author=N.%20Brunner&amp;author=J.%20Wang&amp;author=R.%20Gupta&amp;journal=Oncotarget&amp;volume=7&amp;pages=57239-57253&amp;publication_year=2016"><span><span>Google Scholar</span></span></a></span></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR14" itemprop="citation" itemscope="" itemtype="http://schema.org/ScholarlyArticle"><span itemprop="headline">Coser KR, Wittner BS, Rosenthal NF, Collins SC, Melas A, Smith SL, Mahoney CJ, Shioda K, Isselbacher KJ, Ramaswamy S, Shioda T. Antiestrogen-resistant subclones of MCF-7 human breast cancer cells are derived from a common monoclonal drug-resistant progenitor. Proc Natl Acad Sci U S A. 2009;106:14536–41.</span><span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a target="_blank" rel="noopener" href="https://doi.org/10.1073/pnas.0907560106"><span><span>View Article</span></span></a></span><span class="Occurrence OccurrencePID"><a target="_blank" rel="noopener nofollow" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=19706540"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrencePMCID"><a target="_blank" rel="noopener nofollow" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2732824"><span><span>PubMed Central</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener" href="http://scholar.google.com/scholar_lookup?title=Antiestrogen-resistant%20subclones%20of%20MCF-7%20human%20breast%20cancer%20cells%20are%20derived%20from%20a%20common%20monoclonal%20drug-resistant%20progenitor&amp;author=KR.%20Coser&amp;author=BS.%20Wittner&amp;author=NF.%20Rosenthal&amp;author=SC.%20Collins&amp;author=A.%20Melas&amp;author=SL.%20Smith&amp;author=CJ.%20Mahoney&amp;author=K.%20Shioda&amp;author=KJ.%20Isselbacher&amp;author=S.%20Ramaswamy&amp;author=T.%20Shioda&amp;journal=Proc%20Natl%20Acad%20Sci%20U%20S%20A&amp;volume=106&amp;pages=14536-14541&amp;publication_year=2009"><span><span>Google Scholar</span></span></a></span></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR15" itemprop="citation" itemscope="" itemtype="http://schema.org/ScholarlyArticle"><span itemprop="headline">Ward A, Shukla K, Balwierz A, Soons Z, Konig R, Sahin O, Wiemann S. MicroRNA-519a is a novel oncomir conferring tamoxifen resistance by targeting a network of tumour-suppressor genes in ER+ breast cancer. J Pathol. 2014;233:368–79.</span><span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a target="_blank" rel="noopener" href="https://doi.org/10.1002/path.4363"><span><span>View Article</span></span></a></span><span class="Occurrence OccurrencePID"><a target="_blank" rel="noopener nofollow" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=24752803"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrencePMCID"><a target="_blank" rel="noopener nofollow" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4298809"><span><span>PubMed Central</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener" href="http://scholar.google.com/scholar_lookup?title=MicroRNA-519a%20is%20a%20novel%20oncomir%20conferring%20tamoxifen%20resistance%20by%20targeting%20a%20network%20of%20tumour-suppressor%20genes%20in%20ER%2B%20breast%20cancer&amp;author=A.%20Ward&amp;author=K.%20Shukla&amp;author=A.%20Balwierz&amp;author=Z.%20Soons&amp;author=R.%20Konig&amp;author=O.%20Sahin&amp;author=S.%20Wiemann&amp;journal=J%20Pathol&amp;volume=233&amp;pages=368-379&amp;publication_year=2014"><span><span>Google Scholar</span></span></a></span></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR16" itemprop="citation" itemscope="" itemtype="http://schema.org/ScholarlyArticle"><span itemprop="headline">Li X, Wu Y, Liu A, Tang X. MiR-27b is epigenetically downregulated in tamoxifen resistant breast cancer cells due to promoter methylation and regulates tamoxifen sensitivity by targeting HMGB3. Biochem Biophys Res Commun. 2016;477:768–73.</span><span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a target="_blank" rel="noopener" href="https://doi.org/10.1016/j.bbrc.2016.06.133"><span><span>View Article</span></span></a></span><span class="Occurrence OccurrencePID"><a target="_blank" rel="noopener nofollow" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=27363334"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener" href="http://scholar.google.com/scholar_lookup?title=MiR-27b%20is%20epigenetically%20downregulated%20in%20tamoxifen%20resistant%20breast%20cancer%20cells%20due%20to%20promoter%20methylation%20and%20regulates%20tamoxifen%20sensitivity%20by%20targeting%20HMGB3&amp;author=X.%20Li&amp;author=Y.%20Wu&amp;author=A.%20Liu&amp;author=X.%20Tang&amp;journal=Biochem%20Biophys%20Res%20Commun&amp;volume=477&amp;pages=768-773&amp;publication_year=2016"><span><span>Google Scholar</span></span></a></span></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR17" itemprop="citation" itemscope="" itemtype="http://schema.org/ScholarlyArticle"><span itemprop="headline">Lu M, Ding K, Zhang G, Yin M, Yao G, Tian H, Lian J, Liu L, Liang M, Zhu T, Sun F. MicroRNA-320a sensitizes tamoxifen-resistant breast cancer cells to tamoxifen by targeting ARPP-19 and ERRgamma. Sci Rep. 2015;5:8735.</span><span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a target="_blank" rel="noopener" href="https://doi.org/10.1038/srep08735"><span><span>View Article</span></span></a></span><span class="Occurrence OccurrencePID"><a target="_blank" rel="noopener nofollow" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=25736597"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrencePMCID"><a target="_blank" rel="noopener nofollow" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4348640"><span><span>PubMed Central</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener" href="http://scholar.google.com/scholar_lookup?title=MicroRNA-320a%20sensitizes%20tamoxifen-resistant%20breast%20cancer%20cells%20to%20tamoxifen%20by%20targeting%20ARPP-19%20and%20ERRgamma&amp;author=M.%20Lu&amp;author=K.%20Ding&amp;author=G.%20Zhang&amp;author=M.%20Yin&amp;author=G.%20Yao&amp;author=H.%20Tian&amp;author=J.%20Lian&amp;author=L.%20Liu&amp;author=M.%20Liang&amp;author=T.%20Zhu&amp;author=F.%20Sun&amp;journal=Sci%20Rep&amp;volume=5&amp;pages=8735&amp;publication_year=2015"><span><span>Google Scholar</span></span></a></span></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR18" itemprop="citation" itemscope="" itemtype="http://schema.org/ScholarlyArticle"><span itemprop="headline">Ikeda K, Horie-Inoue K, Ueno T, Suzuki T, Sato W, Shigekawa T, Osaki A, Saeki T, Berezikov E, Mano H, Inoue S. miR-378a-3p modulates tamoxifen sensitivity in breast cancer MCF-7 cells through targeting GOLT1A. Sci Rep. 2015;5:13170.</span><span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a target="_blank" rel="noopener" href="https://doi.org/10.1038/srep13170"><span><span>View Article</span></span></a></span><span class="Occurrence OccurrencePID"><a target="_blank" rel="noopener nofollow" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=26255816"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrencePMCID"><a target="_blank" rel="noopener nofollow" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4530347"><span><span>PubMed Central</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener" href="http://scholar.google.com/scholar_lookup?title=miR-378a-3p%20modulates%20tamoxifen%20sensitivity%20in%20breast%20cancer%20MCF-7%20cells%20through%20targeting%20GOLT1A&amp;author=K.%20Ikeda&amp;author=K.%20Horie-Inoue&amp;author=T.%20Ueno&amp;author=T.%20Suzuki&amp;author=W.%20Sato&amp;author=T.%20Shigekawa&amp;author=A.%20Osaki&amp;author=T.%20Saeki&amp;author=E.%20Berezikov&amp;author=H.%20Mano&amp;author=S.%20Inoue&amp;journal=Sci%20Rep&amp;volume=5&amp;publication_year=2015"><span><span>Google Scholar</span></span></a></span></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR19" itemprop="citation" itemscope="" itemtype="http://schema.org/ScholarlyArticle"><span itemprop="headline">Collisson EA, Sadanandam A, Olson P, Gibb WJ, Truitt M, Gu S, Cooc J, Weinkle J, Kim GE, Jakkula L, et al. Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy. Nat Med. 2011;17:500–3.</span><span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a target="_blank" rel="noopener" href="https://doi.org/10.1038/nm.2344"><span><span>View Article</span></span></a></span><span class="Occurrence OccurrencePID"><a target="_blank" rel="noopener nofollow" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=21460848"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrencePMCID"><a target="_blank" rel="noopener nofollow" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3755490"><span><span>PubMed Central</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener" href="http://scholar.google.com/scholar_lookup?title=Subtypes%20of%20pancreatic%20ductal%20adenocarcinoma%20and%20their%20differing%20responses%20to%20therapy&amp;author=EA.%20Collisson&amp;author=A.%20Sadanandam&amp;author=P.%20Olson&amp;author=WJ.%20Gibb&amp;author=M.%20Truitt&amp;author=S.%20Gu&amp;author=J.%20Cooc&amp;author=J.%20Weinkle&amp;author=GE.%20Kim&amp;author=L.%20Jakkula&amp;journal=Nat%20Med&amp;volume=17&amp;pages=500-503&amp;publication_year=2011"><span><span>Google Scholar</span></span></a></span></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR20" itemprop="citation" itemscope="" itemtype="http://schema.org/ScholarlyArticle"><span itemprop="headline">Barrett T, Wilhite SE, Ledoux P, Evangelista C, Kim IF, Tomashevsky M, Marshall KA, Phillippy KH, Sherman PM, Holko M, et al. NCBI GEO: archive for functional genomics data sets--update. Nucleic Acids Res. 2013;41:D991–5.</span><span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a target="_blank" rel="noopener" href="https://doi.org/10.1093/nar/gks1193"><span><span>View Article</span></span></a></span><span class="Occurrence OccurrencePID"><a target="_blank" rel="noopener nofollow" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=23193258"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener" href="http://scholar.google.com/scholar_lookup?title=NCBI%20GEO%3A%20archive%20for%20functional%20genomics%20data%20sets--update&amp;author=T.%20Barrett&amp;author=SE.%20Wilhite&amp;author=P.%20Ledoux&amp;author=C.%20Evangelista&amp;author=IF.%20Kim&amp;author=M.%20Tomashevsky&amp;author=KA.%20Marshall&amp;author=KH.%20Phillippy&amp;author=PM.%20Sherman&amp;author=M.%20Holko&amp;journal=Nucleic%20Acids%20Res&amp;volume=41&amp;pages=D991-D995&amp;publication_year=2013"><span><span>Google Scholar</span></span></a></span></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR21" itemprop="citation" itemscope="" itemtype="http://schema.org/ScholarlyArticle"><span itemprop="headline">Lanczky A, Nagy A, Bottai G, Munkacsy G, Szabo A, Santarpia L, Gyorffy B. miRpower: a web-tool to validate survival-associated miRNAs utilizing expression data from 2178 breast cancer patients. Breast Cancer Res Treat. 2016;160:439–46.</span><span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a target="_blank" rel="noopener" href="https://doi.org/10.1007/s10549-016-4013-7"><span><span>View Article</span></span></a></span><span class="Occurrence OccurrencePID"><a target="_blank" rel="noopener nofollow" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=27744485"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener" href="http://scholar.google.com/scholar_lookup?title=miRpower%3A%20a%20web-tool%20to%20validate%20survival-associated%20miRNAs%20utilizing%20expression%20data%20from%202178%20breast%20cancer%20patients&amp;author=A.%20Lanczky&amp;author=A.%20Nagy&amp;author=G.%20Bottai&amp;author=G.%20Munkacsy&amp;author=A.%20Szabo&amp;author=L.%20Santarpia&amp;author=B.%20Gyorffy&amp;journal=Breast%20Cancer%20Res%20Treat&amp;volume=160&amp;pages=439-446&amp;publication_year=2016"><span><span>Google Scholar</span></span></a></span></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR22" itemprop="citation" itemscope="" itemtype="http://schema.org/ScholarlyArticle"><span itemprop="headline">Gyorffy B, Lanczky A, Eklund AC, Denkert C, Budczies J, Li Q, Szallasi Z. An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients. Breast Cancer Res Treat. 2010;123:725–31.</span><span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a target="_blank" rel="noopener" href="https://doi.org/10.1007/s10549-009-0674-9"><span><span>View Article</span></span></a></span><span class="Occurrence OccurrencePID"><a target="_blank" rel="noopener nofollow" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=20020197"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener" href="http://scholar.google.com/scholar_lookup?title=An%20online%20survival%20analysis%20tool%20to%20rapidly%20assess%20the%20effect%20of%2022%2C277%20genes%20on%20breast%20cancer%20prognosis%20using%20microarray%20data%20of%201%2C809%20patients&amp;author=B.%20Gyorffy&amp;author=A.%20Lanczky&amp;author=AC.%20Eklund&amp;author=C.%20Denkert&amp;author=J.%20Budczies&amp;author=Q.%20Li&amp;author=Z.%20Szallasi&amp;journal=Breast%20Cancer%20Res%20Treat&amp;volume=123&amp;pages=725-731&amp;publication_year=2010"><span><span>Google Scholar</span></span></a></span></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR23" itemprop="citation" itemscope="" itemtype="http://schema.org/ScholarlyArticle"><span itemprop="headline">Tang Z, Li C, Kang B, Gao G, Li C, Zhang Z. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017;<span xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" class="Occurrences"><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener" href="https://scholar.google.com/scholar?hl=en&amp;q=Tang%20Z%2C%20Li%20C%2C%20Kang%20B%2C%20Gao%20G%2C%20Li%20C%2C%20Zhang%20Z.%20GEPIA%3A%20a%20web%20server%20for%20cancer%20and%20normal%20gene%20expression%20profiling%20and%20interactive%20analyses.%20Nucleic%20Acids%20Res.%202017%3B"><span><span>Google Scholar</span></span></a></span></span></span><span class="Occurrences"></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR24" itemprop="citation" itemscope="" itemtype="http://schema.org/ScholarlyArticle"><span itemprop="headline">Gao J, Aksoy BA, Dogrusoz U, Dresdner G, Gross B, Sumer SO, Sun Y, Jacobsen A, Sinha R, Larsson E, et al: Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Science signaling 2013, 6:pl1.<span xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" class="Occurrences"><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener" href="https://scholar.google.com/scholar?hl=en&amp;q=Gao%20J%2C%20Aksoy%20BA%2C%20Dogrusoz%20U%2C%20Dresdner%20G%2C%20Gross%20B%2C%20Sumer%20SO%2C%20Sun%20Y%2C%20Jacobsen%20A%2C%20Sinha%20R%2C%20Larsson%20E%2C%20et%20al%3A%20Integrative%20analysis%20of%20complex%20cancer%20genomics%20and%20clinical%20profiles%20using%20the%20cBioPortal.%20Science%20signaling%202013%2C%206%3Apl1."><span><span>Google Scholar</span></span></a></span></span></span><span class="Occurrences"></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR25" itemprop="citation" itemscope="" itemtype="http://schema.org/ScholarlyArticle"><span itemprop="headline">Egeland NG, Lunde S, Jonsdottir K, Lende TH, Cronin-Fenton D, Gilje B, Janssen EA, Soiland H. The role of MicroRNAs as predictors of response to tamoxifen treatment in breast cancer patients. Int J Mol Sci. 2015;16:24243–75.</span><span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a target="_blank" rel="noopener" href="https://doi.org/10.3390/ijms161024243"><span><span>View Article</span></span></a></span><span class="Occurrence OccurrencePID"><a target="_blank" rel="noopener nofollow" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=26473850"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrencePMCID"><a target="_blank" rel="noopener nofollow" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4632748"><span><span>PubMed Central</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener" href="http://scholar.google.com/scholar_lookup?title=The%20role%20of%20MicroRNAs%20as%20predictors%20of%20response%20to%20tamoxifen%20treatment%20in%20breast%20cancer%20patients&amp;author=NG.%20Egeland&amp;author=S.%20Lunde&amp;author=K.%20Jonsdottir&amp;author=TH.%20Lende&amp;author=D.%20Cronin-Fenton&amp;author=B.%20Gilje&amp;author=EA.%20Janssen&amp;author=H.%20Soiland&amp;journal=Int%20J%20Mol%20Sci&amp;volume=16&amp;pages=24243-24275&amp;publication_year=2015"><span><span>Google Scholar</span></span></a></span></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR26" itemprop="citation" itemscope="" itemtype="http://schema.org/ScholarlyArticle"><span itemprop="headline">Sun H, Wang G, Peng Y, Zeng Y, Zhu QN, Li TL, Cai JQ, Zhou HH, Zhu YS. H19 lncRNA mediates 17beta-estradiol-induced cell proliferation in MCF-7 breast cancer cells. Oncol Rep. 2015;33:3045–52.</span><span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a target="_blank" rel="noopener" href="https://doi.org/10.3892/or.2015.3899"><span><span>View Article</span></span></a></span><span class="Occurrence OccurrencePID"><a target="_blank" rel="noopener nofollow" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=25846769"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener" href="http://scholar.google.com/scholar_lookup?title=H19%20lncRNA%20mediates%2017beta-estradiol-induced%20cell%20proliferation%20in%20MCF-7%20breast%20cancer%20cells&amp;author=H.%20Sun&amp;author=G.%20Wang&amp;author=Y.%20Peng&amp;author=Y.%20Zeng&amp;author=QN.%20Zhu&amp;author=TL.%20Li&amp;author=JQ.%20Cai&amp;author=HH.%20Zhou&amp;author=YS.%20Zhu&amp;journal=Oncol%20Rep&amp;volume=33&amp;pages=3045-3052&amp;publication_year=2015"><span><span>Google Scholar</span></span></a></span></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR27" itemprop="citation" itemscope="" itemtype="http://schema.org/ScholarlyArticle"><span itemprop="headline">Zhu J, Zou Z, Nie P, Kou X, Wu B, Wang S, Song Z, He J. Downregulation of microRNA-27b-3p enhances tamoxifen resistance in breast cancer by increasing NR5A2 and CREB1 expression. Cell Death Dis. 2016;7:e2454.</span><span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a target="_blank" rel="noopener" href="https://doi.org/10.1038/cddis.2016.361"><span><span>View Article</span></span></a></span><span class="Occurrence OccurrencePID"><a target="_blank" rel="noopener nofollow" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=27809310"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrencePMCID"><a target="_blank" rel="noopener nofollow" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5260890"><span><span>PubMed Central</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener" href="http://scholar.google.com/scholar_lookup?title=Downregulation%20of%20microRNA-27b-3p%20enhances%20tamoxifen%20resistance%20in%20breast%20cancer%20by%20increasing%20NR5A2%20and%20CREB1%20expression&amp;author=J.%20Zhu&amp;author=Z.%20Zou&amp;author=P.%20Nie&amp;author=X.%20Kou&amp;author=B.%20Wu&amp;author=S.%20Wang&amp;author=Z.%20Song&amp;author=J.%20He&amp;journal=Cell%20Death%20Dis&amp;volume=7&amp;publication_year=2016"><span><span>Google Scholar</span></span></a></span></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR28" itemprop="citation" itemscope="" itemtype="http://schema.org/ScholarlyArticle"><span itemprop="headline">Martin EC, Conger AK, Yan TJ, Hoang VT, Miller DF, Buechlein A, Rusch DB, Nephew KP, Collins-Burow BM, Burow ME. MicroRNA-335-5p and -3p synergize to inhibit estrogen receptor alpha expression and promote tamoxifen resistance. FEBS Lett. 2017;591:382–92.</span><span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a target="_blank" rel="noopener" href="https://doi.org/10.1002/1873-3468.12538"><span><span>View Article</span></span></a></span><span class="Occurrence OccurrencePID"><a target="_blank" rel="noopener nofollow" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=28008602"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener" href="http://scholar.google.com/scholar_lookup?title=MicroRNA-335-5p%20and%20-3p%20synergize%20to%20inhibit%20estrogen%20receptor%20alpha%20expression%20and%20promote%20tamoxifen%20resistance&amp;author=EC.%20Martin&amp;author=AK.%20Conger&amp;author=TJ.%20Yan&amp;author=VT.%20Hoang&amp;author=DF.%20Miller&amp;author=A.%20Buechlein&amp;author=DB.%20Rusch&amp;author=KP.%20Nephew&amp;author=BM.%20Collins-Burow&amp;author=ME.%20Burow&amp;journal=FEBS%20Lett&amp;volume=591&amp;pages=382-392&amp;publication_year=2017"><span><span>Google Scholar</span></span></a></span></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR29" itemprop="citation" itemscope="" itemtype="http://schema.org/ScholarlyArticle"><span itemprop="headline">Muluhngwi P, Krishna A, Vittitow SL, Napier JT, Richardson KM, Ellis M, Mott JL, Klinge CM. Tamoxifen differentially regulates miR-29b-1 and miR-29a expression depending on endocrine-sensitivity in breast cancer cells. Cancer Lett. 2016;388:230–8.</span><span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a target="_blank" rel="noopener" href="https://doi.org/10.1016/j.canlet.2016.12.007"><span><span>View Article</span></span></a></span><span class="Occurrence OccurrencePID"><a target="_blank" rel="noopener nofollow" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=27986463"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener" href="http://scholar.google.com/scholar_lookup?title=Tamoxifen%20differentially%20regulates%20miR-29b-1%20and%20miR-29a%20expression%20depending%20on%20endocrine-sensitivity%20in%20breast%20cancer%20cells&amp;author=P.%20Muluhngwi&amp;author=A.%20Krishna&amp;author=SL.%20Vittitow&amp;author=JT.%20Napier&amp;author=KM.%20Richardson&amp;author=M.%20Ellis&amp;author=JL.%20Mott&amp;author=CM.%20Klinge&amp;journal=Cancer%20Lett&amp;volume=388&amp;pages=230-238&amp;publication_year=2016"><span><span>Google Scholar</span></span></a></span></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR30" itemprop="citation" itemscope="" itemtype="http://schema.org/ScholarlyArticle"><span itemprop="headline">Karimi G, Alamolhida N, Behravan J, Mosaffa F. MiR 221/222 as new players in tamoxifen resistance. Curr Pharm Des. 2016;<span xmlns:func="http://oscar.fig.bmc.com" xmlns="http://www.w3.org/1999/xhtml" class="Occurrences"><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener" href="https://scholar.google.com/scholar?hl=en&amp;q=Karimi%20G%2C%20Alamolhida%20N%2C%20Behravan%20J%2C%20Mosaffa%20F.%20MiR%20221%2F222%20as%20new%20players%20in%20tamoxifen%20resistance.%20Curr%20Pharm%20Des.%202016%3B"><span><span>Google Scholar</span></span></a></span></span></span><span class="Occurrences"></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR31" itemprop="citation" itemscope="" itemtype="http://schema.org/ScholarlyArticle"><span itemprop="headline">Rask L, Balslev E, Sokilde R, Hogdall E, Flyger H, Eriksen J, Litman T. Differential expression of miR-139, miR-486 and miR-21 in breast cancer patients sub-classified according to lymph node status. Cell Oncol. 2014;37:215–27.</span><span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a target="_blank" rel="noopener" href="https://doi.org/10.1007/s13402-014-0176-6"><span><span>View Article</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener" href="http://scholar.google.com/scholar_lookup?title=Differential%20expression%20of%20miR-139%2C%20miR-486%20and%20miR-21%20in%20breast%20cancer%20patients%20sub-classified%20according%20to%20lymph%20node%20status&amp;author=L.%20Rask&amp;author=E.%20Balslev&amp;author=R.%20Sokilde&amp;author=E.%20Hogdall&amp;author=H.%20Flyger&amp;author=J.%20Eriksen&amp;author=T.%20Litman&amp;journal=Cell%20Oncol&amp;volume=37&amp;pages=215-227&amp;publication_year=2014"><span><span>Google Scholar</span></span></a></span></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR32" itemprop="citation" itemscope="" itemtype="http://schema.org/ScholarlyArticle"><span itemprop="headline">Schulte JH, Schowe B, Mestdagh P, Kaderali L, Kalaghatgi P, Schlierf S, Vermeulen J, Brockmeyer B, Pajtler K, Thor T, et al. Accurate prediction of neuroblastoma outcome based on miRNA expression profiles. Int J Cancer. 2010;127:2374–85.</span><span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a target="_blank" rel="noopener" href="https://doi.org/10.1002/ijc.25436"><span><span>View Article</span></span></a></span><span class="Occurrence OccurrencePID"><a target="_blank" rel="noopener nofollow" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=20473924"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener" href="http://scholar.google.com/scholar_lookup?title=Accurate%20prediction%20of%20neuroblastoma%20outcome%20based%20on%20miRNA%20expression%20profiles&amp;author=JH.%20Schulte&amp;author=B.%20Schowe&amp;author=P.%20Mestdagh&amp;author=L.%20Kaderali&amp;author=P.%20Kalaghatgi&amp;author=S.%20Schlierf&amp;author=J.%20Vermeulen&amp;author=B.%20Brockmeyer&amp;author=K.%20Pajtler&amp;author=T.%20Thor&amp;journal=Int%20J%20Cancer&amp;volume=127&amp;pages=2374-2385&amp;publication_year=2010"><span><span>Google Scholar</span></span></a></span></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR33" itemprop="citation" itemscope="" itemtype="http://schema.org/ScholarlyArticle"><span itemprop="headline">Bray I, Tivnan A, Bryan K, Foley NH, Watters KM, Tracey L, Davidoff AM, Stallings RL. MicroRNA-542-5p as a novel tumor suppressor in neuroblastoma. Cancer Lett. 2011;303:56–64.</span><span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a target="_blank" rel="noopener" href="https://doi.org/10.1016/j.canlet.2011.01.016"><span><span>View Article</span></span></a></span><span class="Occurrence OccurrencePID"><a target="_blank" rel="noopener nofollow" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=21310526"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrencePMCID"><a target="_blank" rel="noopener nofollow" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3057396"><span><span>PubMed Central</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener" href="http://scholar.google.com/scholar_lookup?title=MicroRNA-542-5p%20as%20a%20novel%20tumor%20suppressor%20in%20neuroblastoma&amp;author=I.%20Bray&amp;author=A.%20Tivnan&amp;author=K.%20Bryan&amp;author=NH.%20Foley&amp;author=KM.%20Watters&amp;author=L.%20Tracey&amp;author=AM.%20Davidoff&amp;author=RL.%20Stallings&amp;journal=Cancer%20Lett&amp;volume=303&amp;pages=56-64&amp;publication_year=2011"><span><span>Google Scholar</span></span></a></span></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR34" itemprop="citation" itemscope="" itemtype="http://schema.org/ScholarlyArticle"><span itemprop="headline">Wang B, Li J, Sun M, Sun L, Zhang X. miRNA expression in breast cancer varies with lymph node metastasis and other clinicopathologic features. IUBMB Life. 2014;66:371–7.</span><span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a target="_blank" rel="noopener" href="https://doi.org/10.1002/iub.1273"><span><span>View Article</span></span></a></span><span class="Occurrence OccurrencePID"><a target="_blank" rel="noopener nofollow" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=24846313"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener" href="http://scholar.google.com/scholar_lookup?title=miRNA%20expression%20in%20breast%20cancer%20varies%20with%20lymph%20node%20metastasis%20and%20other%20clinicopathologic%20features&amp;author=B.%20Wang&amp;author=J.%20Li&amp;author=M.%20Sun&amp;author=L.%20Sun&amp;author=X.%20Zhang&amp;journal=IUBMB%20Life&amp;volume=66&amp;pages=371-377&amp;publication_year=2014"><span><span>Google Scholar</span></span></a></span></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR35" itemprop="citation" itemscope="" itemtype="http://schema.org/ScholarlyArticle"><span itemprop="headline">Castilla MA, Moreno-Bueno G, Romero-Perez L, Van De Vijver K, Biscuola M, Lopez-Garcia MA, Prat J, Matias-Guiu X, Cano A, Oliva E, Palacios J. Micro-RNA signature of the epithelial-mesenchymal transition in endometrial carcinosarcoma. J Pathol. 2011;223:72–80.</span><span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a target="_blank" rel="noopener" href="https://doi.org/10.1002/path.2802"><span><span>View Article</span></span></a></span><span class="Occurrence OccurrencePID"><a target="_blank" rel="noopener nofollow" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=21125666"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener" href="http://scholar.google.com/scholar_lookup?title=Micro-RNA%20signature%20of%20the%20epithelial-mesenchymal%20transition%20in%20endometrial%20carcinosarcoma&amp;author=MA.%20Castilla&amp;author=G.%20Moreno-Bueno&amp;author=L.%20Romero-Perez&amp;author=K.%20Van%20De%20Vijver&amp;author=M.%20Biscuola&amp;author=MA.%20Lopez-Garcia&amp;author=J.%20Prat&amp;author=X.%20Matias-Guiu&amp;author=A.%20Cano&amp;author=E.%20Oliva&amp;author=J.%20Palacios&amp;journal=J%20Pathol&amp;volume=223&amp;pages=72-80&amp;publication_year=2011"><span><span>Google Scholar</span></span></a></span></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR36" itemprop="citation" itemscope="" itemtype="http://schema.org/ScholarlyArticle"><span itemprop="headline">Zhang W, Shi S, Jiang J, Li X, Lu H, Ren F. LncRNA MEG3 inhibits cell epithelial-mesenchymal transition by sponging miR-421 targeting E-cadherin in breast cancer. Biomedicine &amp; pharmacotherapy = Biomedecine &amp; pharmacotherapie. 2017;91:312–9.</span><span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a target="_blank" rel="noopener" href="https://doi.org/10.1016/j.biopha.2017.04.085"><span><span>View Article</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener" href="http://scholar.google.com/scholar_lookup?title=LncRNA%20MEG3%20inhibits%20cell%20epithelial-mesenchymal%20transition%20by%20sponging%20miR-421%20targeting%20E-cadherin%20in%20breast%20cancer&amp;author=W.%20Zhang&amp;author=S.%20Shi&amp;author=J.%20Jiang&amp;author=X.%20Li&amp;author=H.%20Lu&amp;author=F.%20Ren&amp;journal=Biomedicine%20%26%20pharmacotherapy%20%3D%20Biomedecine%20%26%20pharmacotherapie&amp;volume=91&amp;pages=312-319&amp;publication_year=2017"><span><span>Google Scholar</span></span></a></span></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR37" itemprop="citation" itemscope="" itemtype="http://schema.org/ScholarlyArticle"><span itemprop="headline">Pan Y, Jiao G, Wang C, Yang J, Yang W. MicroRNA-421 inhibits breast cancer metastasis by targeting metastasis associated 1. Biomedicine &amp; pharmacotherapy = Biomedecine &amp; pharmacotherapie. 2016;83:1398–406.</span><span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a target="_blank" rel="noopener" href="https://doi.org/10.1016/j.biopha.2016.08.058"><span><span>View Article</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener" href="http://scholar.google.com/scholar_lookup?title=MicroRNA-421%20inhibits%20breast%20cancer%20metastasis%20by%20targeting%20metastasis%20associated%201&amp;author=Y.%20Pan&amp;author=G.%20Jiao&amp;author=C.%20Wang&amp;author=J.%20Yang&amp;author=W.%20Yang&amp;journal=Biomedicine%20%26%20pharmacotherapy%20%3D%20Biomedecine%20%26%20pharmacotherapie&amp;volume=83&amp;pages=1398-1406&amp;publication_year=2016"><span><span>Google Scholar</span></span></a></span></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR38" itemprop="citation" itemscope="" itemtype="http://schema.org/ScholarlyArticle"><span itemprop="headline">Fischer KR, Durrans A, Lee S, Sheng J, Li F, Wong ST, Choi H, El Rayes T, Ryu S, Troeger J, et al. Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance. Nature. 2015;527:472–6.</span><span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a target="_blank" rel="noopener" href="https://doi.org/10.1038/nature15748"><span><span>View Article</span></span></a></span><span class="Occurrence OccurrencePID"><a target="_blank" rel="noopener nofollow" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=26560033"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrencePMCID"><a target="_blank" rel="noopener nofollow" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4662610"><span><span>PubMed Central</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener" href="http://scholar.google.com/scholar_lookup?title=Epithelial-to-mesenchymal%20transition%20is%20not%20required%20for%20lung%20metastasis%20but%20contributes%20to%20chemoresistance&amp;author=KR.%20Fischer&amp;author=A.%20Durrans&amp;author=S.%20Lee&amp;author=J.%20Sheng&amp;author=F.%20Li&amp;author=ST.%20Wong&amp;author=H.%20Choi&amp;author=T.%20El%20Rayes&amp;author=S.%20Ryu&amp;author=J.%20Troeger&amp;journal=Nature&amp;volume=527&amp;pages=472-476&amp;publication_year=2015"><span><span>Google Scholar</span></span></a></span></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR39" itemprop="citation" itemscope="" itemtype="http://schema.org/ScholarlyArticle"><span itemprop="headline">Rane JK, Ylipaa A, Adamson R, Mann VM, Simms MS, Collins AT, Visakorpi T, Nykter M, Maitland NJ. Construction of therapeutically relevant human prostate epithelial fate map by utilising miRNA and mRNA microarray expression data. Br J Cancer. 2015;113:611–5.</span><span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a target="_blank" rel="noopener" href="https://doi.org/10.1038/bjc.2015.262"><span><span>View Article</span></span></a></span><span class="Occurrence OccurrencePID"><a target="_blank" rel="noopener nofollow" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=26203762"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrencePMCID"><a target="_blank" rel="noopener nofollow" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4647689"><span><span>PubMed Central</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener" href="http://scholar.google.com/scholar_lookup?title=Construction%20of%20therapeutically%20relevant%20human%20prostate%20epithelial%20fate%20map%20by%20utilising%20miRNA%20and%20mRNA%20microarray%20expression%20data&amp;author=JK.%20Rane&amp;author=A.%20Ylipaa&amp;author=R.%20Adamson&amp;author=VM.%20Mann&amp;author=MS.%20Simms&amp;author=AT.%20Collins&amp;author=T.%20Visakorpi&amp;author=M.%20Nykter&amp;author=NJ.%20Maitland&amp;journal=Br%20J%20Cancer&amp;volume=113&amp;pages=611-615&amp;publication_year=2015"><span><span>Google Scholar</span></span></a></span></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR40" itemprop="citation" itemscope="" itemtype="http://schema.org/ScholarlyArticle"><span itemprop="headline">Faraonio R, Salerno P, Passaro F, Sedia C, Iaccio A, Bellelli R, Nappi TC, Comegna M, Romano S, Salvatore G, et al. A set of miRNAs participates in the cellular senescence program in human diploid fibroblasts. Cell Death Differ. 2012;19:713–21.</span><span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a target="_blank" rel="noopener" href="https://doi.org/10.1038/cdd.2011.143"><span><span>View Article</span></span></a></span><span class="Occurrence OccurrencePID"><a target="_blank" rel="noopener nofollow" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=22052189"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener" href="http://scholar.google.com/scholar_lookup?title=A%20set%20of%20miRNAs%20participates%20in%20the%20cellular%20senescence%20program%20in%20human%20diploid%20fibroblasts&amp;author=R.%20Faraonio&amp;author=P.%20Salerno&amp;author=F.%20Passaro&amp;author=C.%20Sedia&amp;author=A.%20Iaccio&amp;author=R.%20Bellelli&amp;author=TC.%20Nappi&amp;author=M.%20Comegna&amp;author=S.%20Romano&amp;author=G.%20Salvatore&amp;journal=Cell%20Death%20Differ&amp;volume=19&amp;pages=713-721&amp;publication_year=2012"><span><span>Google Scholar</span></span></a></span></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR41" itemprop="citation" itemscope="" itemtype="http://schema.org/ScholarlyArticle"><span itemprop="headline">Tobin LA, Robert C, Nagaria P, Chumsri S, Twaddell W, Ioffe OB, Greco GE, Brodie AH, Tomkinson AE, Rassool FV. Targeting abnormal DNA repair in therapy-resistant breast cancers. Molecular cancer research : MCR. 2012;10:96–107.</span><span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a target="_blank" rel="noopener" href="https://doi.org/10.1158/1541-7786.MCR-11-0255"><span><span>View Article</span></span></a></span><span class="Occurrence OccurrencePID"><a target="_blank" rel="noopener nofollow" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=22112941"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener" href="http://scholar.google.com/scholar_lookup?title=Targeting%20abnormal%20DNA%20repair%20in%20therapy-resistant%20breast%20cancers&amp;author=LA.%20Tobin&amp;author=C.%20Robert&amp;author=P.%20Nagaria&amp;author=S.%20Chumsri&amp;author=W.%20Twaddell&amp;author=OB.%20Ioffe&amp;author=GE.%20Greco&amp;author=AH.%20Brodie&amp;author=AE.%20Tomkinson&amp;author=FV.%20Rassool&amp;journal=Molecular%20cancer%20research%20%3A%20MCR&amp;volume=10&amp;pages=96-107&amp;publication_year=2012"><span><span>Google Scholar</span></span></a></span></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR42" itemprop="citation" itemscope="" itemtype="http://schema.org/ScholarlyArticle"><span itemprop="headline">Berindan-Neagoe I, Monroig Pdel C, Pasculli B, Calin GA. MicroRNAome genome: a treasure for cancer diagnosis and therapy. CA Cancer J Clin. 2014;64:311–36.</span><span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a target="_blank" rel="noopener" href="https://doi.org/10.3322/caac.21244"><span><span>View Article</span></span></a></span><span class="Occurrence OccurrencePID"><a target="_blank" rel="noopener nofollow" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=25104502"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrencePMCID"><a target="_blank" rel="noopener nofollow" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4461198"><span><span>PubMed Central</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener" href="http://scholar.google.com/scholar_lookup?title=MicroRNAome%20genome%3A%20a%20treasure%20for%20cancer%20diagnosis%20and%20therapy&amp;author=I.%20Berindan-Neagoe&amp;author=C.%20Monroig%20Pdel&amp;author=B.%20Pasculli&amp;author=GA.%20Calin&amp;journal=CA%20Cancer%20J%20Clin&amp;volume=64&amp;pages=311-336&amp;publication_year=2014"><span><span>Google Scholar</span></span></a></span></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR43" itemprop="citation" itemscope="" itemtype="http://schema.org/ScholarlyArticle"><span itemprop="headline">Zhang Y, Li M, Wei L, Zhu L, Hu S, Wu S, Ma S, Gao Y. Differential protein expression in perfusates from metastasized rat livers. Proteome Sci. 2013;11:37.</span><span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a target="_blank" rel="noopener" href="https://doi.org/10.1186/1477-5956-11-37"><span><span>View Article</span></span></a></span><span class="Occurrence OccurrencePID"><a target="_blank" rel="noopener nofollow" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=23895178"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrencePMCID"><a target="_blank" rel="noopener nofollow" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3734188"><span><span>PubMed Central</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener" href="http://scholar.google.com/scholar_lookup?title=Differential%20protein%20expression%20in%20perfusates%20from%20metastasized%20rat%20livers&amp;author=Y.%20Zhang&amp;author=M.%20Li&amp;author=L.%20Wei&amp;author=L.%20Zhu&amp;author=S.%20Hu&amp;author=S.%20Wu&amp;author=S.%20Ma&amp;author=Y.%20Gao&amp;journal=Proteome%20Sci&amp;volume=11&amp;pages=37&amp;publication_year=2013"><span><span>Google Scholar</span></span></a></span></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR44" itemprop="citation" itemscope="" itemtype="http://schema.org/ScholarlyArticle"><span itemprop="headline">Akekawatchai C, Roytrakul S, Kittisenachai S, Isarankura-Na-Ayudhya P, Jitrapakdee S. Protein profiles associated with Anoikis resistance of metastatic MDA-MB-231 breast cancer cells. Asian Pacific journal of cancer prevention : APJCP. 2016;17:581–90.</span><span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a target="_blank" rel="noopener" href="https://doi.org/10.7314/APJCP.2016.17.2.581"><span><span>View Article</span></span></a></span><span class="Occurrence OccurrencePID"><a target="_blank" rel="noopener nofollow" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=26925647"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener" href="http://scholar.google.com/scholar_lookup?title=Protein%20profiles%20associated%20with%20Anoikis%20resistance%20of%20metastatic%20MDA-MB-231%20breast%20cancer%20cells&amp;author=C.%20Akekawatchai&amp;author=S.%20Roytrakul&amp;author=S.%20Kittisenachai&amp;author=P.%20Isarankura-Na-Ayudhya&amp;author=S.%20Jitrapakdee&amp;journal=Asian%20Pacific%20journal%20of%20cancer%20prevention%20%3A%20APJCP&amp;volume=17&amp;pages=581-590&amp;publication_year=2016"><span><span>Google Scholar</span></span></a></span></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR45" itemprop="citation" itemscope="" itemtype="http://schema.org/ScholarlyArticle"><span itemprop="headline">Tilli TM, Carels N, Tuszynski JA, Pasdar M. Validation of a network-based strategy for the optimization of combinatorial target selection in breast cancer therapy: siRNA knockdown of network targets in MDA-MB-231 cells as an in vitro model for inhibition of tumor development. Oncotarget. 2016;7:63189–203.</span><span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a target="_blank" rel="noopener" href="https://doi.org/10.18632/oncotarget.11055"><span><span>View Article</span></span></a></span><span class="Occurrence OccurrencePID"><a target="_blank" rel="noopener nofollow" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=27527857"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrencePMCID"><a target="_blank" rel="noopener nofollow" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5325356"><span><span>PubMed Central</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener" href="http://scholar.google.com/scholar_lookup?title=Validation%20of%20a%20network-based%20strategy%20for%20the%20optimization%20of%20combinatorial%20target%20selection%20in%20breast%20cancer%20therapy%3A%20siRNA%20knockdown%20of%20network%20targets%20in%20MDA-MB-231%20cells%20as%20an%20in%20vitro%20model%20for%20inhibition%20of%20tumor%20development&amp;author=TM.%20Tilli&amp;author=N.%20Carels&amp;author=JA.%20Tuszynski&amp;author=M.%20Pasdar&amp;journal=Oncotarget&amp;volume=7&amp;pages=63189-63203&amp;publication_year=2016"><span><span>Google Scholar</span></span></a></span></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR46" itemprop="citation" itemscope="" itemtype="http://schema.org/ScholarlyArticle"><span itemprop="headline">Graham DB, Bell MP, McCausland MM, Huntoon CJ, van Deursen J, Faubion WA, Crotty S, McKean DJ. Ly9 (CD229)-deficient mice exhibit T cell defects yet do not share several phenotypic characteristics associated with SLAM- and SAP-deficient mice. J Immunol. 2006;176:291–300.</span><span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a target="_blank" rel="noopener" href="https://doi.org/10.4049/jimmunol.176.1.291"><span><span>View Article</span></span></a></span><span class="Occurrence OccurrencePID"><a target="_blank" rel="noopener nofollow" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=16365421"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener" href="http://scholar.google.com/scholar_lookup?title=Ly9%20%28CD229%29-deficient%20mice%20exhibit%20T%20cell%20defects%20yet%20do%20not%20share%20several%20phenotypic%20characteristics%20associated%20with%20SLAM-%20and%20SAP-deficient%20mice&amp;author=DB.%20Graham&amp;author=MP.%20Bell&amp;author=MM.%20McCausland&amp;author=CJ.%20Huntoon&amp;author=J.%20van%20Deursen&amp;author=WA.%20Faubion&amp;author=S.%20Crotty&amp;author=DJ.%20McKean&amp;journal=J%20Immunol&amp;volume=176&amp;pages=291-300&amp;publication_year=2006"><span><span>Google Scholar</span></span></a></span></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR47" itemprop="citation" itemscope="" itemtype="http://schema.org/ScholarlyArticle"><span itemprop="headline">Hagberg N, Theorell J, Schlums H, Eloranta ML, Bryceson YT, Ronnblom L. Systemic lupus erythematosus immune complexes increase the expression of SLAM family members CD319 (CRACC) and CD229 (LY-9) on plasmacytoid dendritic cells and CD319 on CD56(dim) NK cells. J Immunol. 2013;191:2989–98.</span><span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a target="_blank" rel="noopener" href="https://doi.org/10.4049/jimmunol.1301022"><span><span>View Article</span></span></a></span><span class="Occurrence OccurrencePID"><a target="_blank" rel="noopener nofollow" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=23956418"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener" href="http://scholar.google.com/scholar_lookup?title=Systemic%20lupus%20erythematosus%20immune%20complexes%20increase%20the%20expression%20of%20SLAM%20family%20members%20CD319%20%28CRACC%29%20and%20CD229%20%28LY-9%29%20on%20plasmacytoid%20dendritic%20cells%20and%20CD319%20on%20CD56%28dim%29%20NK%20cells&amp;author=N.%20Hagberg&amp;author=J.%20Theorell&amp;author=H.%20Schlums&amp;author=ML.%20Eloranta&amp;author=YT.%20Bryceson&amp;author=L.%20Ronnblom&amp;journal=J%20Immunol&amp;volume=191&amp;pages=2989-2998&amp;publication_year=2013"><span><span>Google Scholar</span></span></a></span></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR48" itemprop="citation" itemscope="" itemtype="http://schema.org/ScholarlyArticle"><span itemprop="headline">Kong LY, Xue M, Zhang QC, CF S. In vivo and in vitro effects of microRNA-27a on proliferation, migration and invasion of breast cancer cells through targeting of SFRP1 gene via Wnt/beta-catenin signaling pathway. Oncotarget. 2017;8:15507–19.</span><span class="Occurrences"><span class="Occurrence OccurrencePID"><a target="_blank" rel="noopener nofollow" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=28099945"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrencePMCID"><a target="_blank" rel="noopener nofollow" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5362502"><span><span>PubMed Central</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener" href="http://scholar.google.com/scholar_lookup?title=In%20vivo%20and%20in%20vitro%20effects%20of%20microRNA-27a%20on%20proliferation%2C%20migration%20and%20invasion%20of%20breast%20cancer%20cells%20through%20targeting%20of%20SFRP1%20gene%20via%20Wnt%2Fbeta-catenin%20signaling%20pathway&amp;author=LY.%20Kong&amp;author=M.%20Xue&amp;author=QC.%20Zhang&amp;author=S.%20CF&amp;journal=Oncotarget&amp;volume=8&amp;pages=15507-15519&amp;publication_year=2017"><span><span>Google Scholar</span></span></a></span></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR49" itemprop="citation" itemscope="" itemtype="http://schema.org/ScholarlyArticle"><span itemprop="headline">Cooper SJ, von Roemeling CA, Kang KH, Marlow LA, Grebe SK, Menefee ME, Tun HW, Colon-Otero G, Perez EA, Copland JA. Reexpression of tumor suppressor, sFRP1, leads to antitumor synergy of combined HDAC and methyltransferase inhibitors in chemoresistant cancers. Mol Cancer Ther. 2012;11:2105–15.</span><span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a target="_blank" rel="noopener" href="https://doi.org/10.1158/1535-7163.MCT-11-0873"><span><span>View Article</span></span></a></span><span class="Occurrence OccurrencePID"><a target="_blank" rel="noopener nofollow" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=22826467"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrencePMCID"><a target="_blank" rel="noopener nofollow" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3928542"><span><span>PubMed Central</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener" href="http://scholar.google.com/scholar_lookup?title=Reexpression%20of%20tumor%20suppressor%2C%20sFRP1%2C%20leads%20to%20antitumor%20synergy%20of%20combined%20HDAC%20and%20methyltransferase%20inhibitors%20in%20chemoresistant%20cancers&amp;author=SJ.%20Cooper&amp;author=CA.%20von%20Roemeling&amp;author=KH.%20Kang&amp;author=LA.%20Marlow&amp;author=SK.%20Grebe&amp;author=ME.%20Menefee&amp;author=HW.%20Tun&amp;author=G.%20Colon-Otero&amp;author=EA.%20Perez&amp;author=JA.%20Copland&amp;journal=Mol%20Cancer%20Ther&amp;volume=11&amp;pages=2105-2115&amp;publication_year=2012"><span><span>Google Scholar</span></span></a></span></span></cite></li><li class="Citation"><cite class="CitationContent" id="CR50" itemprop="citation" itemscope="" itemtype="http://schema.org/ScholarlyArticle"><span itemprop="headline">Atschekzei F, Hennenlotter J, Janisch S, Grosshennig A, Trankenschuh W, Waalkes S, Peters I, Dork T, Merseburger AS, Stenzl A, et al. SFRP1 CpG island methylation locus is associated with renal cell cancer susceptibility and disease recurrence. Epigenetics. 2012;7:447–57.</span><span class="Occurrences"><span class="Occurrence OccurrenceDOI"><a target="_blank" rel="noopener" href="https://doi.org/10.4161/epi.19614"><span><span>View Article</span></span></a></span><span class="Occurrence OccurrencePID"><a target="_blank" rel="noopener nofollow" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=22419128"><span><span>PubMed</span></span></a></span><span class="Occurrence OccurrenceGS"><a target="_blank" rel="noopener" href="http://scholar.google.com/scholar_lookup?title=SFRP1%20CpG%20island%20methylation%20locus%20is%20associated%20with%20renal%20cell%20cancer%20susceptibility%20and%20disease%20recurrence&amp;author=F.%20Atschekzei&amp;author=J.%20Hennenlotter&amp;author=S.%20Janisch&amp;author=A.%20Grosshennig&amp;author=W.%20Trankenschuh&amp;author=S.%20Waalkes&amp;author=I.%20Peters&amp;author=T.%20Dork&amp;author=AS.%20Merseburger&amp;author=A.%20Stenzl&amp;journal=Epigenetics&amp;volume=7&amp;pages=447-457&amp;publication_year=2012"><span><span>Google Scholar</span></span></a></span></span></cite></li></ol></div></section><section xmlns="" xmlns:fn="http://www.w3.org/2005/xpath-functions" xmlns:meta="http://www.springer.com/app/meta" class="Section1 RenderAsSection1 c-section" id="CopyrightMessage"><h2 class="Heading js-ToggleCollapseSection c-section__heading" data-sticky-update="true"><a href="#TheAuthors" data-toggle="collapse" data-toggle-disable-clickoff="" data-target="TheAuthors">Copyright</a></h2><div class="js-CollapseSection CollapseSection c-section__content" data-test="collapse-section" id="TheAuthors"><div xmlns="http://www.w3.org/1999/xhtml" class="ArticleCopyright">©&nbsp;The Author(s)&nbsp;2018</div></div></section></div>
                        


                    </article>
                </main>

                <div class="c-content-layout__side u-text-sm">
                    <aside>
                        <div class="p-separator">
                            
        <p class="u-margin-bottom-sm">
            <a id="articlePdf" data-test="download-pdf" class="c-button c-button--primary c-button--full-width" target="_blank" rel="noopener" href="//hereditasjournal.biomedcentral.com/track/pdf/10.1186/s41065-018-0055-7" data-track="click" data-track-category="PDF Download"
            data-track-action="Click download article PDF"
            data-track-label="10.1186/s41065-018-0055-7">Download PDF</a>
        </p>
    
                            
                            
    <button type="button"
       class="c-button c-button--secondary c-button--full-width c-button--expandable"
       data-toggle="collapse"
       data-target="export-citations"
       data-test="export-citations-button"
       data-sticky-update="true"
       aria-controls="export-citations"
       aria-expanded="false">
        <span class="c-dropdown__toggle">Export citations</span>
    </button>
    <div id="export-citations" class="c-export-citations" data-test="export-citations-content">
        <div class="c-export-citations__section">
            <h4 class="c-export-citations__title">Papers, Zotero, Reference Manager, RefWorks (<strong>.RIS</strong>)</h4>
            <ul class="c-export-citations__list" id="articleReferences">
                <li><a data-track="click" data-track-category="Article Page" data-track-action="Download Papers, Zotero, Reference Manager, RefWorks article citations" data-track-label="10.1186/s41065-018-0055-7"
                       href="http://citation-needed.springer.com/v2/references/10.1186/s41065-018-0055-7?format=refman&flavour=citation">
                    <svg class="c-export-citations__icon" width="12" height="12" aria-hidden="true">
                        <use xlink:href="#icon-download"></use>
                    </svg>
                    <span class="u-visually-hidden">Download </span>Citations
                </a></li>
                <li><a data-track="click" data-track-category="Article Page" data-track-action="Download Papers, Zotero, Reference Manager, RefWorks references" data-track-label="10.1186/s41065-018-0055-7"
                       href="http://citation-needed.springer.com/v2/references/10.1186/s41065-018-0055-7?format=refman&flavour=references">
                    <svg class="c-export-citations__icon" width="12" height="12" aria-hidden="true">
                        <use xlink:href="#icon-download"></use>
                    </svg>
                    <span class="u-visually-hidden">Download </span>References
                </a></li>
                <li><a data-track="click" data-track-category="Article Page" data-track-action="Download Papers, Zotero, Reference Manager, RefWorks citations and references" data-track-label="10.1186/s41065-018-0055-7"
                       href="http://citation-needed.springer.com/v2/references/10.1186/s41065-018-0055-7?format=refman&flavour=full">
                    <svg class="c-export-citations__icon" width="12" height="12" aria-hidden="true">
                        <use xlink:href="#icon-download"></use>
                    </svg>
                    <span class="u-visually-hidden">Download </span>Both
                </a></li>
            </ul>
        </div>
        <div class="c-export-citations__section">
            <h4 class="c-export-citations__title">EndNote (<strong>.ENW</strong>)</h4>
            <ul class="c-export-citations__list">
                <li><a data-track="click" data-track-category="Article Page" data-track-action="Download EndNote article citations" data-track-label="10.1186/s41065-018-0055-7"
                       href="http://citation-needed.springer.com/v2/references/10.1186/s41065-018-0055-7?format=endnote&flavour=citation">
                    <svg class="c-export-citations__icon" width="12" height="12" aria-hidden="true">
                        <use xlink:href="#icon-download"></use>
                    </svg>
                    <span class="u-visually-hidden">Download </span>Citations
                </a></li>
                <li><a data-track="click" data-track-category="Article Page" data-track-action="Download EndNote references" data-track-label="10.1186/s41065-018-0055-7"
                       href="http://citation-needed.springer.com/v2/references/10.1186/s41065-018-0055-7?format=endnote&flavour=references">
                    <svg class="c-export-citations__icon" width="12" height="12" aria-hidden="true">
                        <use xlink:href="#icon-download"></use>
                    </svg>
                    <span class="u-visually-hidden">Download </span>References
                </a></li>
                <li><a data-track="click" data-track-category="Article Page" data-track-action="Download EndNote citations and references" data-track-label="10.1186/s41065-018-0055-7"
                       href="http://citation-needed.springer.com/v2/references/10.1186/s41065-018-0055-7?format=endnote&flavour=full">
                    <svg class="c-export-citations__icon" width="12" height="12" aria-hidden="true">
                        <use xlink:href="#icon-download"></use>
                    </svg>
                    <span class="u-visually-hidden">Download </span>Both
                </a></li>
            </ul>
        </div>
        <div class="c-export-citations__section">
            <h4 class="c-export-citations__title">Mendeley, JabRef (<strong>.BIB</strong>)</h4>
            <ul class="c-export-citations__list">
                <li><a data-track="click" data-track-category="Article Page" data-track-action="Download Mendeley, JabRef article citations" data-track-label="10.1186/s41065-018-0055-7"
                       href="http://citation-needed.springer.com/v2/references/10.1186/s41065-018-0055-7?format=bibtex&flavour=citation">
                    <svg class="c-export-citations__icon" width="12" height="12" aria-hidden="true">
                        <use xlink:href="#icon-download"></use>
                    </svg>
                    <span class="u-visually-hidden">Download </span>Citations
                </a></li>
                <li><a data-track="click" data-track-category="Article Page" data-track-action="Download Mendeley, JabRef references" data-track-label="10.1186/s41065-018-0055-7"
                       href="http://citation-needed.springer.com/v2/references/10.1186/s41065-018-0055-7?format=bibtex&flavour=references">
                    <svg class="c-export-citations__icon" width="12" height="12" aria-hidden="true">
                        <use xlink:href="#icon-download"></use>
                    </svg>
                    <span class="u-visually-hidden">Download </span>References
                </a></li>
                <li><a data-track="click" data-track-category="Article Page" data-track-action="Download Mendeley, JabRef citations and references" data-track-label="10.1186/s41065-018-0055-7"
                       href="http://citation-needed.springer.com/v2/references/10.1186/s41065-018-0055-7?format=bibtex&flavour=full">
                    <svg class="c-export-citations__icon" width="12" height="12" aria-hidden="true">
                        <use xlink:href="#icon-download"></use>
                    </svg>
                    <span class="u-visually-hidden">Download </span>Both
                </a></li>
            </ul>
        </div>
    </div>

                        </div>
                        
    
 
                        
    
 
                        <div class="p-separator">
                            <h3 class="p-section-title">Metrics</h3>
                            <ul class="c-list-group c-list-group--md">
                                <div id="article-access-count-loader" class="placeholder" data-replace="true" data-placeholder="/placeholder/v1/article/access-count/10.1186/s41065-018-0055-7 #accessCount-container"></div>
                                <div id="citation-count-loader" class="placeholder" data-replace="true" data-placeholder="/placeholder/v1/article/citation-count/10.1186/s41065-018-0055-7 #count-container"></div>
                                <div id="altmetric-loader" class="placeholder" data-replace="true" data-placeholder="/placeholder/v1/article/altmetric/10.1186/s41065-018-0055-7 #altmetric-container"></div>
                            </ul>
                        </div>
                        
    <div id="sociaMediaShare" class="p-separator u-js-shown">
        <h3 class="p-section-title">Share this article</h3>
        <ul id="shareButtons" class="c-social-links">
            <li class="c-social-links__item">
                <button id="shareOnTwitter" class="js-btnShareOnTwitter" data-track="click"
                        data-track-category="Article Page" data-track-action="Share Twitter" data-track-label="10.1186/s41065-018-0055-7">
                    <span class="u-visually-hidden">Share on Twitter</span>
                    <svg class="c-icon c-social-links__icon" width="24" height="24" aria-hidden="true">
                        <use xlink:href="#icon-twitter"></use>
                    </svg>
                </button>
            </li>
            <li class="c-social-links__item">
                <button id="shareOnFacebook" class="js-btnShareOnFacebook" data-track="click"
                        data-track-category="Article Page" data-track-action="Share Facebook" data-track-label="10.1186/s41065-018-0055-7">
                    <span class="u-visually-hidden">Share on Facebook</span>
                    <svg class="c-icon c-social-links__icon" width="24" height="24" aria-hidden="true">
                        <use xlink:href="#icon-facebook"></use>
                    </svg>
                </button>
            </li>
            <li class="c-social-links__item">
                <button id="shareOnLinkedIn" class="js-btnShareOnLinkedIn" data-track="click"
                        data-track-category="Article Page" data-track-action="Share LinkedIn" data-track-label="10.1186/s41065-018-0055-7">
                    <span class="u-visually-hidden">Share on LinkedIn</span>
                    <svg class="c-icon c-social-links__icon" width="24" height="24" aria-hidden="true">
                        <use xlink:href="#icon-linkedin"></use>
                    </svg>
                </button>
            </li>
            <li class="c-social-links__item">
                <button id="shareOnWeibo" class="js-btnShareOnWeibo" data-track="click"
                        data-track-category="Article Page" data-track-action="Share Weibo" data-track-label="10.1186/s41065-018-0055-7">
                    <span class="u-visually-hidden">Share on Weibo</span>
                    <svg class="c-icon c-social-links__icon" width="24" height="24" aria-hidden="true">
                        <use xlink:href="#icon-weibo"></use>
                    </svg>
                </button>
            </li>
            <li class="c-social-links__item">
                <button id="shareOnGooglePlus" class="js-btnShareOnGplus" data-track="click"
                        data-track-category="Article Page" data-track-action="Share Google+" data-track-label="10.1186/s41065-018-0055-7">
                    <span class="u-visually-hidden">Share on Google Plus</span>
                    <svg class="c-icon c-social-links__icon" width="24" height="24" aria-hidden="true">
                        <use xlink:href="#icon-gplus"></use>
                    </svg>
                </button>
            </li>
            <li class="c-social-links__item">
                <button id="shareOnReddit" class="js-btnShareOnReddit" data-track="click"
                        data-track-category="Article Page" data-track-action="Share Reddit" data-track-label="10.1186/s41065-018-0055-7">
                    <span class="u-visually-hidden">Share on Reddit</span>
                    <svg class="c-icon c-social-links__icon" width="24" height="24" aria-hidden="true">
                        <use xlink:href="#icon-reddit"></use>
                    </svg>
                </button>
            </li>
        </ul>
    </div>
 
                        
    
        <div class="p-separator u-js-shown">
            <h3 class="p-section-title">See updates</h3>
            <button class="c-crossmark-button" data-target="crossmark" data-test="crossmark" data-track="click" data-track-category="Article Page" data-track-action="Click CrossMark" data-track-label="10.1186/s41065-018-0055-7">
                <img id="crossmark-icon" src="https://crossmark-cdn.crossref.org/widget/v2.0/logos/CROSSMARK_Color_horizontal.svg" alt="Crossmark logo" />
            </button>
        </div>
    
 
                        <div class="p-separator">
                            <h3 class="p-section-title">Other Actions</h3>
                            <ul class="c-list-group c-list-group--bordered c-list-group c-list-group--md">
                                <li class="c-list-group__item">
                                    
    <a data-track="click" data-track-category="Article Page" data-track-action="Order article reprints" data-track-label="10.1186/s41065-018-0055-7" href="https://www.odysseypress.com/onlinehost/reprint_order.php?type=A&page=0&journal=738&doi=10.1186%2Fs41065-018-0055-7&volume=155&issue=1&title=Bioinformatics-based+identification+of+miR-542-5p+as+a+predictive+biomarker+in+breast+cancer+therapy&author_name=Qiong-Ni+Zhu&start_page=1&end_page=11">Order reprint</a>

                                </li>
                            </ul>
                        </div>
                    </aside>
                    
    <div id="FulltextAd" class="adsbox c-ad c-ad--skyscraper">
        <div class="c-ad__inner" data-component="sticky" data-test="fulltext-ad">
            <p class="c-ad__label">Advertisement</p>
            <div class="c-ad__content">
                <span id="pbgrd-43415139"></span>
            </div>
        </div>
    </div>

                </div>
            </div>
        </div>


        
            <div class="c-journal-footer">
                <div class="c-journal-footer__inner">
                    <div class="c-journal-footer__summary">
                        <h4 class="c-journal-title c-journal-title--footer">
                            
                            <span class="c-journal-title__text">Hereditas</span>
                        </h4>
                        <p class="c-journal-footer__issn">ISSN: 1601-5223</p>
                    </div>
                    
                        <div class="c-journal-footer__contact">
                            <h4 class="c-journal-footer__contact-title ">Contact us</h4>
                            <ul class="c-journal-footer__contact-list">
                                
                                    <li class="c-journal-footer__contact-item">Submission enquiries: <a href="https://www.editorialmanager.com/here/" target="_blank">Access here and click Contact Us</a></li>
                                
                                
                                    <li class="c-journal-footer__contact-item">General enquiries: <a href="mailto:info@biomedcentral.com">info@biomedcentral.com</a></li>
                                
                            </ul>
                        </div>
                    
                </div>
            </div>
        
        
    <img rel="nofollow" class='tracker' style='display:none' src='/track/article/10.1186/s41065-018-0055-7' alt=""/>

         
    <footer>
        <div class="ctx-publisher-footer">
    <div class="c-navbar">
        <div class="u-container">
            <div class="c-navbar__logo u-margin-right-xl">
                <a href="https://www.biomedcentral.com">
                    <img src=/static/images/bmc/logos/logo-bmc-aj-594e03e20d.svg alt="BMC logo" data-test="navbar-logo-footer">

                </a>
            </div>
            <div class="c-navbar__content">
                
    <ul class="c-navbar__nav" data-test="publisher-navigation">
        
        <li class="c-navbar__item">
            <a class="c-navbar__link" href="//www.biomedcentral.com/journals">
                Explore journals
            </a>
        </li>
        
        <li class="c-navbar__item">
            <a class="c-navbar__link" href="//www.biomedcentral.com/getpublished">
                Get published
            </a>
        </li>
        
        <li class="c-navbar__item">
            <a class="c-navbar__link" href="//www.biomedcentral.com/about">
                About BMC
            </a>
        </li>
        
    </ul>


            </div>
        </div>
    </div>
    <div class="c-publisher-footer" data-test="publisher-footer">
        <div class="u-container">
            
            <div class="c-flex c-flex--wrap c-flex--space-between" role="navigation" data-test="publisher-footer-menu">
                <div class="c-flex" aria-label="Publisher footer links">
                    
                        
                            <ul class="c-list-group c-list-group--sm u-margin-right-lg u-margin-bottom-md">
                                
                                    <li class="c-list-group__item">
                                        <a class="u-text-inherit" href="http://blogs.biomedcentral.com/">Read more on our blogs</a>
                                    </li>
                                
                                    <li class="c-list-group__item">
                                        <a class="u-text-inherit" href="//www.biomedcentral.com/login">Receive BMC newsletters</a>
                                    </li>
                                
                                    <li class="c-list-group__item">
                                        <a class="u-text-inherit" href="//www.biomedcentral.com/account">Manage article alerts</a>
                                    </li>
                                
                                    <li class="c-list-group__item">
                                        <a class="u-text-inherit" href="https://authorservices.springernature.com/go/10BMC">Language editing for authors</a>
                                    </li>
                                
                                    <li class="c-list-group__item">
                                        <a class="u-text-inherit" href="http://authorservices.springernature.com/scientific-editing/">Scientific editing for authors</a>
                                    </li>
                                
                            </ul>
                        
                            <ul class="c-list-group c-list-group--sm u-margin-right-lg u-margin-bottom-md">
                                
                                    <li class="c-list-group__item">
                                        <a class="u-text-inherit" href="//www.biomedcentral.com/about/policies">Policies</a>
                                    </li>
                                
                                    <li class="c-list-group__item">
                                        <a class="u-text-inherit" href="//www.biomedcentral.com/accessibility">Accessibility</a>
                                    </li>
                                
                                    <li class="c-list-group__item">
                                        <a class="u-text-inherit" href="//www.biomedcentral.com/about/press-centre">Press center</a>
                                    </li>
                                
                            </ul>
                        
                            <ul class="c-list-group c-list-group--sm u-margin-right-lg u-margin-bottom-md">
                                
                                    <li class="c-list-group__item">
                                        <a class="u-text-inherit" href="//www.biomedcentral.com/about/contact-us">Contact us</a>
                                    </li>
                                
                                    <li class="c-list-group__item">
                                        <a class="u-text-inherit" href="https://biomedcentral.typeform.com/to/VLXboo">Leave feedback</a>
                                    </li>
                                
                                    <li class="c-list-group__item">
                                        <a class="u-text-inherit" href="//www.biomedcentral.com/about/jobs">Careers</a>
                                    </li>
                                
                            </ul>
                        
                    
                </div>
                <div class="u-margin-bottom-lg">
                    <h3 id="social-menu" class="u-text-sm u-reset-margin u-text-normal">Follow BMC</h3>
                    <ul class="c-flex u-reset-list" data-test="footer-social-links">
                        
                            <li class="u-margin-top-xs u-margin-right-xs">
                                <a href="https://twitter.com/biomedcentral"
                                   class="u-text-inherit"
                                   data-track="click"
                                   data-track-action="Click Twitter link"
                                   data-track-category="Publisher footer">
                                    <span class="u-visually-hidden">BMC Twitter page</span>
                                    <svg class="c-icon" width="24" height="24" aria-hidden="true">
                                        <use xlink:href="#icon-twitter-bordered"></use>
                                    </svg>
                                </a>
                            </li>
                        
                            <li class="u-margin-top-xs u-margin-right-xs">
                                <a href="https://www.facebook.com/BioMedCentral"
                                   class="u-text-inherit"
                                   data-track="click"
                                   data-track-action="Click Facebook link"
                                   data-track-category="Publisher footer">
                                    <span class="u-visually-hidden">BMC Facebook page</span>
                                    <svg class="c-icon" width="24" height="24" aria-hidden="true">
                                        <use xlink:href="#icon-facebook-bordered"></use>
                                    </svg>
                                </a>
                            </li>
                        
                            <li class="u-margin-top-xs u-margin-right-xs">
                                <a href="https://plus.google.com/106226337984152901734/"
                                   class="u-text-inherit"
                                   data-track="click"
                                   data-track-action="Click Google Plus link"
                                   data-track-category="Publisher footer">
                                    <span class="u-visually-hidden">BMC Google Plus page</span>
                                    <svg class="c-icon" width="24" height="24" aria-hidden="true">
                                        <use xlink:href="#icon-gplus-bordered"></use>
                                    </svg>
                                </a>
                            </li>
                        
                            <li class="u-margin-top-xs u-margin-right-xs">
                                <a href="http://www.weibo.com/biomedcentral"
                                   class="u-text-inherit"
                                   data-track="click"
                                   data-track-action="Click Weibo link"
                                   data-track-category="Publisher footer">
                                    <span class="u-visually-hidden">BMC Weibo page</span>
                                    <svg class="c-icon" width="24" height="24" aria-hidden="true">
                                        <use xlink:href="#icon-weibo-bordered"></use>
                                    </svg>
                                </a>
                            </li>
                        
                    </ul>
                </div>
            </div>
            <p class="u-reset-margin">
                By using this website, you agree to our
                <a class="u-text-inherit" href="//www.biomedcentral.com/terms-and-conditions">Terms and Conditions</a>,
                <a class="u-text-inherit" href="//www.biomedcentral.com/privacy-statement">Privacy
                    statement</a> and
                <a class="u-text-inherit" href="//www.biomedcentral.com/cookies" data-test="cookie-link">Cookies</a> policy.
                
                    <a class="optanon-toggle-display u-text-inherit" href="javascript:void(0);">Manage the cookies</a> we use in the preference centre.
                
            </p>
        </div>
    </div>
</div>


        <div class="c-sn-footer c-sn-footer--neutral">
    <div class="u-container">
        <img src=/static/images/bmc/logos/logo-springernature-8bd4e8d82f.svg class="c-sn-footer__logo" alt="Springer Nature Logo" itemprop="logo" >
        <p data-test="copyright">&#169; 2018 BioMed Central Ltd unless otherwise stated. Part of
            <a href="http://www.springernature.com"
               data-track="click"
               data-track-action="Click Springer Nature link"
               data-track-category="Corporate footer"
               itemscope itemtype="http://schema.org/Organization" itemid="#parentOrganization">Springer Nature</a>.
        </p>
    </div>
</div>

    </footer>

    </div>

    
    <script type="text/javascript" src="//cdn.pbgrd.com/bmc.js" async="async"></script>
    <noscript>
	<img hidden src="https://verify.nature.com/verify/nature.png" border="0" width="0" height="0" style="display: none">
</noscript>
    <!-- SpringerLink's event tracker, as per: https://github.com/springernature/springerlink-event-tracker -->

<script id="springerlink-event-tracker" src="https://event-tracker.springernature.com/dist/eventTracker.js"></script>
<script type="text/javascript">
    (function(){
        var dataLayer = window.dataLayer[0];
        var doi = dataLayer.content.article.doi;
        var imprint = dataLayer.content.contentInfo.imprint;
        var bpids = dataLayer.session.authentication.authenticationID;
        var publisher;
        var pageType = dataLayer.page.category.pageType;
        if (pageType) {
            pageType = pageType.charAt(0).toUpperCase() + pageType.substring(1);
        }
        var eventObject = {'content_type' : pageType,'doi' : doi};

        if (imprint === 'BioMed Central') { publisher = 'BMC' }
        else if (imprint === 'SpringerOpen') { publisher = 'SpringerOpen' }
        else { throw new Error('Event Tracker Error: The publisher has an unexpected value') }

        if (bpids.length > 0) {
            eventObject['business_partner_ids'] = bpids;
        }
        new EventTracker({'platform':publisher}).sendEvent('display', eventObject);
    })();
</script>


    </body>
</html>

